BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, Feng ZZ, Reddy KR, Schiff ER. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 2002;97:2614-2618. [PMID: 12385448 DOI: 10.1111/j.1572-0241.2002.06038.x] [Cited by in Crossref: 1397] [Cited by in F6Publishing: 1342] [Article Influence: 73.5] [Reference Citation Analysis]
Number Citing Articles
1 Theise ND, Bodenheimer HC, Guido M. Viral Hepatitis. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 372-415. [DOI: 10.1016/b978-0-7020-6697-9.00006-6] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Aby E, Jimenez MA, Grotts JF, Agopian V, French SW, Busuttil RW, Saab S. Diminishing Use of Liver Biopsy among Liver Transplant Recipients for Hepatitis C. J Clin Transl Hepatol 2017;5:197-202. [PMID: 28936400 DOI: 10.14218/JCTH.2016.00073] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Chen SH, Peng CY, Lai HC, Chang IP, Lee CJ, Su WP, Lin CH, Kao JT, Chuang PH. Head-to-Head Comparison between Collagen Proportionate Area and Acoustic Radiation Force Impulse Elastography in Liver Fibrosis Quantification in Chronic Hepatitis C. PLoS One. 2015;10:e0140554. [PMID: 26461105 DOI: 10.1371/journal.pone.0140554pone-d-15-32031] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Yao M, Wang L, Leung PSC, Li Y, Liu S, Wang L, Guo X, Zhou G, Yan Y, Guan G, Chen X, Bowlus CL, Liu T, Jia J, Gershwin ME, Ma X, Zhao J, Lu F. The Clinical Significance of GP73 in Immunologically Mediated Chronic Liver Diseases: Experimental Data and Literature Review. Clin Rev Allergy Immunol. 2018;54:282-294. [PMID: 29256057 DOI: 10.1007/s12016-017-8655-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
5 Kolhe KM, Amarapurkar A, Parikh P, Chaubal A, Chauhan S, Khairnar H, Walke S, Ingle M, Pandey V, Shukla A. Aspartate transaminase to platelet ratio index (APRI) but not FIB-5 or FIB-4 is accurate in ruling out significant fibrosis in patients with non-alcoholic fatty liver disease (NAFLD) in an urban slum-dwelling population. BMJ Open Gastroenterol. 2019;6:e000288. [PMID: 31275584 DOI: 10.1136/bmjgast-2019-000288] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
6 Morrison M, Hughes HY, Naggie S, Syn WK. Nonalcoholic Fatty Liver Disease Among Individuals with HIV Mono-infection: A Growing Concern? Dig Dis Sci 2019;64:3394-401. [PMID: 31643035 DOI: 10.1007/s10620-019-05861-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Gaia S, Carenzi S, Barilli AL, Bugianesi E, Smedile A, Brunello F, Marzano A, Rizzetto M. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol. 2011;54:64-71. [PMID: 20932598 DOI: 10.1016/j.jhep.2010.06.022] [Cited by in Crossref: 158] [Cited by in F6Publishing: 152] [Article Influence: 14.4] [Reference Citation Analysis]
8 Nilsson H, Karlgren S, Blomqvist L, Jonas E. The inhomogeneous distribution of liver function: possible impact on the prediction of post-operative remnant liver function. HPB (Oxford). 2015;17:272-277. [PMID: 25297934 DOI: 10.1111/hpb.12348] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
9 Ueda N, Kawaoka T, Imamura M, Aikata H, Nakahara T, Murakami E, Tsuge M, Hiramatsu A, Hayes CN, Yokozaki M, Chayama K. Liver fibrosis assessments using FibroScan, virtual-touch tissue quantification, the FIB-4 index, and mac-2 binding protein glycosylation isomer levels compared with pathological findings of liver resection specimens in patients with hepatitis C infection. BMC Gastroenterol 2020;20:314. [PMID: 32977741 DOI: 10.1186/s12876-020-01459-w] [Reference Citation Analysis]
10 Ishibashi H, Maruyama H, Takahashi M, Shimada T, Kamesaki H, Fujiwara K, Imazeki F, Yokosuka O. Demonstration of intrahepatic accumulated microbubble on ultrasound represents the grade of hepatic fibrosis. Eur Radiol 2012;22:1083-90. [PMID: 22207268 DOI: 10.1007/s00330-011-2346-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
11 Godfrey EM, Mannelli L, Griffin N, Lomas DJ. Magnetic resonance elastography in the diagnosis of hepatic fibrosis. Semin Ultrasound CT MR. 2013;34:81-88. [PMID: 23395320 DOI: 10.1053/j.sult.2012.11.007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
12 Halfon P. Les limites du fibrotest dans la prise en charge de l’hépatite C. Gastroentérologie Clinique et Biologique 2006;30:117-20. [DOI: 10.1016/s0399-8320(06)73125-6] [Cited by in Crossref: 6] [Article Influence: 0.4] [Reference Citation Analysis]
13 Bhan I, Ting DT, Corey KE, Malhi H. Somatic Mutations in Liver Disease: Adaptation Without Carcinogenesis? Hepatology 2020;71:2162-3. [DOI: 10.1002/hep.31169] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Everson GT, Shiffman ML, Hoefs JC, Morgan TR, Sterling RK, Wagner DA, Lauriski S, Curto TM, Stoddard A, Wright EC; HALT-C Trial Group. Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: results from the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial. Hepatology. 2012;55:1019-1029. [PMID: 22030902 DOI: 10.1002/hep.24752] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
15 Godfrey EM, Patterson AJ, Priest AN, Davies SE, Joubert I, Krishnan AS, Griffin N, Shaw AS, Alexander GJ, Allison ME, Griffiths WJH, Gimson AES, Lomas DJ. A comparison of MR elastography and 31P MR spectroscopy with histological staging of liver fibrosis. Eur Radiol 2012;22:2790-7. [DOI: 10.1007/s00330-012-2527-x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.2] [Reference Citation Analysis]
16 Jensen VS, Tveden-Nyborg P, Zacho-Rasmussen C, Quaade ML, Ipsen DH, Hvid H, Fledelius C, Wulff EM, Lykkesfeldt J. Variation in diagnostic NAFLD/NASH read-outs in paired liver samples from rodent models. J Pharmacol Toxicol Methods 2020;101:106651. [PMID: 31733366 DOI: 10.1016/j.vascn.2019.106651] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
17 Gökçe S, Atbinici Z, Aycan Z, Çınar HG, Zorlu P. The Relationship Between Pediatric Nonalcoholic Fatty Liver Disease and Cardiovascular Risk Factors and Increased Risk of Atherosclerosis in Obese Children. Pediatr Cardiol 2013;34:308-15. [DOI: 10.1007/s00246-012-0447-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
18 Liu J, Zhao J, Zhang Y, Ji Y, Lin S, Dun G, Guo S. Noninvasive Assessment of Liver Fibrosis Stage Using Ultrasound-Based Shear Wave Velocity Measurements and Serum Algorithms in Patients With Viral Hepatitis B: A Retrospective Cohort Study. J Ultrasound Med. 2017;36:285-293. [PMID: 28039877 DOI: 10.7863/ultra.16.01069] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
19 Cho HJ, Seo YS, Lee KG, Hyun JJ, An H, Keum B, Kim JH, Yim HJ, Jeen YT, Lee HS, Chun HJ, Um SH, Kim CD, Ryu HS. Serum aminotransferase levels instead of etiology affects the accuracy of transient elastography in chronic viral hepatitis patients. J Gastroenterol Hepatol. 2011;26:492-500. [PMID: 21332545 DOI: 10.1111/j.1440-1746.2010.06419.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
20 Li RK, Ren XP, Yan FH, Qiang JW, Lin HM, Tao Wang, Zhao HF, Chen WB. Liver fibrosis detection and staging: a comparative study of T1ρ MR imaging and 2D real-time shear-wave elastography. Abdom Radiol (NY) 2018;43:1713-22. [PMID: 29198003 DOI: 10.1007/s00261-017-1381-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
21 Wong S, Huynh D, Zhang F, Nguyen NQ. Use of aspartate aminotransferase to platelet ratio to reduce the need for FibroScan in the evaluation of liver fibrosis. World J Hepatol 2017; 9(17): 791-796 [PMID: 28660013 DOI: 10.4254/wjh.v9.i17.791] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
22 Zhong W, Zhang F, Huang K, Zou Y, Liu Y. Development and Validation of a Nomogram Based on Noninvasive Liver Reserve and Fibrosis (PALBI and FIB-4) Model to Predict Posthepatectomy Liver Failure Grade B-C in Patients with Hepatocellular Carcinoma. J Oncol 2021;2021:6665267. [PMID: 34221013 DOI: 10.1155/2021/6665267] [Reference Citation Analysis]
23 Shehab H, Elattar I, Elbaz T, Mohey M, Esmat G. CUFA algorithm: assessment of liver fibrosis using routine laboratory data. J Viral Hepat 2014;21:956-64. [DOI: 10.1111/jvh.12270] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
24 Burrage L, Zimmerman H, Higgins S, Param K, Orme C, Mitchell J, O'Beirne J. Performance of simple serum-based tests to exclude cirrhosis prior to hepatitis C treatment in non-hospital settings in Australia. Intern Med J 2021;51:533-9. [PMID: 31994285 DOI: 10.1111/imj.14767] [Reference Citation Analysis]
25 Martin J, Khatri G, Gopal P, Singal AG. Accuracy of ultrasound and noninvasive markers of fibrosis to identify patients with cirrhosis. Dig Dis Sci. 2015;60:1841-1847. [PMID: 25586089 DOI: 10.1007/s10620-015-3531-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
26 Ghabril M, Dickson RC, Krishna M, Lloyd R, Aranda-Michel J, Keaveny A, Satyanarayana R, Bonatti H. Persistence of hepatitis C RNA in liver allografts is associated with histologic progression independent of serologic viral clearance. J Transplant 2009;2009:297528. [PMID: 20107579 DOI: 10.1155/2009/297528] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Seto WK, Lai CL, Ip PP, Fung J, Wong DK, Yuen JC, Hung IF, Yuen MF. A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B. PLoS One. 2012;7:e32622. [PMID: 22389715 DOI: 10.1371/journal.pone.0032622] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 5.3] [Reference Citation Analysis]
28 Sporea I, Şirli R, Deleanu A, Tudora A, Curescu M, Cornianu M, Lazăr D. Comparison of the liver stiffness measurement by transient elastography with the liver biopsy. World J Gastroenterol 2008; 14(42): 6513-6517 [PMID: 19030204 DOI: 10.3748/wjg.14.6513] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 33] [Article Influence: 2.2] [Reference Citation Analysis]
29 Qu Y, Li M, Hamilton G, Zhang YN, Song B. Diagnostic accuracy of hepatic proton density fat fraction measured by magnetic resonance imaging for the evaluation of liver steatosis with histology as reference standard: a meta-analysis. Eur Radiol 2019;29:5180-9. [PMID: 30877459 DOI: 10.1007/s00330-019-06071-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
30 Ferrigno A, Palladini G, Bianchi A, Rizzo V, Di Pasqua LG, Perlini S, Richelmi P, Vairetti M. Lobe-specific heterogeneity in asymmetric dimethylarginine and matrix metalloproteinase levels in a rat model of obstructive cholestasis. Biomed Res Int. 2014;2014:327537. [PMID: 25013773 DOI: 10.1155/2014/327537] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
31 Hauff P, Gottwald U, Ocker M. Early to Phase II drugs currently under investigation for the treatment of liver fibrosis. Expert Opin Investig Drugs. 2015;24:309-327. [PMID: 25547844 DOI: 10.1517/13543784.2015.997874] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
32 Sebastiani G. Non-invasive assessment of liver fibrosis in chronic liver diseases: Implementation in clinical practice and decisional algorithms. World J Gastroenterol 2009; 15(18): 2190-2203 [PMID: 19437558 DOI: 10.3748/wjg.15.2190] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 50] [Article Influence: 4.2] [Reference Citation Analysis]
33 Jayakumar S, Middleton MS, Lawitz EJ, Mantry PS, Caldwell SH, Arnold H, Mae Diehl A, Ghalib R, Elkhashab M, Abdelmalek MF, Kowdley KV, Stephen Djedjos C, Xu R, Han L, Mani Subramanian G, Myers RP, Goodman ZD, Afdhal NH, Charlton MR, Sirlin CB, Loomba R. Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib. J Hepatol. 2019;70:133-141. [PMID: 30291868 DOI: 10.1016/j.jhep.2018.09.024] [Cited by in Crossref: 84] [Cited by in F6Publishing: 82] [Article Influence: 28.0] [Reference Citation Analysis]
34 Abenavoli L, Corpechot C, Poupon R. Elastography in hepatology. Can J Gastroenterol 2007;21:839-42. [PMID: 18080057 DOI: 10.1155/2007/621489] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
35 Osakabe K, Ichino N, Nishikawa T, Sugiyama H, Kato M, Kitahara S, Hashimoto S, Kawabe N, Harata M, Nitta Y, Murao M, Nakano T, Shimazaki H, Arima Y, Suzuki K, Yoshioka K. Reduction of liver stiffness by antiviral therapy in chronic hepatitis B. J Gastroenterol. 2011;46:1324-1334. [PMID: 21822591 DOI: 10.1007/s00535-011-0444-4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.9] [Reference Citation Analysis]
36 Lens S, Torres F, Puigvehi M, Mariño Z, Londoño MC, Martinez SM, García-Juárez I, García-Criado Á, Gilabert R, Bru C, Solà R, Sanchez-Tapias JM, Carrión JA, Forns X. Predicting the development of liver cirrhosis by simple modelling in patients with chronic hepatitis C. Aliment Pharmacol Ther 2016;43:364-74. [PMID: 26582599 DOI: 10.1111/apt.13472] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
37 Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines: management of hepatitis C. Clin Mol Hepatol 2014;20:89-136. [PMID: 25032178 DOI: 10.3350/cmh.2014.20.2.89] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
38 Bedossa P, Carrat F. Liver biopsy: the best, not the gold standard. J Hepatol. 2009;50:1-3. [PMID: 19017551 DOI: 10.1016/j.jhep.2008.10.014] [Cited by in Crossref: 193] [Cited by in F6Publishing: 174] [Article Influence: 14.8] [Reference Citation Analysis]
39 Peleg N, Issachar A, Sneh-Arbib O, Shlomai A. AST to Platelet Ratio Index and fibrosis 4 calculator scores for non-invasive assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease. Dig Liver Dis. 2017;49:1133-1138. [PMID: 28572039 DOI: 10.1016/j.dld.2017.05.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
40 Theise ND, Jia J, Sun Y, Wee A, You H. Progression and regression of fibrosis in viral hepatitis in the treatment era: the Beijing classification. Mod Pathol. 2018;31:1191-1200. [PMID: 29700417 DOI: 10.1038/s41379-018-0048-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
41 Valva P, Casciato P, Diaz Carrasco JM, Gadano A, Galdame O, Galoppo MC, Mullen E, De Matteo E, Preciado MV. The role of serum biomarkers in predicting fibrosis progression in pediatric and adult hepatitis C virus chronic infection. PLoS One. 2011;6:e23218. [PMID: 21858035 DOI: 10.1371/journal.pone.0023218] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
42 Martinez SM, Fernández-Varo G, González P, Sampson E, Bruguera M, Navasa M, Jiménez W, Sánchez-Tapias JM, Forns X. Assessment of liver fibrosis before and after antiviral therapy by different serum marker panels in patients with chronic hepatitis C. Aliment Pharmacol Ther. 2011;33:138-148. [PMID: 21083589 DOI: 10.1111/j.1365-2036.2010.04500.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 5.9] [Reference Citation Analysis]
43 Hagan M, Asrani SK, Talwalkar J. Non-invasive assessment of liver fibrosis and prognosis. Expert Review of Gastroenterology & Hepatology 2015;9:1251-60. [DOI: 10.1586/17474124.2015.1075391] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
44 Verloh N, Utpatel K, Haimerl M, Zeman F, Beyer L, Fellner C, Brennfleck F, Dahlke MH, Stroszczynski C, Evert M, Wiggermann P. Detecting liver fibrosis with Gd-EOB-DTPA-enhanced MRI: A confirmatory study. Sci Rep 2018;8:6207. [PMID: 29670136 DOI: 10.1038/s41598-018-24316-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
45 Theise ND, Bodenheimer HC, Ferrell LD. Acute and chronic viral hepatitis. MacSween's Pathology of the Liver. Elsevier; 2012. pp. 361-401. [DOI: 10.1016/b978-0-7020-3398-8.00007-6] [Cited by in Crossref: 6] [Article Influence: 0.7] [Reference Citation Analysis]
46 Pockros PJ. Noninvasive Markers of Fibrosis in Chronic Hepatitis Patients: . Journal of Clinical Gastroenterology 2006;40:461-3. [DOI: 10.1097/00004836-200607000-00001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
47 Chen X, Wen H, Zhang X, Dong C, Lin H, Guo Y, Shan L, Yao S, Yang M, Le X, Liu Y. Development of a Simple Noninvasive Model to Predict Significant Fibrosis in Patients with Chronic Hepatitis B: Combination of Ultrasound Elastography, Serum Biomarkers, and Individual Characteristics. Clin Transl Gastroenterol. 2017;8:e84. [PMID: 28383564 DOI: 10.1038/ctg.2017.11] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
48 Haafiz AB. Liver fibrosis in biliary atresia. Expert Rev Gastroenterol Hepatol. 2010;4:335-343. [PMID: 20528120 DOI: 10.1586/egh.10.29] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
49 Chon YE, Jung KS, Ha Y, Kim MN, Lee JH, Hwang SG, Ahn SH, Kim DY, Han KH, Park JY. High body mass index hinders fibrosis improvement in patients receiving long-term tenofovir therapy in hepatitis B virus-related cirrhosis. J Viral Hepat 2020;27:1119-26. [PMID: 32558181 DOI: 10.1111/jvh.13345] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Schmilovitz-weiss H, Niv Y, Pappo O, Halpern M, Sulkes J, Braun M, Barak N, Rotman Y, Cohen M, Waked A, Tur-kaspa R, Ben-ari Z. The 13C-Caffeine Breath Test Detects Significant Fibrosis in Patients With Nonalcoholic Steatohepatitis. Journal of Clinical Gastroenterology 2008;42:408-12. [DOI: 10.1097/mcg.0b013e318046ea65] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
51 Chimoriya R, Piya MK, Simmons D, Ahlenstiel G, Ho V. The Use of Two-Dimensional Shear Wave Elastography in People with Obesity for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease. J Clin Med 2020;10:E95. [PMID: 33383965 DOI: 10.3390/jcm10010095] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
52 Myers RP, Elkashab M, Ma M, Crotty P, Pomier-Layrargues G. Transient elastography for the noninvasive assessment of liver fibrosis: a multicentre Canadian study. Can J Gastroenterol. 2010;24:661-670. [PMID: 21157581 DOI: 10.1155/2010/153986] [Cited by in Crossref: 37] [Cited by in F6Publishing: 45] [Article Influence: 3.7] [Reference Citation Analysis]
53 Chen HW, Chiu YL, Hsieh TY, Chen PJ, Huang TY, Lin HH, Shih YL, Lin JC. Relationships Between Vitamin D Status and Cytokine: Results from Interferon-Based Therapy in Non-Cirrhotic, Treatment-Naïve Patients with Chronic Hepatitis C Infection. J Inflamm Res 2020;13:1207-18. [PMID: 33402842 DOI: 10.2147/JIR.S283768] [Reference Citation Analysis]
54 Sterling RK, Lyons CD, Stravitz RT, Luketic VA, Sanyal AJ, Carr ME, Smith TJ, Hackney MH, Contos MJ, Mills SA, Kuhn JG, Nolte ME, Shiffman ML. Percutaneous liver biopsy in adult haemophiliacs with hepatitis C virus: safety of outpatient procedure and impact of human immunodeficiency virus coinfection on the spectrum of liver disease. Haemophilia 2007;13:164-71. [DOI: 10.1111/j.1365-2516.2006.01322.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
55 Sasso M, Tengher-Barna I, Ziol M, Miette V, Fournier C, Sandrin L, Poupon R, Cardoso AC, Marcellin P, Douvin C. Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan(®): validation in chronic hepatitis C. J Viral Hepat. 2012;19:244-253. [PMID: 22404722 DOI: 10.1111/j.1365-2893.2011.01534.x] [Cited by in Crossref: 139] [Cited by in F6Publishing: 123] [Article Influence: 13.9] [Reference Citation Analysis]
56 Chen BB, Hsu CY, Yu CW, Kao JH, Lee HS, Liang PC, Wei SY, Hwang RM, Shih TT. Hepatic necro-inflammation and elevated liver enzymes: evaluation with MRI perfusion imaging with gadoxetic acid in chronic hepatitis patients. Clin Radiol. 2014;69:473-480. [PMID: 24556468 DOI: 10.1016/j.crad.2013.12.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
57 Singh S, Venkatesh SK, Loomba R, Wang Z, Sirlin C, Chen J, Yin M, Miller FH, Low RN, Hassanein T, Godfrey EM, Asbach P, Murad MH, Lomas DJ, Talwalkar JA, Ehman RL. Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis. Eur Radiol. 2016;26:1431-1440. [PMID: 26314479 DOI: 10.1007/s00330-015-3949-z] [Cited by in Crossref: 118] [Cited by in F6Publishing: 105] [Article Influence: 19.7] [Reference Citation Analysis]
58 Lee DM, Moon EJ, Hwang JA, Lee MS, Cheong JY, Cho SW, Kim YB, Kim DJ, Hwang SG, Yang JM. Factors associated with liver stiffness in chronic liver disease. Korean J Hepatol 2009;15:464. [DOI: 10.3350/kjhep.2009.15.4.464] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
59 Picó Aliaga S, Muro Velilla D, García-martí G, Sangüesa Nebot C, Martí-bonmatí L. La elastografía mediante técnica Acoustic radiation force impulse es eficaz en la detección de fibrosis hepática en el niño. Radiología 2015;57:314-20. [DOI: 10.1016/j.rx.2014.04.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
60 Castera L. Assessing liver fibrosis. Expert Rev Gastroenterol Hepatol. 2008;2:541-552. [PMID: 19072402 DOI: 10.1586/17474124.2.4.541] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
61 Park SH, Bang CS, Kim DJ. Biomarkers in HCV Infection. Adv Clin Chem 2015;70:131-96. [PMID: 26231487 DOI: 10.1016/bs.acc.2015.03.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
62 Boddu S, Brylka D, Dutruel SP, Spincemaille P, Prince MR. Quantitative evaluation of gadoxetate hepatocyte phase homogeneity: potential imaging markers for detection of early cirrhosis. Clinical Imaging 2016;40:979-86. [DOI: 10.1016/j.clinimag.2016.05.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
63 Ku NO, Strnad P, Bantel H, Omary MB. Keratins: Biomarkers and modulators of apoptotic and necrotic cell death in the liver. Hepatology 2016;64:966-76. [PMID: 26853542 DOI: 10.1002/hep.28493] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 11.2] [Reference Citation Analysis]
64 Enomoto H, Aizawa N, Nakamura H, Sakai Y, Iwata Y, Tanaka H, Ikeda N, Aoki T, Yuri Y, Yoh K. An Increased Ratio of Glycated Albumin to HbA1c Is Associated with the Degree of Liver Fibrosis in Hepatitis B Virus-Positive Patients. Gastroenterol Res Pract. 2014;2014:351396. [PMID: 24693282 DOI: 10.1155/2014/351396] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
65 Hall A, Germani G, Isgrò G, Burroughs AK, Dhillon AP. Fibrosis distribution in explanted cirrhotic livers. Histopathology. 2012;60:270-277. [PMID: 22211285 DOI: 10.1111/j.1365-2559.2011.04094.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
66 Cheong JY, Um SH, Seo YS, Kim DJ, Hwang SG, Lee YJ, Cho M, Yang JM, Kim YB, Park YN. Non-invasive index for predicting significant liver fibrosis: comparison of diagnostic performances in patients with chronic hepatitis B and C. Dig Dis Sci. 2011;56:555-563. [PMID: 20585981 DOI: 10.1007/s10620-010-1305-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
67 El-Mezayen HA, Habib S, Marzok HF, Saad MH. Diagnostic performance of collagen IV and laminin for the prediction of fibrosis and cirrhosis in chronic hepatitis C patients: a multicenter study. Eur J Gastroenterol Hepatol. 2015;27:378-385. [PMID: 25874509 DOI: 10.1097/meg.0000000000000298] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
68 Halfon P, Bourlière M, Pénaranda G, Cacoub P. Intérêt et limites des méthodes non invasives de prédiction de la fibrose hépatique au cours de l'hépatite C: une alternative à la biopsie hépatique. La Presse Médicale 2007;36:457-66. [DOI: 10.1016/j.lpm.2007.01.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
69 Lin HC, Melin-Aldana H, Mohammad S, Ekong UD, Alonso EM. Extended follow-up of pediatric liver transplantation patients receiving once daily calcineurin inhibitor. Pediatr Transplant 2015;19:709-15. [PMID: 26256288 DOI: 10.1111/petr.12557] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
70 Li J, Tsai C, Huang H. Assessment of hepatic fatty infiltration using dual-energy computed tomography: a phantom study. Physiol Meas 2014;35:597-606. [DOI: 10.1088/0967-3334/35/4/597] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
71 Pinzani M, Rombouts K, Colagrande S. Fibrosis in chronic liver diseases: diagnosis and management. J Hepatol. 2005;42 Suppl:S22-S36. [PMID: 15777570 DOI: 10.1016/j.jhep.2004.12.008] [Cited by in Crossref: 163] [Cited by in F6Publishing: 147] [Article Influence: 9.6] [Reference Citation Analysis]
72 Imajo K, Kessoku T, Honda Y, Tomeno W, Ogawa Y, Mawatari H, Fujita K, Yoneda M, Taguri M, Hyogo H, Sumida Y, Ono M, Eguchi Y, Inoue T, Yamanaka T, Wada K, Saito S, Nakajima A. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography. Gastroenterology 2016; 150: 626-637. e7. [PMID: 26677985 DOI: 10.1053/j.gastro.2015.11.048] [Cited by in Crossref: 360] [Cited by in F6Publishing: 324] [Article Influence: 60.0] [Reference Citation Analysis]
73 Lu Y, Wang Q, Zhang T, Li J, Liu H, Yao D, Hou L, Tu B, Wang D. Staging Liver Fibrosis: Comparison of Native T1 Mapping, T2 Mapping, and T1ρ: An Experimental Study in Rats With Bile Duct Ligation and Carbon Tetrachloride at 11.7 T MRI. J Magn Reson Imaging 2021. [PMID: 34254388 DOI: 10.1002/jmri.27822] [Reference Citation Analysis]
74 Barreiro P, Martin-carbonero L, Nunez M, Rivas P, Morente A, Simarro N, Labarga P, Gonzalez-lahoz J, Soriano V. Predictors of Liver Fibrosis in HIV-Infected Patients with Chronic Hepatitis C Virus (HCV) Infection: Assessment Using Transient Elastometry and the Role of HCV Genotype 3. Clinical Infectious Diseases 2006;42:1032-9. [DOI: 10.1086/501021] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
75 Fahmy DM, Shokeir M, El Zeiny SM, Jonas MM, Abdallah A. Changes in Liver Stiffness and Noninvasive Fibrosis Scores in Egyptian Adolescents Successfully Treated with Ledipasvir-Sofosbuvir for Chronic Hepatitis C Virus Infection. J Pediatr 2021;231:110-6. [PMID: 33347957 DOI: 10.1016/j.jpeds.2020.12.031] [Reference Citation Analysis]
76 Wang HW, Peng CY, Lai HC, Su WP, Lin CH, Chuang PH, Chen SH, Chen CH, Hsu WF, Huang GT. New noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitis. Sci Rep 2017;7:3259. [PMID: 28607450 DOI: 10.1038/s41598-017-03589-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
77 Saokaew S, Kanchanasuwan S, Apisarnthanarak P, Charoensak A, Charatcharoenwitthaya P, Phisalprapa P, Chaiyakunapruk N. Clinical risk scoring for predicting non-alcoholic fatty liver disease in metabolic syndrome patients (NAFLD-MS score). Liver Int 2017;37:1535-43. [PMID: 28294515 DOI: 10.1111/liv.13413] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
78 Tamaki N, Kurosaki M, Matsuda S, Muraoka M, Yasui Y, Suzuki S, Hosokawa T, Ueda K, Tsuchiya K, Nakanishi H, Itakura J, Takahashi Y, Asahina Y, Izumi N. Non-invasive prediction of hepatocellular carcinoma development using serum fibrosis marker in chronic hepatitis C patients. J Gastroenterol. 2014;49:1495-1503. [PMID: 24337828 DOI: 10.1007/s00535-013-0914-y] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
79 Bourliere M, Penaranda G, Ouzan D, Renou C, Botta-fridlund D, Tran A, Rosenthal E, Wartelle-bladou C, Delasalle P, Oules V, Portal I, Castellani P, Lecomte L, Rosenthal-allieri MA, Halfon P. Optimized stepwise combination algorithms of non-invasive liver fibrosis scores including Hepascore in hepatitis C virus patients. Alimentary Pharmacology & Therapeutics 2008;28:458-67. [DOI: 10.1111/j.1365-2036.2008.03742.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
80 de Franchis R, Dell’Era A. Non-invasive diagnosis of cirrhosis and the natural history of its complications. Best Pract Res Clin Gastroenterol. 2007;21:3-18. [PMID: 17223493 DOI: 10.1016/j.bpg.2006.07.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
81 Caussy C, Johansson L. Magnetic resonance-based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.Endocrinol Diabetes Metab. 2020;3:e00134. [PMID: 33102797 DOI: 10.1002/edm2.134] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
82 Besa C, Bane O, Jajamovich G, Marchione J, Taouli B. 3D T1 relaxometry pre and post gadoxetic acid injection for the assessment of liver cirrhosis and liver function. Magnetic Resonance Imaging 2015;33:1075-82. [DOI: 10.1016/j.mri.2015.06.013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
83 Mueller S, Sandrin L. Liver stiffness: a novel parameter for the diagnosis of liver disease. Hepat Med. 2010;2:49-67. [PMID: 24367208 DOI: 10.2147/hmer.s7394] [Cited by in Crossref: 196] [Cited by in F6Publishing: 81] [Article Influence: 17.8] [Reference Citation Analysis]
84 Halfon P, Bourlière M, Pénaranda G, Cacoub P. [Serum markers of non-invasive fibrosis in chronic hepatitis C virus infection]. Rev Med Interne 2006;27:751-61. [PMID: 16815598 DOI: 10.1016/j.revmed.2006.03.037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
85 Qi M, Chen Y, Zhang GQ, Meng YJ, Zhao FL, Wang J, Ma J. Clinical significance of preoperative liver stiffness measurements in primary HBV-positive hepatocellular carcinoma. Future Oncol 2017;13:2799-810. [PMID: 29189041 DOI: 10.2217/fon-2017-0281] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
86 Guha I, Rosenberg W. Noninvasive Assessment of Liver Fibrosis: Serum Markers, Imaging, and Other Modalities. Clinics in Liver Disease 2008;12:883-900. [DOI: 10.1016/j.cld.2008.07.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
87 Lucidarme D, Foucher J, Le Bail B, Vergniol J, Castera L, Duburque C, Forzy G, Filoche B, Couzigou P, de Lédinghen V. Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology. 2009;49:1083-1089. [PMID: 19140221 DOI: 10.1002/hep.22748] [Cited by in Crossref: 160] [Cited by in F6Publishing: 163] [Article Influence: 13.3] [Reference Citation Analysis]
88 Wu Z, Ma AL, Xie Q, Zhang XQ, Cheng J, Zhang DZ, Wang GQ, Zhao H. Significant histological changes and satisfying antiviral efficacy in chronic hepatitis B virus infection patients with normal alanine aminotransferase. Antiviral therapy decision in chronic HBV patients with normal ALT. Clin Res Hepatol Gastroenterol 2021;45:101463. [PMID: 32571749 DOI: 10.1016/j.clinre.2020.05.011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
89 Pacifico L, Poggiogalle E, Cantisani V, Menichini G, Ricci P, Ferraro F, Chiesa C. Pediatric nonalcoholic fatty liver disease: A clinical and laboratory challenge. World J Hepatol 2010; 2(7): 275-288 [PMID: 21161009 DOI: 10.4254/wjh.v2.i7.275] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
90 Friedman SL. Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol 2010;7:425-36. [DOI: 10.1038/nrgastro.2010.97] [Cited by in Crossref: 377] [Cited by in F6Publishing: 379] [Article Influence: 34.3] [Reference Citation Analysis]
91 Ho MC, Tsui PH, Lee YH, Chen YS, Chen CN, Lin JJ, Chang CC. Early detection of liver fibrosis in rats using 3-D ultrasound Nakagami imaging: a feasibility evaluation. Ultrasound Med Biol 2014;40:2272-84. [PMID: 25023115 DOI: 10.1016/j.ultrasmedbio.2014.04.019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
92 Elbanna KY, Mansoori B, Mileto A, Rogalla P, S. Guimarães L. Dual-energy CT in diffuse liver disease: is there a role? Abdom Radiol 2020;45:3413-24. [DOI: 10.1007/s00261-020-02702-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
93 Durante-Mangoni E, Parrella A, Pafundi PC, Vitrone M, Ragone E, De Rosa I, Amarelli C, Zampino R. Liver histopathological findings in advanced heart failure: a reappraisal of cardiac cirrhosis concept. Intern Emerg Med 2019;14:931-40. [PMID: 30689135 DOI: 10.1007/s11739-019-02033-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 Poynard T, Morra R, Ingiliz P, Imbert-Bismut F, Thabut D, Messous D, Munteanu M, Massard J, Benhamou Y, Ratziu V. Assessment of liver fibrosis: noninvasive means. Saudi J Gastroenterol. 2008;14:163-173. [PMID: 19568532 DOI: 10.4103/1319-3767.43273] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
95 Idilman IS, Li J, Yin M, Venkatesh SK. MR elastography of liver: current status and future perspectives. Abdom Radiol (NY) 2020;45:3444-62. [PMID: 32705312 DOI: 10.1007/s00261-020-02656-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
96 Deng Y, Zhao H, Zhou J, Yan L, Wang G; China HepB-Related Fibrosis Assessment Research Group. Angiopoietin-like protein as a novel marker for liver fibrosis in chronic hepatitis B patients with normal to minimally raised ALT. BMC Infect Dis 2017;17:650. [PMID: 28962551 DOI: 10.1186/s12879-017-2728-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
97 Qin S, Zhou Y, Lok AS, Tsodikov A, Yan X, Gray L, Yuan M, Moritz RL, Galas D, Omenn GS. SRM targeted proteomics in search for biomarkers of HCV-induced progression of fibrosis to cirrhosis in HALT-C patients. Proteomics. 2012;12:1244-1252. [PMID: 22577025 DOI: 10.1002/pmic.201100601] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
98 Hessien MH, El-Sharkawi IM, El-Barbary AA, El-Beltagy DM, Snyder N. Non-invasive index of liver fibrosis induced by alcohol, thioacetamide and Schistosomal infection in mice. BMC Gastroenterol 2010;10:53. [PMID: 20515488 DOI: 10.1186/1471-230X-10-53] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
99 Lee YJ, Lee JM, Lee JE, Lee KB, Lee ES, Yoon J, Yu MH, Baek JH, Shin CI, Han JK, Choi BI. MR elastography for noninvasive assessment of hepatic fibrosis: Reproducibility of the examination and reproducibility and repeatability of the liver stiffness value measurement: MRE for Stiffness Assessment of Hepatic Fibrosis. J Magn Reson Imaging 2014;39:326-31. [DOI: 10.1002/jmri.24147] [Cited by in Crossref: 69] [Cited by in F6Publishing: 62] [Article Influence: 8.6] [Reference Citation Analysis]
100 Conti F, Serra C, Vukotic R, Felicani C, Mazzotta E, Gitto S, Vitale G, D’errico A, Andreone P. Assessment of Liver Fibrosis With Elastography Point Quantification vs Other Noninvasive Methods. Clinical Gastroenterology and Hepatology 2019;17:510-517.e3. [DOI: 10.1016/j.cgh.2018.06.027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
101 Schiavon LL, Narciso-Schiavon JL, Carvalho-Filho RJ. Non-invasive diagnosis of liver fibrosis in chronic hepatitis C. World J Gastroenterol 2014; 20(11): 2854-2866 [PMID: 24659877 DOI: 10.3748/wjg.v20.i11.2854] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 44] [Article Influence: 6.7] [Reference Citation Analysis]
102 Osakabe K, Ichino N, Nishikawa T, Sugiyama H, Kato M, Shibata A, Asada W, Kawabe N, Hashimoto S, Murao M, Nakano T, Shimazaki H, Kan T, Nakaoka K, Takagawa Y, Ohki M, Kurashita T, Takamura T, Yoshioka K. Changes of shear-wave velocity by interferon-based therapy in chronic hepatitis C. World J Gastroenterol 2015; 21(35): 10215-10223 [PMID: 26401087 DOI: 10.3748/wjg.v21.i35.10215] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
103 Lim AK, Patel N, Eckersley RJ, Cobbold JF, Crossey MM, Cosgrove DO, Goldin RD, Thomas HC, Taylor-Robinson SD. Hepatic vein transit times of a microbubble agent in assessing response to antiviral treatment in patients with chronic hepatitis C. J Viral Hepat 2010;17:778-83. [PMID: 20002308 DOI: 10.1111/j.1365-2893.2009.01234.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
104 Vanderschaeghe D, Laroy W, Sablon E, Halfon P, Van Hecke A, Delanghe J, Callewaert N. GlycoFibroTest is a highly performant liver fibrosis biomarker derived from DNA sequencer-based serum protein glycomics. Mol Cell Proteomics. 2009;8:986-994. [PMID: 19181623 DOI: 10.1074/mcp.M800470-MCP20042] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
105 Yoshimaru D, Miyati T, Suzuki Y, Hamada Y, Mogi N, Funaki A, Tabata A, Masunaga A, Shimada M, Tobari M, Nishino T. Diffusion kurtosis imaging with the breath-hold technique for staging hepatic fibrosis: A preliminary study. Magn Reson Imaging 2018;47:33-8. [PMID: 29158186 DOI: 10.1016/j.mri.2017.11.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
106 Sebastiani G, Gkouvatsos K, Pantopoulos K. Chronic hepatitis C and liver fibrosis. World J Gastroenterol 2014; 20(32): 11033-11053 [PMID: 25170193 DOI: 10.3748/wjg.v20.i32.11033] [Cited by in CrossRef: 117] [Cited by in F6Publishing: 97] [Article Influence: 16.7] [Reference Citation Analysis]
107 Yegin EG, Yegin K, Ozdogan OC. Digital image analysis in liver fibrosis: basic requirements and clinical implementation. Biotechnology & Biotechnological Equipment 2016;30:653-60. [DOI: 10.1080/13102818.2016.1181989] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
108 Chinnaratha MA, Jeffrey GP, Macquillan G, Rossi E, de Boer BW, Speers DJ, Adams LA. Prediction of morbidity and mortality in patients with chronic hepatitis C by non-invasive liver fibrosis models. Liver Int 2014;34:720-7. [DOI: 10.1111/liv.12306] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
109 Fabila-bustos DA, Arroyo-camarena UD, López-vancell MD, Durán-padilla MA, Azuceno-garcía I, Stolik-isakina S, Ibarra-coronado E, Brown B, Escobedo G, de la Rosa-vázquez JM. Diffuse Reflectance Spectroscopy as a Possible Tool to Complement Liver Biopsy for Grading Hepatic Fibrosis in Paraffin-Preserved Human Liver Specimens. Appl Spectrosc 2014;68:1357-64. [DOI: 10.1366/14-07462] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
110 Houlihan DD, Armstrong MJ, Newsome PN. Investigation of jaundice. Medicine 2011;39:518-22. [DOI: 10.1016/j.mpmed.2011.06.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
111 Sasso M, Miette V, Sandrin L, Beaugrand M. The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan. Clin Res Hepatol Gastroenterol. 2012;36:13-20. [PMID: 21920839 DOI: 10.1016/j.clinre.2011.08.001] [Cited by in Crossref: 135] [Cited by in F6Publishing: 123] [Article Influence: 13.5] [Reference Citation Analysis]
112 Cazanave SC, Warren AD, Pacula M, Touti F, Zagorska A, Gural N, Huang EK, Sherman S, Cheema M, Ibarra S, Bates J, Billin AN, Liles JT, Budas GR, Breckenridge DG, Tiniakos D, Ratziu V, Daly AK, Govaere O, Anstee QM, Gelrud L, Luther J, Chung RT, Corey KE, Winckler W, Bhatia S, Kwong GA. Peptide-based urinary monitoring of fibrotic nonalcoholic steatohepatitis by mass-barcoded activity-based sensors. Sci Transl Med 2021;13:eabe8939. [PMID: 34669440 DOI: 10.1126/scitranslmed.abe8939] [Reference Citation Analysis]
113 Albanis E, Friedman SL. Antifibrotic agents for liver disease. Am J Transplant. 2006;6:12-19. [PMID: 16433751 DOI: 10.1111/j.1600-6143.2005.01143.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 2.8] [Reference Citation Analysis]
114 Fujimoto K, Shiinoki T, Yuasa Y, Tanaka H. Estimation of liver elasticity using the finite element method and four-dimensional computed tomography images as a biomarker of liver fibrosis. Med Phys 2021;48:1286-98. [PMID: 33449406 DOI: 10.1002/mp.14723] [Reference Citation Analysis]
115 Harouni AA, Gharib AM, Osman NF, Morse C, Heller T, Abd-Elmoniem KZ. Assessment of liver fibrosis using fast strain-encoded MRI driven by inherent cardiac motion. Magn Reson Med 2015;74:106-14. [PMID: 25081734 DOI: 10.1002/mrm.25379] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
116 Mindikoglu A, Regev A, Casanova-romero P, Bejarano P, Martinez E, Tzakis A, Schiff E. The Impact of Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome on Progression of Fibrosis in Patients With Recurrent HCV After Liver Transplantation. Transplantation Proceedings 2006;38:1440-4. [DOI: 10.1016/j.transproceed.2006.02.060] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
117 Hirooka M, Koizumi Y, Hiasa Y, Abe M, Ikeda Y, Matsuura B, Onji M. Hepatic Elasticity in Patients With Ascites: Evaluation With Real-Time Tissue Elastography. American Journal of Roentgenology 2011;196:W766-71. [DOI: 10.2214/ajr.10.4867] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
118 Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy. J Magn Reson Imaging. 2011;34:729-749. [PMID: 22025886 DOI: 10.1002/jmri.22775] [Cited by in Crossref: 52] [Cited by in F6Publishing: 266] [Article Influence: 5.2] [Reference Citation Analysis]
119 Tseng PL, Wang JH, Hung CH, Tung HD, Chen TM, Huang WS, Liu SL, Hu TH, Lee CM, Lu SN. Comparisons of noninvasive indices based on daily practice parameters for predicting liver cirrhosis in chronic hepatitis B and hepatitis C patients in hospital and community populations. Kaohsiung J Med Sci. 2013;29:385-395. [PMID: 23768703 DOI: 10.1016/j.kjms.2012.11.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
120 Nitta Y, Kawabe N, Hashimoto S, Harata M, Komura N, Kobayashi K, Arima Y, Shimazaki H, Nakano T, Murao M. Liver stiffness measured by transient elastography correlates with fibrosis area in liver biopsy in patients with chronic hepatitis C. Hepatol Res. 2009;39:675-684. [PMID: 19261000 DOI: 10.1111/j.1872-034x.2009.00500.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
121 Chon YE, Park JY, Myoung S, Jung KS, Kim BK, Kim SU, Kim DY, Ahn SH, Han K. Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis. American Journal of Gastroenterology 2017;112:882-91. [DOI: 10.1038/ajg.2017.93] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
122 Ferraioli G, Filice C, Castera L, Choi BI, Sporea I, Wilson SR, Cosgrove D, Dietrich CF, Amy D, Bamber JC, Barr R, Chou Y, Ding H, Farrokh A, Friedrich-rust M, Hall TJ, Nakashima K, Nightingale KR, Palmeri ML, Schafer F, Shiina T, Suzuki S, Kudo M. WFUMB Guidelines and Recommendations for Clinical Use of Ultrasound Elastography: Part 3: Liver. Ultrasound in Medicine & Biology 2015;41:1161-79. [DOI: 10.1016/j.ultrasmedbio.2015.03.007] [Cited by in Crossref: 344] [Cited by in F6Publishing: 291] [Article Influence: 57.3] [Reference Citation Analysis]
123 Sarkar M, Dodge JL, Greenblatt RM, Kuniholm MH, DeHovitz J, Plankey M, Kovacs A, French AL, Seaberg EC, Ofotokun I, Fischl M, Overton E, Kelly E, Bacchetti P, Peters MG; Women’s Interagency HIV Study. Reproductive Aging and Hepatic Fibrosis Progression in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Women. Clin Infect Dis 2017;65:1695-702. [PMID: 29020239 DOI: 10.1093/cid/cix643] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
124 Li J, Venkatesh SK, Yin M. Advances in Magnetic Resonance Elastography of Liver. Magn Reson Imaging Clin N Am 2020;28:331-40. [PMID: 32624152 DOI: 10.1016/j.mric.2020.03.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
125 Venkatesh SK, Talwalkar JA. When and How to Use Magnetic Resonance Elastography for Patients With Liver Disease in Clinical Practice. American Journal of Gastroenterology 2018;113:923-6. [DOI: 10.1038/s41395-018-0012-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
126 Cross TJ, Rizzi P, Berry PA, Bruce M, Portmann B, Harrison PM. King's Score: an accurate marker of cirrhosis in chronic hepatitis C. Eur J Gastroenterol Hepatol. 2009;21:730-738. [PMID: 19430302 DOI: 10.1097/meg.0b013e32830dfcb3] [Cited by in Crossref: 78] [Cited by in F6Publishing: 35] [Article Influence: 7.1] [Reference Citation Analysis]
127 Chen B, Schreiber RA, Human DG, Potts JE, Guttman OR. Assessment of Liver Stiffness in Pediatric Fontan Patients Using Transient Elastography. Can J Gastroenterol Hepatol 2016;2016:7125193. [PMID: 27656638 DOI: 10.1155/2016/7125193] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 4.6] [Reference Citation Analysis]
128 Wang J, Li J, Zhou Q, Zhang D, Bi Q, Wu Y, Huang W. Liver stiffness measurement predicted liver-related events and all-cause mortality: A systematic review and nonlinear dose-response meta-analysis. Hepatol Commun 2018;2:467-76. [PMID: 29619424 DOI: 10.1002/hep4.1154] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
129 Iacob S, Cicinnati V, Kabar I, Hüsing-Kabar A, Radtke A, Iacob R, Baba H, Schmidt HH, Paul A, Beckebaum S. Prediction of late allograft dysfunction following liver transplantation by immunological blood biomarkers. Transpl Immunol 2021;69:101448. [PMID: 34391882 DOI: 10.1016/j.trim.2021.101448] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
130 Martinez SM, Foucher J, Combis JM, Métivier S, Brunetto M, Capron D, Bourlière M, Bronowicki JP, Dao T, Maynard-Muet M, Lucidarme D, Merrouche W, Forns X, de Lédinghen V. Longitudinal liver stiffness assessment in patients with chronic hepatitis C undergoing antiviral therapy. PLoS One 2012;7:e47715. [PMID: 23082200 DOI: 10.1371/journal.pone.0047715] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis]
131 Leroy V, Halfon P, Bacq Y, Boursier J, Rousselet MC, Bourlière M, de Muret A, Sturm N, Hunault G, Penaranda G. Diagnostic accuracy, reproducibility and robustness of fibrosis blood tests in chronic hepatitis C: a meta-analysis with individual data. Clin Biochem. 2008;41:1368-1376. [PMID: 18655779 DOI: 10.1016/j.clinbiochem.2008.06.020] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 3.6] [Reference Citation Analysis]
132 Haimerl M, Utpatel K, Verloh N, Zeman F, Fellner C, Nickel D, Teufel A, Fichtner-Feigl S, Evert M, Stroszczynski C, Wiggermann P. Gd-EOB-DTPA-enhanced MR relaxometry for the detection and staging of liver fibrosis. Sci Rep 2017;7:41429. [PMID: 28128291 DOI: 10.1038/srep41429] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
133 Fiel MI. Pathology of chronic hepatitis B and chronic hepatitis C. Clin Liver Dis. 2010;14:555-575. [PMID: 21055682 DOI: 10.1016/j.cld.2010.07.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
134 Koksal AR, Alkim H, Boga S, Ergun M, Bayram M, Ozguven BY, Alkim C. Effect of Entecavir and Tenofovir Treatment on Noninvasive Fibrosis Scores: Which One Is Better? Am J Ther. 2016;23:e429-e438. [PMID: 25650531 DOI: 10.1097/mjt.0000000000000203] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
135 Chen YW, Tsai MY, Pan HB, Tseng HH, Hung YT, Chou CP. Gadoxetic acid-enhanced MRI and sonoelastography: non-invasive assessments of chemoprevention of liver fibrosis in thioacetamide-induced rats with Sho-Saiko-To. PLoS One 2014;9:e114756. [PMID: 25490034 DOI: 10.1371/journal.pone.0114756] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
136 Malik R, Lai M, Sadiq A, Farnan R, Mehta S, Nasser I, Challies T, Schuppan D, Afdhal N. Comparison of transient elastography, serum markers and clinical signs for the diagnosis of compensated cirrhosis. J Gastroenterol Hepatol. 2010;25:1562-1568. [PMID: 20796156 DOI: 10.1111/j.1440-1746.2010.06371.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
137 Ricci P, Marigliano C, Cantisani V, Porfiri A, Marcantonio A, Lodise P, D’Ambrosio U, Labbadia G, Maggini E, Mancuso E. Ultrasound evaluation of liver fibrosis: preliminary experience with acoustic structure quantification (ASQ) software. Radiol Med. 2013;118:995-1010. [PMID: 23801388 DOI: 10.1007/s11547-013-0940-0] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 4.8] [Reference Citation Analysis]
138 Bonnard P, Elsharkawy A, Zalata K, Delarocque-Astagneau E, Biard L, Le Fouler L, Hassan AB, Abdel-Hamid M, El-Daly M, Gamal ME. Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients infected with HCV-genotype 4 in Egypt. J Viral Hepat. 2015;22:245-253. [PMID: 25073725 DOI: 10.1111/jvh.12285] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
139 Batman B, Altun H, Simsek B, Aslan E, Namli Koc S. The Effect of Laparoscopic Sleeve Gastrectomy on Nonalcoholic Fatty Liver Disease. Surg Laparosc Endosc Percutan Tech 2019;29:509-12. [PMID: 31107849 DOI: 10.1097/SLE.0000000000000672] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
140 Banerjee R, Pavlides M, Tunnicliffe EM, Piechnik SK, Sarania N, Philips R, Collier JD, Booth JC, Schneider JE, Wang LM, Delaney DW, Fleming KA, Robson MD, Barnes E, Neubauer S. Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. J Hepatol. 2014;60:69-77. [PMID: 24036007 DOI: 10.1016/j.jhep.2013.09.002] [Cited by in Crossref: 239] [Cited by in F6Publishing: 208] [Article Influence: 29.9] [Reference Citation Analysis]
141 Agrawal S, Dhiman RK, Limdi JK. Evaluation of abnormal liver function tests. Postgrad Med J 2016;92:223-34. [DOI: 10.1136/postgradmedj-2015-133715] [Cited by in Crossref: 39] [Cited by in F6Publishing: 21] [Article Influence: 7.8] [Reference Citation Analysis]
142 Bota S, Herkner H, Sporea I, Salzl P, Sirli R, Neghina AM, Peck-Radosavljevic M. Meta-analysis: ARFI elastography vs transient elastography for the evaluation of liver fibrosis. Liver Int. 2013;33:1138-1147. [PMID: 23859217 DOI: 10.1111/liv.12240] [Cited by in Crossref: 279] [Cited by in F6Publishing: 255] [Article Influence: 34.9] [Reference Citation Analysis]
143 Kim BH, Lee JM, Lee YJ, Lee KB, Suh KS, Han JK, Choi BI. MR elastography for noninvasive assessment of hepatic fibrosis: experience from a tertiary center in Asia. J Magn Reson Imaging. 2011;34:1110-1116. [PMID: 21932355 DOI: 10.1002/jmri.22723] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 7.3] [Reference Citation Analysis]
144 Norén B, Forsgren MF, Dahlqvist Leinhard O, Dahlström N, Kihlberg J, Romu T, Kechagias S, Almer S, Smedby Ö, Lundberg P. Separation of advanced from mild hepatic fibrosis by quantification of the hepatobiliary uptake of Gd-EOB-DTPA. Eur Radiol. 2013;23:174-181. [PMID: 22836161 DOI: 10.1007/s00330-012-2583-2] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 6.0] [Reference Citation Analysis]
145 Kim D, Kim WR, Talwalkar JA, Kim HJ, Ehman RL. Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography. Radiology. 2013;268:411-419. [PMID: 23564711 DOI: 10.1148/radiol.13121193] [Cited by in Crossref: 152] [Cited by in F6Publishing: 142] [Article Influence: 19.0] [Reference Citation Analysis]
146 Jeong JY, Cho YS, Sohn JH. Role of two-dimensional shear wave elastography in chronic liver diseases: A narrative review. World J Gastroenterol 2018; 24(34): 3849-3860 [PMID: 30228779 DOI: 10.3748/wjg.v24.i34.3849] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
147 Wang B, Sun Y, Zhou J, Wu X, Chen S, Shi Y, Wu S, Liu H, Ren Y, Ou X, Jia J, You H. SHG/TPEF-based image technology improves liver fibrosis assessment of minimally sized needle biopsies. Hepatol Int 2019;13:501-9. [PMID: 31187402 DOI: 10.1007/s12072-019-09955-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
148 Frulio N, Trillaud H, Perez P, Asselineau J, Vandenhende M, Hessamfar M, Bonnet F, Maire F, Delaune J, De Ledinghen V, Morlat P. Acoustic Radiation Force Impulse (ARFI) and Transient Elastography (TE) for evaluation of liver fibrosis in HIV-HCV co-infected patients. BMC Infect Dis. 2014;14:405. [PMID: 25041708 DOI: 10.1186/1471-2334-14-405] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
149 Mak LY, Wong DK, Seto WK, Ning Q, Cheung KS, Fung J, Lai CL, Yuen MF. Correlation of serum Mac-2-binding protein glycosylation isomer (M2BPGi) and liver stiffness in chronic hepatitis B infection. Hepatol Int. 2019;13:148-156. [PMID: 30671807 DOI: 10.1007/s12072-019-09928-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
150 Castera L. Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver disease. Best Pract Res Clin Gastroenterol. 2011;25:291-303. [PMID: 21497746 DOI: 10.1016/j.bpg.2011.02.003] [Cited by in Crossref: 91] [Cited by in F6Publishing: 79] [Article Influence: 9.1] [Reference Citation Analysis]
151 Parkes J, Guha IN, Roderick P, Rosenberg W. Performance of serum marker panels for liver fibrosis in chronic hepatitis C. J Hepatol. 2006;44:462-474. [PMID: 16427156 DOI: 10.1016/j.jhep.2005.10.019] [Cited by in Crossref: 169] [Cited by in F6Publishing: 162] [Article Influence: 10.6] [Reference Citation Analysis]
152 Raghuwanshi B, Jain N, Jain M. Normal values in healthy liver in central India by acoustic radiation force impulse imaging. J Clin Diagn Res. 2013;7:2498-2501. [PMID: 24392382 DOI: 10.7860/jcdr/2013/7479.3589] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
153 Castera L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology. 2012;142:1293-1302.e4. [PMID: 22537436 DOI: 10.1053/j.gastro.2012.02.017] [Cited by in Crossref: 411] [Cited by in F6Publishing: 368] [Article Influence: 45.7] [Reference Citation Analysis]
154 Albazaz R, Guthrie JA. Virtual Special Issue - Chronic liver disease. Clin Radiol 2017;72:429-32. [PMID: 28438323 DOI: 10.1016/j.crad.2017.03.016] [Reference Citation Analysis]
155 Junatas KL, Tonar Z, Kubíková T, Liška V, Pálek R, Mik P, Králíčková M, Witter K. Stereological analysis of size and density of hepatocytes in the porcine liver. J Anat 2017;230:575-88. [PMID: 28032348 DOI: 10.1111/joa.12585] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
156 Cardoso AC, A Villela-Nogueira C, de Figueiredo-Mendes C, Leão Filho H, Pinto Silva RA, Valle Tovo C, Perazzo H, Matteoni AC, de Carvalho-Filho RJ, Lisboa Bittencourt P. Brazilian Society of Hepatology and Brazilian College of Radiology practice guidance for the use of elastography in liver diseases. Ann Hepatol 2021;22:100341. [PMID: 33737252 DOI: 10.1016/j.aohep.2021.100341] [Reference Citation Analysis]
157 Au TH, Destache CJ, Vivekanandan R. Hepatitis C therapy: Looking toward interferon-sparing regimens. Journal of the American Pharmacists Association 2015;55:e72-86. [DOI: 10.1331/japha.2015.15508] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
158 Muddu AK, Guha IN, Elsharkawy AM, Mann DA. Resolving fibrosis in the diseased liver: translating the scientific promise to the clinic. Int J Biochem Cell Biol 2007;39:695-714. [PMID: 17110155 DOI: 10.1016/j.biocel.2006.10.006] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 2.3] [Reference Citation Analysis]
159 Romagnuolo J, Andrews CN, Bain VG, Bonacini M, Cotler SJ, Ma M, Sherman M. Simple clinical variables predict liver histology in hepatitis C: prospective validation of a clinical prediction model. Scand J Gastroenterol 2005;40:1365-71. [PMID: 16334447 DOI: 10.1080/00365520500287400] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
160 Almpanis Z, Demonakou M, Tiniakos D. Evaluation of liver fibrosis: "Something old, something new…". Ann Gastroenterol 2016;29:445-53. [PMID: 27708509 DOI: 10.20524/aog.2016.0046] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
161 Cequera A, García de León Méndez MC. [Biomarkers for liver fibrosis: advances, advantages and disadvantages]. Rev Gastroenterol Mex 2014;79:187-99. [PMID: 24954541 DOI: 10.1016/j.rgmx.2014.05.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
162 Schiavon LL, Carvalho-filho RJ, Narciso-schiavon JL, Medina-pestana JO, Lanzoni VP, Ferraz MLG, Silva AEB. YKL-40 and hyaluronic acid (HA) as noninvasive markers of liver fibrosis in kidney transplant patients with HCV chronic infection. Scandinavian Journal of Gastroenterology 2010;45:615-22. [DOI: 10.3109/00365521003637203] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
163 Hepburn MJ, Vos JA, Fillman EP, Lawitz EJ. The accuracy of the report of hepatic steatosis on ultrasonography in patients infected with hepatitis C in a clinical setting: a retrospective observational study. BMC Gastroenterol. 2005;5:14. [PMID: 15829009 DOI: 10.1186/1471-230x-5-14] [Cited by in Crossref: 56] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
164 Takemoto R, Nakamuta M, Aoyagi Y, Fujino T, Yasutake K, Koga K, Yoshimoto T, Miyahara T, Fukuizumi K, Wada Y. Validity of FibroScan values for predicting hepatic fibrosis stage in patients with chronic HCV infection. J Dig Dis. 2009;10:145-148. [PMID: 19426398 DOI: 10.1111/j.1751-2980.2009.00377.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
165 Petzold G, Porsche M, Ellenrieder V, Kunsch S, Neesse A. Impact of Food Intake on Liver Stiffness Determined by 2-D Shear Wave Elastography: Prospective Interventional Study in 100 Healthy Patients. Ultrasound Med Biol 2019;45:402-10. [PMID: 30396598 DOI: 10.1016/j.ultrasmedbio.2018.09.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
166 Roccarina D, Iogna Prat L, Buzzetti E, Guerrero Misas M, Aricó FM, Saffioti F, Rosselli M, Pinzani M, Marshall A, Thorburn D, Tsochatzis E. Establishing Reliability Criteria for Liver ElastPQ Shear Wave Elastography (ElastPQ-SWE): Comparison Between 10, 5 and 3 Measurements. Ultraschall Med 2021;42:204-13. [PMID: 31594008 DOI: 10.1055/a-1010-6052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
167 Venkatesh SK, Ehman RL. Magnetic resonance elastography of liver. Magn Reson Imaging Clin N Am. 2014;22:433-446. [PMID: 25086938 DOI: 10.1016/j.mric.2014.05.001] [Cited by in Crossref: 100] [Cited by in F6Publishing: 83] [Article Influence: 16.7] [Reference Citation Analysis]
168 Chamarthi SK, Raterman B, Mazumder R, Michaels A, Oza VM, Hanje J, Bolster B, Jin N, White RD, Kolipaka A. Rapid acquisition technique for MR elastography of the liver. Magn Reson Imaging. 2014;32:679-683. [PMID: 24637083 DOI: 10.1016/j.mri.2014.02.013] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
169 Marcellin P, Ziol M, Bedossa P, Douvin C, Poupon R, de Lédinghen V, Beaugrand M. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver International 2009;29:242-7. [DOI: 10.1111/j.1478-3231.2008.01802.x] [Cited by in Crossref: 339] [Cited by in F6Publishing: 333] [Article Influence: 28.3] [Reference Citation Analysis]
170 Zhuang Y, Ding H, Zhang Y, Sun H, Xu C, Wang W. Two-dimensional Shear-Wave Elastography Performance in the Noninvasive Evaluation of Liver Fibrosis in Patients with Chronic Hepatitis B: Comparison with Serum Fibrosis Indexes. Radiology. 2017;283:873-882. [PMID: 27982760 DOI: 10.1148/radiol.2016160131] [Cited by in Crossref: 58] [Cited by in F6Publishing: 48] [Article Influence: 11.6] [Reference Citation Analysis]
171 Calvaruso V, Di Marco V, Ferraro D, Petta S, Calì A, Grazia Bavetta M, Conte E, Luigi Almasio P. Fibrosis evaluation by transient elastography in patients with long-term sustained HCV clearance. Hepat Mon 2013;13:e7176. [PMID: 23967020 DOI: 10.5812/hepatmon.7176] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
172 Houlihan DD, Newsome PN. Critical Review of Clinical Trials of Bone Marrow Stem Cells in Liver Disease. Gastroenterology 2008;135:438-50. [DOI: 10.1053/j.gastro.2008.05.040] [Cited by in Crossref: 137] [Cited by in F6Publishing: 118] [Article Influence: 10.5] [Reference Citation Analysis]
173 Rath T, Hage L, Kügler M, Menendez Menendez K, Zachoval R, Naehrlich L, Schulz R, Roderfeld M, Roeb E. Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver disease. PLoS One. 2013;8:e58955. [PMID: 23516586 DOI: 10.1371/journal.pone.0058955] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
174 Liu GJ, Lu MD. Diagnosis of liver cirrhosis with contrast-enhanced ultrasound. World J Radiol 2010; 2(1): 32-36 [PMID: 21160737 DOI: 10.4329/wjr.v2.i1.32] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
175 Limketkai BN, Mehta SH, Sutcliffe CG, Higgins YM, Torbenson MS, Brinkley SC, Moore RD, Thomas DL, Sulkowski MS. Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV. JAMA. 2012;308:370-378. [PMID: 22820790 DOI: 10.1001/jama.2012.7844] [Cited by in Crossref: 144] [Cited by in F6Publishing: 142] [Article Influence: 16.0] [Reference Citation Analysis]
176 Cardoso AC, Beaugrand M, de Ledinghen V, Douvin C, Poupon R, Trinchet JC, Ziol M, Bedossa P, Marcellin P. Diagnostic performance of controlled attenuation parameter for predicting steatosis grade in chronic hepatitis B. Ann Hepatol 2015;14:826-36. [PMID: 26436354 DOI: 10.5604/16652681.1171762] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
177 Wang J, Guo L, Shi X, Pan W, Bai Y, Ai H. Real-time elastography with a novel quantitative technology for assessment of liver fibrosis in chronic hepatitis B. Eur J Radiol. 2012;81:e31-e36. [PMID: 21216123 DOI: 10.1016/j.ejrad.2010.12.013] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 5.2] [Reference Citation Analysis]
178 Shayesteh M, Shayesteh AA, Motamedfar A, Tahmasebi M, Bagheri S, Gharibvand MM. The clinical value of the apparent diffusion coefficient of liver magnetic resonance images in patients with liver fibrosis compared to healthy subjects. J Family Med Prim Care 2018;7:1501-5. [PMID: 30613549 DOI: 10.4103/jfmpc.jfmpc_299_18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
179 Shen Y, Wu SD, Wu L, Wang SQ, Chen Y, Liu LL, Li J, Yang CQ, Wang JY, Jiang W. The prognostic role of liver stiffness in patients with chronic liver disease: a systematic review and dose-response meta-analysis. Hepatol Int 2019;13:560-72. [PMID: 31273618 DOI: 10.1007/s12072-019-09952-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
180 Perez NE, Siddiqui FA, Mutchnick MG, Dhar R, Tobi M, Ullah N, Saksouk FA, Wheeler DE, Ehrinpreis MN. Ultrasound diagnosis of fatty liver in patients with chronic liver disease: a retrospective observational study. J Clin Gastroenterol. 2007;41:624-629. [PMID: 17577120 DOI: 10.1097/01.mcg.0000225680.45088.01] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
181 Lorenzo-zúñiga V, Bartolí R, Masnou H, Montoliu S, Morillas RMA, Planas R. Serum Concentrations of Insulin-Like Growth Factor-I (IGF-I) as a Marker of Liver Fibrosis in Patients With Chronic Hepatitis C. Dig Dis Sci 2007;52:3245-50. [DOI: 10.1007/s10620-006-9437-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
182 Kamalraj N, Sathishkumar M, Arunvignesh M, Baskar V, Jebarani S, Amutha A, Deepa M, Shanthi Rani CS, Chandru S, Unnikrishnan R, Anjana RM, Harish M, Mohan V. Retrospective analysis (2009-2017) of factors associated with progression and regression of non-alcoholic fatty liver disease (Hepatic steatosis) in patients with type 2 diabetes seen at a tertiary diabetes centre in Southern India. Diabetes Metab Syndr 2021;15:102261. [PMID: 34464909 DOI: 10.1016/j.dsx.2021.102261] [Reference Citation Analysis]
183 Ekiz F, Yuksel İ, Arikök AT, Yilmaz B, Altinbas A, Aktas B, Deveci M, Basar O, Coban S, Yuksel O. Will a second biopsy sample affect treatment decisions in patients with chronic hepatitis B? Hepatol Int 2016;10:602-5. [PMID: 26416085 DOI: 10.1007/s12072-015-9666-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
184 Xu S, Kang CH, Gou X, Peng Q, Yan J, Zhuo S, Cheng CL, He Y, Kang Y, Xia W, So PT, Welsch R, Rajapakse JC, Yu H. Quantification of liver fibrosis via second harmonic imaging of the Glisson's capsule from liver surface. J Biophotonics 2016;9:351-63. [PMID: 26131709 DOI: 10.1002/jbio.201500001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
185 Yang L, Li J, Ma L, Xiang H, He D, Lu C, Tang L, Luo Y, Chen S. Noninvasive assessment of liver fibrosis in chronic hepatitis B carriers with sound touch elastography: study of surgical pathology specimens. Expert Rev Med Devices 2020;17:845-53. [PMID: 32686517 DOI: 10.1080/17434440.2020.1798226] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
186 Czul F, Bhamidimarri KR. Noninvasive Markers to Assess Liver Fibrosis. J Clin Gastroenterol 2016;50:445-57. [PMID: 27105176 DOI: 10.1097/MCG.0000000000000534] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
187 Calle-Toro JS, Serai SD, Hartung EA, Goldberg DJ, Bolster BD Jr, Darge K, Anupindi SA. Magnetic resonance elastography SE-EPI vs GRE sequences at 3T in a pediatric population with liver disease. Abdom Radiol (NY) 2019;44:894-902. [PMID: 30600386 DOI: 10.1007/s00261-018-1884-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
188 Tajiri K, Kawai K, Sugiyama T. Strain elastography for assessment of liver fibrosis and prognosis in patients with chronic liver diseases. J Gastroenterol 2017;52:724-33. [PMID: 27787686 DOI: 10.1007/s00535-016-1277-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
189 Kim SU, Lee JH, Kim DY, Ahn SH, Jung KS, Choi EH, Park YN, Han KH, Chon CY, Park JY. Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis. PLoS One. 2012;7:e36676. [PMID: 22574212 DOI: 10.1371/journal.pone.0036676] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 7.8] [Reference Citation Analysis]
190 Rockstroh JK. Hot topics in HIV and hepatitis coinfection: noninvasive diagnosis of liver disease, liver transplantation, and new drugs for treatment of hepatitis coinfection. HIV Clin Trials 2009;10:110-5. [PMID: 19487181 DOI: 10.1310/hct1002-110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
191 Ou H, Bonekamp S, Bonekamp D, Corona-villalobos CP, Torbenson MS, Geiger B, Kamel IR. MRI Arterial Enhancement Fraction in Hepatic Fibrosis and Cirrhosis. American Journal of Roentgenology 2013;201:W596-602. [DOI: 10.2214/ajr.12.10048] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
192 Hanai T, Shiraki M, Ohnishi S, Miyazaki T, Ideta T, Kochi T, Imai K, Suetsugu A, Takai K, Shimizu M, Moriwaki H. Impact of serum glycosylated Wisteria floribunda agglutinin positive Mac-2 binding protein levels on liver functional reserves and mortality in patients with liver cirrhosis. Hepatol Res 2015;45:1083-90. [PMID: 25565570 DOI: 10.1111/hepr.12473] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
193 Villani R, Cavallone F, Romano AD, Bellanti F, Serviddio G. Two-Dimensional Shear Wave Elastography versus Transient Elastography: A Non-Invasive Comparison for the Assessment of Liver Fibrosis in Patients with Chronic Hepatitis C. Diagnostics (Basel) 2020;10:E313. [PMID: 32429410 DOI: 10.3390/diagnostics10050313] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Bambha K, Pierce C, Cox C, French AL, Tien PC, Sharp GB, Augenbraun M, Glesby MJ, Villacres MC, Plankey M, Strickler HD, Gange SJ, Peters MG. Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis. AIDS 2012;26:599-607. [PMID: 22156972 DOI: 10.1097/QAD.0b013e32834fa121] [Cited by in Crossref: 42] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
195 Resino S, Micheloud D, Miralles P, Bellã³n J, Vargas A, Catalã¡n P, Álvarez E, Cosã­n J, Lorente R, Lã³pez J, Muã±oz-fernã¡ndez M, Berenguer J. Diagnosis of advanced fibrosis in HIV and hepatitis C virus-coinfected patients via a new noninvasive index: the HGM-3 index: Diagnosis of advanced fibrosis. HIV Medicine 2010;11:64-73. [DOI: 10.1111/j.1468-1293.2009.00745.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
196 Patel J, Sigmund EE, Rusinek H, Oei M, Babb JS, Taouli B. Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J MagnReson Imaging. 2010;31:589-600. [PMID: 20187201 DOI: 10.1002/jmri.22081] [Cited by in Crossref: 286] [Cited by in F6Publishing: 270] [Article Influence: 26.0] [Reference Citation Analysis]
197 Chandel R, Saxena R, Das A, Kaur J. Association of rno‐miR‐183‐96‐182 cluster with diethyinitrosamine induced liver fibrosis in Wistar rats. J Cell Biochem 2018;119:4072-84. [DOI: 10.1002/jcb.26583] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
198 Wei R, Wang J, Wang X, Xie G, Wang Y, Zhang H, Peng CY, Rajani C, Kwee S, Liu P, Jia W. Clinical prediction of HBV and HCV related hepatic fibrosis using machine learning. EBioMedicine 2018;35:124-32. [PMID: 30100397 DOI: 10.1016/j.ebiom.2018.07.041] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 9.7] [Reference Citation Analysis]
199 Wang JC, Fu R, Tao XW, Mao YF, Wang F, Zhang ZC, Yu WW, Chen J, He J, Sun BC. A radiomics-based model on non-contrast CT for predicting cirrhosis: make the most of image data.Biomark Res. 2020;8:47. [PMID: 32963787 DOI: 10.1186/s40364-020-00219-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
200 Korean Association for the Study of the Liver. KASL Clinical Practice Guidelines: Management of chronic hepatitis B. Clin Mol Hepatol. 2012;18:109-162. [PMID: 22893865 DOI: 10.3350/cmh.2012.18.2.109] [Cited by in Crossref: 109] [Cited by in F6Publishing: 121] [Article Influence: 12.1] [Reference Citation Analysis]
201 Spengler U, Fischer H. Die Leberbiopsie im Schnittpunkt von klinischer und pathologischer Diagnostik. Pathologe 2008;29:6-14. [DOI: 10.1007/s00292-007-0960-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
202 Salavrakos M, Piessevaux H, Komuta M, Lanthier N, Stärkel P. Fibroscan Reliably Rules Out Advanced Liver Fibrosis and Significant Portal Hypertension in Alcoholic Patients. J Clin Gastroenterol 2019;53:772-8. [PMID: 30106835 DOI: 10.1097/MCG.0000000000001119] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
203 Baxter S, Wang ZJ, Joe BN, Qayyum A, Taouli B, Yeh BM. Timing bolus dynamic contrast-enhanced (DCE) MRI assessment of hepatic perfusion: Initial experience. J Magn Reson Imaging. 2009;29:1317-1322. [PMID: 19472388 DOI: 10.1002/jmri.21795] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
204 Schmilovitz-Weiss H, Cohen M, Pappo O, Sulkes J, Braun M, Tur-Kaspa R, Ben-Ari Z. Serum globulin levels in predicting the extent of hepatic fibrosis in patients with recurrent post-transplant hepatitis C infection. Clin Transplant. 2007;21:391-397. [PMID: 17488390 DOI: 10.1111/j.1399-0012.2007.00657.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
205 Ferraioli G, Tinelli C, Dal Bello B, Zicchetti M, Lissandrin R, Filice G, Filice C, Above E, Barbarini G, Brunetti E, Calderon W, Di Gregorio M, Gulminetti R, Lanzarini P, Ludovisi S, Maiocchi L, Malfitano A, Michelone G, Minoli L, Mondelli M, Novati S, Patruno SF, Perretti A, Poma G, Sacchi P, Zanaboni D, Zaramella M. Performance of liver stiffness measurements by transient elastography in chronic hepatitis. World J Gastroenterol 2013; 19(1): 49-56 [PMID: 23326162 DOI: 10.3748/wjg.v19.i1.49] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
206 Schuppan D. Liver fibrosis: Common mechanisms and antifibrotic therapies. Clinics and Research in Hepatology and Gastroenterology 2015;39:S51-9. [DOI: 10.1016/j.clinre.2015.05.005] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 11.0] [Reference Citation Analysis]
207 Ogura S, Saitoh S, Kawamura Y, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Suzuki F, Suzuki Y, Arase Y, Ikeda K, Kumada H. Magnetic resonance laparoscopy: A new non-invasive technique for the assessment of chronic viral liver disease: Magnetic resonance laparoscopy. Hepatol Res 2013;43:836-45. [DOI: 10.1111/hepr.12025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
208 Pu K, Wang Y, Bai S, Wei H, Zhou Y, Fan J, Qiao L. Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis. BMC Gastroenterol 2019;19:51. [PMID: 30961539 DOI: 10.1186/s12876-019-0961-9] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 24.0] [Reference Citation Analysis]
209 Ble M, Procopet B, Miquel R, Hernandez-Gea V, García-Pagán JC. Transjugular liver biopsy. Clin Liver Dis. 2014;18:767-778. [PMID: 25438282 DOI: 10.1016/j.cld.2014.07.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
210 Poynard T, Imbert-bismut F. Laboratory Testing for Liver Disease. Zakim and Boyer's Hepatology. Elsevier; 2012. pp. 201-15. [DOI: 10.1016/b978-1-4377-0881-3.00014-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
211 Coskun Y, Yuksel I. Serum rheumatoid factor is correlated with liver fibrosis in patients with chronic hepatitis B. Wien Klin Wochenschr 2021;133:432-40. [PMID: 32929574 DOI: 10.1007/s00508-020-01732-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
212 Colombo S, Buonocore M, Del Poggio A, Jamoletti C, Elia S, Mattiello M, Zabbialini D, Del Poggio P. Head-to-head comparison of transient elastography (TE), real-time tissue elastography (RTE), and acoustic radiation force impulse (ARFI) imaging in the diagnosis of liver fibrosis. J Gastroenterol. 2012;47:461-469. [PMID: 22223175 DOI: 10.1007/s00535-011-0509-4] [Cited by in Crossref: 67] [Cited by in F6Publishing: 62] [Article Influence: 7.4] [Reference Citation Analysis]
213 Myers RP, Tainturier MH, Ratziu V, Piton A, Thibault V, Imbert-Bismut F, Messous D, Charlotte F, Di Martino V, Benhamou Y. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J Hepatol. 2003;39:222-230. [PMID: 12873819 DOI: 10.1016/s0168-8278(03)00171-5] [Cited by in Crossref: 233] [Cited by in F6Publishing: 80] [Article Influence: 13.7] [Reference Citation Analysis]
214 Aubé C. Imaging modalities for the diagnosis of hepatic fibrosis and cirrhosis. Clin Res Hepatol Gastroenterol. 2015;39:38-44. [PMID: 25037179 DOI: 10.1016/j.clinre.2014.06.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
215 Chen CH, Hung CH, Lee CM, Hu TH, Wang JH, Wang JC, Lu SN, Changchien CS. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients. Gastroenterology. 2007;133:1466-1474. [PMID: 17915220 DOI: 10.1053/j.gastro.2007.09.002] [Cited by in Crossref: 167] [Cited by in F6Publishing: 167] [Article Influence: 11.9] [Reference Citation Analysis]
216 Zou X, Zhu MY, Yu DM, Li W, Zhang DH, Lu FJ, Gong QM, Liu F, Jiang JH, Zheng MH, Kuno A, Narimatsu H, Zhang Y, Zhang XX. Serum WFA+ -M2BP levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection. Liver Int 2017;37:35-44. [PMID: 27300763 DOI: 10.1111/liv.13188] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 8.6] [Reference Citation Analysis]
217 Petzold G, Bremer SCB, Knoop RF, Amanzada A, Raddatz D, Ellenrieder V, Ströbel P, Kunsch S, Neesse A. Noninvasive assessment of liver fibrosis in a real-world cohort of patients with known or suspected chronic liver disease using 2D-shear wave elastography. Eur J Gastroenterol Hepatol 2020;32:1559-65. [PMID: 31922976 DOI: 10.1097/MEG.0000000000001675] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
218 Horowitz JM, Kamel IR, Arif-tiwari H, Asrani SK, Hindman NM, Kaur H, Mcnamara MM, Noto RB, Qayyum A, Lalani T. ACR Appropriateness Criteria ® Chronic Liver Disease. Journal of the American College of Radiology 2017;14:S103-17. [DOI: 10.1016/j.jacr.2017.02.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
219 Nahon P, Thabut G, Ziol M, Htar MT, Cesaro F, Barget N, Grando-Lemaire V, Ganne-Carrie N, Trinchet JC, Beaugrand M. Liver stiffness measurement versus clinicians' prediction or both for the assessment of liver fibrosis in patients with chronic hepatitis C. Am J Gastroenterol. 2006;101:2744-2751. [PMID: 17227522 DOI: 10.1111/j.1572-0241.2006.00816.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
220 Venkatesh SK, Wells ML, Miller FH, Jhaveri KS, Silva AC, Taouli B, Ehman RL. Magnetic resonance elastography: beyond liver fibrosis-a case-based pictorial review. Abdom Radiol (NY) 2018;43:1590-611. [PMID: 29143076 DOI: 10.1007/s00261-017-1383-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
221 Bosselut N, Taibi L, Guéchot J, Zarski JP, Sturm N, Gelineau MC, Poggi B, Thoret S, Lasnier E, Baudin B. Including osteoprotegerin and collagen IV in a score-based blood test for liver fibrosis increases diagnostic accuracy. Clin Chim Acta. 2013;415:63-68. [PMID: 23022619 DOI: 10.1016/j.cca.2012.09.020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
222 A. Marcos L, Yi P, Machicado A, Andrade R, Samalvides F, Sánchez J, Terashima A. Hepatic fibrosis and Fasciola hepatica infection in cattle. J Helminthol 2007;81:381-6. [DOI: 10.1017/s0022149x07850231] [Cited by in Crossref: 35] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
223 Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD;  American Association for the Study of Liver Diseases. Liver biopsy. Hepatology. 2009;49:1017-1044. [PMID: 19243014 DOI: 10.1002/hep.22742] [Cited by in Crossref: 1217] [Cited by in F6Publishing: 1044] [Article Influence: 101.4] [Reference Citation Analysis]
224 Yada N, Kudo M, Morikawa H, Fujimoto K, Kato M, Kawada N. Assessment of liver fibrosis with real-time tissue elastography in chronic viral hepatitis. Oncology. 2013;84 Suppl 1:13-20. [PMID: 23428853 DOI: 10.1159/000345884] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 5.4] [Reference Citation Analysis]
225 Bedossa P. Liver biopsy. Gastroenterol Clin Biol. 2008;32:4-7. [PMID: 18973842 DOI: 10.1016/s0399-8320(08)73989-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 5] [Article Influence: 2.1] [Reference Citation Analysis]
226 Portincasa P, Grattagliano I, Lauterburg BH, Palmieri VO, Palasciano G, Stellaard F. Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis. Clin Sci (Lond) 2006;111:135-43. [PMID: 16603025 DOI: 10.1042/CS20050346] [Cited by in Crossref: 65] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
227 Razek AA, Abdalla A, Omran E, Fathy A, Zalata K. Diagnosis and quantification of hepatic fibrosis in children with diffusion weighted MR imaging. Eur J Radiol. 2011;78:129-134. [PMID: 19926420 DOI: 10.1016/j.ejrad.2009.10.012] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
228 Li J, Gordon SC, Rupp LB, Zhang T, Boscarino JA, Vijayadeva V, Schmidt MA, Lu M. The validity of serum markers for fibrosis staging in chronic hepatitis B and C. J Viral Hepat. 2014;21:930-937. [PMID: 24472062 DOI: 10.1111/jvh.12224] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 9.9] [Reference Citation Analysis]
229 Gourtsoyianni S, Santinha J, Matos C, Papanikolaou N. Diffusion-weighted imaging and texture analysis: current role for diffuse liver disease. Abdom Radiol (NY) 2020;45:3523-31. [PMID: 33064169 DOI: 10.1007/s00261-020-02772-4] [Reference Citation Analysis]
230 Goodman ZD. Liver Biopsy Diagnosis of Cirrhosis. In: Berzigotti A, Bosch J, editors. Diagnostic Methods for Cirrhosis and Portal Hypertension. Cham: Springer International Publishing; 2018. pp. 17-31. [DOI: 10.1007/978-3-319-72628-1_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
231 Reeder SB, Sirlin CB. Quantification of liver fat with magnetic resonance imaging. Magn Reson Imaging Clin N Am. 2010;18:337-357, ix. [PMID: 21094444 DOI: 10.1016/j.mric.2010.08.013] [Cited by in Crossref: 172] [Cited by in F6Publishing: 158] [Article Influence: 17.2] [Reference Citation Analysis]
232 Schneider AR, Teuber G, Kriener S, Caspary WF. Noninvasive assessment of liver steatosis, fibrosis and inflammation in chronic hepatitis C virus infection. Liver Int 2005;25:1150-5. [PMID: 16343065 DOI: 10.1111/j.1478-3231.2005.01164.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
233 Chalouni M, Sogni P, Miailhes P, Lacombe K, Poizot-Martin I, Chas J, Vittecoq D, Neau D, Aumaitre H, Alric L, Piroth L, Bouchaud O, Katlama C, Morlat P, Lascoux-Combe C, Gervais A, Naqvi A, Rosenthal E, Garipuy D, Barange K, Esterle L, Salmon D, Wittkop L;  ANRS CO13 HEPAVIH study group. Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort. Eur J Gastroenterol Hepatol. 2019;31:1387-1396. [PMID: 31033848 DOI: 10.1097/meg.0000000000001408] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
234 Loaeza-del-castillo A, Paz-pineda F, Oviedo-cárdenas E, Sánchez-ávila F, Vargas-vorácková F. AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis. Annals of Hepatology 2008;7:350-7. [DOI: 10.1016/s1665-2681(19)31836-8] [Cited by in Crossref: 108] [Article Influence: 8.3] [Reference Citation Analysis]
235 Sang C, Yan H, Chan WK, Zhu X, Sun T, Chang X, Xia M, Sun X, Hu X, Gao X, Jia W, Bian H, Chen T, Xie G. Diagnosis of Fibrosis Using Blood Markers and Logistic Regression in Southeast Asian Patients With Non-alcoholic Fatty Liver Disease. Front Med (Lausanne) 2021;8:637652. [PMID: 33708783 DOI: 10.3389/fmed.2021.637652] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
236 Gómez-Dominguez E, Mendoza J, García-Buey L, Trapero M, Gisbert JP, Jones EA, Moreno-Otero R. Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis. Aliment Pharmacol Ther. 2008;27:441-447. [PMID: 18081731 DOI: 10.1111/j.1365-2036.2007.03585.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]
237 Hayashi T, Fukuzawa K, Kondo H, Onodera H, Toyotaka S, Tojo R, Yano S, Tano M, Miyati T, Kotoku J, Okamoto T, Toyoda K, Oba H. Influence of Gd-EOB-DTPA on proton density fat fraction using the six-echo Dixon method in 3 Tesla magnetic resonance imaging. Radiol Phys Technol 2017;10:483-8. [DOI: 10.1007/s12194-017-0420-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
238 Rosenthal-allieri MA, Tran A, Halfon P, Imbert-bismut F, Munteanu M, Messous D, Peritore M, Poynard T, Bernard A. Optimal correlation between different instruments for Fibrotest-Actitest protein measurement in patients with chronic hepatitis C. Gastroentérologie Clinique et Biologique 2007;31:815-21. [DOI: 10.1016/s0399-8320(07)73971-4] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
239 Theise ND. Liver biopsy assessment in chronic viral hepatitis: a personal, practical approach. Mod Pathol. 2007;20 Suppl 1:S3-14. [PMID: 17486049 DOI: 10.1038/modpathol.3800693] [Cited by in Crossref: 95] [Cited by in F6Publishing: 83] [Article Influence: 6.8] [Reference Citation Analysis]
240 Singh S, Muir AJ, Dieterich DT, Falck-Ytter YT. American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases. Gastroenterology 2017;152:1544-77. [PMID: 28442120 DOI: 10.1053/j.gastro.2017.03.016] [Cited by in Crossref: 135] [Cited by in F6Publishing: 137] [Article Influence: 33.8] [Reference Citation Analysis]
241 Wadhva RK, Haque MM, Luck NH, Tasneem AA, Abbas Z, Mubarak M. Diagnostic Accuracy of Aspartate Aminotransferase to Platelet Ratio Index and Fibrosis 4 Scores in Predicting Advanced Liver Fibrosis in Patients with End-stage Renal Disease and Chronic Viral Hepatitis: Experience from Pakistan. J Transl Int Med 2018;6:38-42. [PMID: 29607303 DOI: 10.2478/jtim-2018-0008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
242 Morling JR, Guha IN. Biomarkers of liver fibrosis. Clin Liver Dis (Hoboken) 2016;7:139-42. [PMID: 31041049 DOI: 10.1002/cld.555] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
243 Mak LY, Seto WK, Hui RW, Fung J, Wong DK, Lai CL, Yuen MF. Fibrosis evolution in chronic hepatitis B e antigen-negative patients across a 10-year interval. J Viral Hepat 2019;26:818-27. [PMID: 30895682 DOI: 10.1111/jvh.13095] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
244 Yoo BW, Choi JY, Eun LY, Park HK, Park YH, Kim SU. Congestive hepatopathy after Fontan operation and related factors assessed by transient elastography. J Thorac Cardiovasc Surg. 2014;148:1498-1505. [PMID: 24823284 DOI: 10.1016/j.jtcvs.2014.04.010] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
245 Morikawa H, Kawada N. Non-invasive diagnosis of liver fibrosis. Clin J Gastroenterol 2011;4:283-91. [DOI: 10.1007/s12328-011-0248-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
246 Fontana RJ. Nonresponders to hepatitis C virus antiviral therapy: pegylated interferons and beyond. Gastroenterology Clinics of North America 2004;33:527-47. [DOI: 10.1016/j.gtc.2004.04.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
247 Conti F, Serra C, Vukotic R, Fiorini E, Felicani C, Mazzotta E, D'Errico A, Verucchi G, Lenzi M, Andreone P. Accuracy of elastography point quantification and steatosis influence on assessing liver fibrosis in patients with chronic hepatitis C. Liver Int 2017;37:187-95. [PMID: 27369740 DOI: 10.1111/liv.13197] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
248 Mikołajczyk-Korniak N, Tronina O, Ślubowska K, Perkowska-Ptasińska A, Pacholczyk M, Bączkowska T, Durlik M. Dynamic Elastography in Diagnostics of Liver Fibrosis in Patients After Liver Transplantation Due to Cirrhosis in the Course of Hepatitis C. Transplant Proc 2016;48:1725-9. [PMID: 27496480 DOI: 10.1016/j.transproceed.2016.01.081] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
249 Unal E, Idilman IS, Karçaaltıncaba M. Multiparametric or practical quantitative liver MRI: towards millisecond, fat fraction, kilopascal and function era. Expert Rev Gastroenterol Hepatol 2017;11:167-82. [PMID: 27937040 DOI: 10.1080/17474124.2017.1271710] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
250 Borroni G, Ceriani R, Cazzaniga M, Tommasini M, Roncalli M, Maltempo C, Felline C, Salerno F. Comparison of simple tests for the non-invasive diagnosis of clinically silent cirrhosis in chronic hepatitis C. Aliment Pharmacol Ther 2006;24:797-804. [PMID: 16918883 DOI: 10.1111/j.1365-2036.2006.03034.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
251 Cheung KJ, Tilleman K, Deforce D, Colle I, Van Vlierberghe H. Proteomics in liver fibrosis is more than meets the eye: . European Journal of Gastroenterology & Hepatology 2008;20:450-64. [DOI: 10.1097/meg.0b013e3282f4de92] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
252 Hamesch K, Strnad P. Non-Invasive Assessment and Management of Liver Involvement in Adults With Alpha-1 Antitrypsin Deficiency. Chronic Obstr Pulm Dis 2020;7:260-71. [PMID: 32697896 DOI: 10.15326/jcopdf.7.3.2019.0161] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
253 Chen SS, Yu KK, Ling QX, Huang C, Li N, Zheng JM, Bao SX, Cheng Q, Zhu MQ, Chen MQ. Factors associated with significant liver necroinflammation in chronic hepatitis B patients with cirrhosis. Sci Rep 2016;6:33093. [PMID: 27615602 DOI: 10.1038/srep33093] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
254 Ichikawa S, Motosugi U, Nakazawa T, Morisaka H, Sano K, Ichikawa T, Enomoto N, Matsuda M, Fujii H, Onishi H. Hepatitis activity should be considered a confounder of liver stiffness measured with MR elastography. J Magn Reson Imaging 2015;41:1203-8. [PMID: 24889753 DOI: 10.1002/jmri.24666] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
255 Righi S, Fiorini E, De Molo C, Cipriano V, Cassani F, Muratori L, Lenzi M, Morselli Labate AM, Serra C. ARFI elastography in patients with chronic autoimmune liver diseases: A preliminary study. J Ultrasound. 2012;15:226-231. [PMID: 23730386 DOI: 10.1016/j.jus.2012.10.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
256 Cross TJ, Quaglia A, Hughes S, Joshi D, Harrison PM. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection. J Viral Hepat. 2009;16:492-499. [PMID: 19200134 DOI: 10.1111/j.1365-2893.2009.01098.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
257 Saito K, Tajima Y, Harada TL. Diffusion-weighted imaging of the liver: Current applications. World J Radiol 2016; 8(11): 857-867 [PMID: 27928467 DOI: 10.4329/wjr.v8.i11.857] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
258 Fransen van de Putte DE, Fischer K, de Knegt RJ, Posthouwer D, van Erpecum KJ, Biesma DH, Mauser-Bunschoten EP. Beneficial effect of successful HCV treatment in patients with inherited bleeding disorders, assessed by liver stiffness measurements. Haemophilia 2012;18:e266-72. [PMID: 22103568 DOI: 10.1111/j.1365-2516.2011.02697.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
259 Klibansky DA, Mehta SH, Curry M, Nasser I, Challies T, Afdhal NH. Transient elastography for predicting clinical outcomes in patients with chronic liver disease. J Viral Hepat. 2012;19:e184-e193. [PMID: 22239518 DOI: 10.1111/j.1365-2893.2011.01493.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 4.7] [Reference Citation Analysis]
260 Iwata R, Baur K, Stieger B, Mertens JC, Daly AK, Frei P, Braun J, Vergopoulos A, Stickel F, Sabrane K. A common polymorphism in the ABCB11 gene is associated with advanced fibrosis in hepatitis C but not in non-alcoholic fatty liver disease. Clin Sci (Lond). 2011;120:287-296. [PMID: 20883210 DOI: 10.1042/cs20100246] [Cited by in Crossref: 33] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
261 Kapadia AJ, Tourassi GD, Sharma AC, Crowell AS, Kiser MR, Howell CR. Experimental detection of iron overload in liver through neutron stimulated emission spectroscopy. Phys Med Biol 2008;53:2633-49. [PMID: 18443387 DOI: 10.1088/0031-9155/53/10/013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
262 Loko MA, Castera L, Dabis F, Le Bail B, Winnock M, Coureau G, Bioulac-Sage P, de Ledinghen V, Neau D. Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort. Am J Gastroenterol. 2008;103:1973-1980. [PMID: 18796094 DOI: 10.1111/j.1572-0241.2008.01954.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 3.9] [Reference Citation Analysis]
263 Koizumi Y, Hirooka M, Tamaki N, Yada N, Nakashima O, Izumi N, Kudo M, Hiasa Y. New diagnostic technique to evaluate hepatic steatosis using the attenuation coefficient on ultrasound B mode. PLoS One 2019;14:e0221548. [PMID: 31454369 DOI: 10.1371/journal.pone.0221548] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
264 Mendes LC, Ferreira PA, Miotto N, Zanaga L, Gonçales ESL, Pedro MN, Lazarini MS, Júnior FLG, Stucchi RSB, Vigani AG. Elastogram quality assessment score in vibration-controlled transient elastography: Diagnostic performance compared to digital morphometric analysis of liver biopsy in chronic hepatitis C. J Viral Hepat 2018;25:335-43. [PMID: 29091321 DOI: 10.1111/jvh.12822] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
265 Ki YJ, Ji SH, Min JS, Jin SH, Park S, Yu HJ, Bang HY, Lee JI. Test execution variation in peritoneal lavage cytology could be related to poor diagnostic accuracy and stage migration in patients with gastric cancer. J Gastric Cancer 2013;13:214-25. [PMID: 24511417 DOI: 10.5230/jgc.2013.13.4.214] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
266 Kishanifarahani Z, Ahadi M, Kazeminejad B, Mollasharifi T, Saber Afsharian M, Sadeghi A, Bidari F, Jamali E, Hasanzadeh N, Movafagh A, Dehghan A, Moradi A, Moradi A. Inter-observer Variability in Histomorphological Evaluation of Non-neoplastic Liver Biopsy Tissue and Impact of Clinical Information on Final Diagnosis in Shahid Beheshti University of Medical Sciences Affiliated Hospitals. Iran J Pathol 2019;14:243-7. [PMID: 31583002 DOI: 10.30699/ijp.2019.99566.1985] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
267 Ichikawa S, Motosugi U, Morisaka H, Sano K, Ichikawa T, Enomoto N, Matsuda M, Fujii H, Onishi H. MRI-based staging of hepatic fibrosis: Comparison of intravoxel incoherent motion diffusion-weighted imaging with magnetic resonance elastography: IVIM vs. MRE for Hepatic Fibrosis. J Magn Reson Imaging 2015;42:204-10. [DOI: 10.1002/jmri.24760] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 7.0] [Reference Citation Analysis]
268 Lédinghen V, Vergniol J, Foucher J, Merrouche W, Bail B. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. Liver Int 2012;32:911-8. [DOI: 10.1111/j.1478-3231.2012.02820.x] [Cited by in Crossref: 206] [Cited by in F6Publishing: 189] [Article Influence: 22.9] [Reference Citation Analysis]
269 Byenfeldt M, Elvin A, Fransson P. On Patient Related Factors and Their Impact on Ultrasound-Based Shear Wave Elastography of the Liver. Ultrasound Med Biol 2018;44:1606-15. [PMID: 29735314 DOI: 10.1016/j.ultrasmedbio.2018.03.031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
270 Adams LA, Angulo P. Vitamins E and C for the treatment of NASH: duplication of results but lack of demonstration of efficacy. Am J Gastroenterol. 2003;98:2348-2350. [PMID: 14638333 DOI: 10.1111/j.1572-0241.2003.08695.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
271 Salarian M, Turaga RC, Xue S, Nezafati M, Hekmatyar K, Qiao J, Zhang Y, Tan S, Ibhagui OY, Hai Y, Li J, Mukkavilli R, Sharma M, Mittal P, Min X, Keilholz S, Yu L, Qin G, Farris AB, Liu ZR, Yang JJ. Early detection and staging of chronic liver diseases with a protein MRI contrast agent. Nat Commun 2019;10:4777. [PMID: 31664017 DOI: 10.1038/s41467-019-11984-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
272 Malik R, Afdhal N. Stiffness and Impedance: The New Liver Biomarkers. Clinical Gastroenterology and Hepatology 2007;5:1144-6. [DOI: 10.1016/j.cgh.2007.07.024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
273 Hennedige TP, Wang G, Leung FP, Alsaif HS, Teo LL, Lim SG, Wee A, Venkatesh SK. Magnetic Resonance Elastography and Diffusion Weighted Imaging in the Evaluation of Hepatic Fibrosis in Chronic Hepatitis B. Gut Liver. 2017;11:401-408. [PMID: 27965475 DOI: 10.5009/gnl16079] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 8.7] [Reference Citation Analysis]
274 Hong Y, Shi Y, Liao W, Klahr N, Xia F, Xu C, Li Y, Guo Q. Relative ADC measurement for liver fibrosis diagnosis in chronic hepatitis B using spleen/renal cortex as the reference organs at 3 T. Clinical Radiology 2014;69:581-8. [DOI: 10.1016/j.crad.2014.01.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
275 Hanafy AS, Basha MAK, Wadea FM. Novel markers of endothelial dysfunction in hepatitis C virus-related cirrhosis: More than a mere prediction of esophageal varices. World J Hepatol 2020; 12(10): 850-862 [PMID: 33200022 DOI: 10.4254/wjh.v12.i10.850] [Reference Citation Analysis]
276 Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371:838-851. [PMID: 18328931 DOI: 10.1016/s0140-6736(08)60383-9] [Cited by in Crossref: 1212] [Cited by in F6Publishing: 538] [Article Influence: 93.2] [Reference Citation Analysis]
277 Faria SC, Ganesan K, Mwangi I, Shiehmorteza M, Viamonte B, Mazhar S, Peterson M, Kono Y, Santillan C, Casola G. MR imaging of liver fibrosis: current state of the art. Radiographics. 2009;29:1615-1635. [PMID: 19959511 DOI: 10.1148/rg.296095512] [Cited by in Crossref: 168] [Cited by in F6Publishing: 145] [Article Influence: 15.3] [Reference Citation Analysis]
278 Verhelst XP, Troisi RI, Colle I, Geerts A, van Vlierberghe H. Biomarkers for the diagnosis of acute cellular rejection in liver transplant recipients: A review. Hepatol Res. 2013;43:165-178. [PMID: 23186289 DOI: 10.1111/hepr.12012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
279 Bende F, Sporea I, Şirli R, Nistorescu S, Fofiu R, Bâldea V, Popescu A. The Performance of a 2-Dimensional Shear-Wave Elastography Technique for Predicting Different Stages of Liver Fibrosis Using Transient Elastography as the Control Method. Ultrasound Q 2020;37:97-104. [PMID: 33136935 DOI: 10.1097/RUQ.0000000000000527] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
280 Sagnelli C, Martini S, Pisaturo M, Pasquale G, Macera M, Zampino R, Coppola N, Sagnelli E. Liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact. World J Hepatol 2015; 7(24): 2510-2521 [PMID: 26523204 DOI: 10.4254/wjh.v7.i24.2510] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
281 Ratziu V, Poynard T. NASH: a hidden and silent fibroser finally revealed? Journal of Hepatology 2005;42:12-4. [DOI: 10.1016/j.jhep.2004.11.027] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
282 Liang B, Li Y, Zhao A, Xie F, Guo Z. Clinical utility of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 concentrations in the assessment of liver fibrosis due to chronic hepatitis B. J Int Med Res. 2012;40:631-639. [PMID: 22613424 DOI: 10.1177/147323001204000225] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
283 Vergara S, Macías J, Rivero A, Gutiérrez-Valencia A, González-Serrano M, Merino D, Ríos MJ, García-García JA, Camacho A, López-Cortés L, Ruiz J, de la Torre J, Viciana P, Pineda JA; Grupo para el Estudio de las Hepatitis Viricas de la SAEI. The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection. Clin Infect Dis 2007;45:969-74. [PMID: 17879910 DOI: 10.1086/521857] [Cited by in Crossref: 142] [Cited by in F6Publishing: 131] [Article Influence: 10.1] [Reference Citation Analysis]
284 Bansal MB, Friedman SL. Hepatic Fibrogenesis. In: Dooley JS, Lok ASF, Burroughs AK, Heathcote EJ, editors. Sherlock's Diseases of the Liver and Biliary System. Oxford: Wiley-Blackwell; 2011. pp. 94-102. [DOI: 10.1002/9781444341294.ch6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
285 Batheja M, Vargas H, Silva AM, Walker F, Chang YH, De Petris G, Silva AC. Magnetic resonance elastography (MRE) in assessing hepatic fibrosis: performance in a cohort of patients with histological data. Abdom Imaging. 2015;40:760-765. [PMID: 25542217 DOI: 10.1007/s00261-014-0321-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
286 Park GJ, Katelaris PH, Jones DB, Seow F, Lin BPC, Le Couteur DG, Ngu MC. The 13C-caffeine breath test distinguishes significant fibrosis in chronic hepatitis B and reflects response to lamivudine therapy. Aliment Pharmacol Ther 2005;22:395-403. [DOI: 10.1111/j.1365-2036.2005.02623.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
287 Kemp SD, Zimmerman KL, Panciera DL, Monroe WE, Leib MS. Histopathologic variation between liver lobes in dogs. J Vet Intern Med 2015;29:58-62. [PMID: 25581717 DOI: 10.1111/jvim.12520] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
288 Garcia-Tsao G, Friedman S, Iredale J, Pinzani M. Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis. Hepatology. 2010;51:1445-1449. [PMID: 20077563 DOI: 10.1002/hep.23478] [Cited by in Crossref: 319] [Cited by in F6Publishing: 291] [Article Influence: 29.0] [Reference Citation Analysis]
289 Yang L, Ling W, He D, Lu C, Ma L, Tang L, Luo Y, Chen S. Shear wave-based sound touch elastography in liver fibrosis assessment for patients with autoimmune liver diseases. Quant Imaging Med Surg 2021;11:1532-42. [PMID: 33816189 DOI: 10.21037/qims-20-521] [Reference Citation Analysis]
290 Abrams GA, Kunde SS, Lazenby AJ, Clements RH. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease. Hepatology. 2004;40:475-483. [PMID: 15368453 DOI: 10.1002/hep.20323] [Cited by in Crossref: 129] [Cited by in F6Publishing: 119] [Article Influence: 7.6] [Reference Citation Analysis]
291 Kohla MAS, Abbasy M, Abozeid M, El-Abd O, Ezzat S, Kohla S, Abdel-Rahman M. Assessment of liver fibrosis with acoustic radiation force impulse imaging versus liver histology in patients with chronic hepatitis C: a pilot study. Eur J Gastroenterol Hepatol 2017;29:951-5. [PMID: 28471822 DOI: 10.1097/MEG.0000000000000903] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
292 Merriman RB, Ferrell LD, Patti MG, Weston SR, Pabst MS, Aouizerat BE, Bass NM. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology. 2006;44:874-880. [PMID: 17006934 DOI: 10.1002/hep.21346] [Cited by in Crossref: 213] [Cited by in F6Publishing: 204] [Article Influence: 14.2] [Reference Citation Analysis]
293 Higaki A, Ito K, Tamada T, Teruki S, Yamamoto A, Higashi H, Kanki A, Sato T, Noda Y. High-risk nodules detected in the hepatobiliary phase of Gd-EOB-DTPA-enhanced mr imaging in cirrhosis or chronic hepatitis: Incidence and predictive factors for hypervascular transformation, preliminary results. J Magn Reson Imaging 2013;37:1377-83. [DOI: 10.1002/jmri.23933] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
294 Tawada A, Maruyama H, Kamezaki H, Shimada T, Ishibashi H, Takahashi M, Kanda T, Fujiwara K, Imazeki F, Yokosuka O. Magnitude of contrast-enhanced ultrasonography as a noninvasive predictor for hepatic fibrosis: comparison with liver stiffness measurement and serum-based models. Hepatol Int 2013;7:749-57. [PMID: 26201810 DOI: 10.1007/s12072-012-9370-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
295 Nielsen MJ, Veidal SS, Karsdal MA, Ørsnes-leeming DJ, Vainer B, Gardner SD, Hamatake R, Goodman ZD, Schuppan D, Patel K. Plasma Pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C. Liver Int 2015;35:429-37. [DOI: 10.1111/liv.12700] [Cited by in Crossref: 85] [Cited by in F6Publishing: 77] [Article Influence: 12.1] [Reference Citation Analysis]
296 Reeder SB, Robson PM, Yu H, Shimakawa A, Hines CD, McKenzie CA, Brittain JH. Quantification of hepatic steatosis with MRI: the effects of accurate fat spectral modeling. J Magn Reson Imaging. 2009;29:1332-1339. [PMID: 19472390 DOI: 10.1002/jmri.21751] [Cited by in Crossref: 178] [Cited by in F6Publishing: 168] [Article Influence: 14.8] [Reference Citation Analysis]
297 Lin B, Ma Y, Wu S, Liu Y, Liu L, Wu L. Novel Serum Biomarkers for Noninvasive Diagnosis and Screening of Nonalcoholic Fatty Liver Disease-Related Hepatic Fibrosis. OMICS 2019;23:181-9. [PMID: 30932742 DOI: 10.1089/omi.2019.0035] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
298 Stauber RE, Lackner C. Noninvasive diagnosis of hepatic fibrosis in chronic hepatitis C. World J Gastroenterol 2007; 13(32): 4287-4294 [PMID: 17708599 DOI: 10.3748/wjg.v13.i32.4287] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
299 Sarfaraz MO, Myers RP, Coffin CS, Gao ZH, Shaheen AA, Crotty PM, Zhang P, Vogel HJ, Weljie AM. A quantitative metabolomics profiling approach for the noninvasive assessment of liver histology in patients with chronic hepatitis C. Clin Transl Med. 2016;5:33. [PMID: 27539580 DOI: 10.1186/s40169-016-0109-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
300 Foucher J, Reiller B, Jullien V, Léal F, di Cesare ES, Merrouche W, Delile JM, de Lédinghen V. FibroScan used in street-based outreach for drug users is useful for hepatitis C virus screening and management: a prospective study. J Viral Hepat 2009;16:121-31. [PMID: 19175876 DOI: 10.1111/j.1365-2893.2008.01050.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
301 Pham TTT, Ho DT, Nguyen T. Usefulness of Mac-2 binding protein glycosylation isomer in non-invasive probing liver disease in the Vietnamese population. World J Hepatol 2020; 12(5): 220-229 [PMID: 32547689 DOI: 10.4254/wjh.v12.i5.220] [Reference Citation Analysis]
302 Zhang Y, Shi Y, Wu R, Wang X, Gao X, Niu J. Primary biliary cholangitis is more severe in previous hepatitis B virus infection patients. Eur J Gastroenterol Hepatol. 2018;30:682-686. [PMID: 29462025 DOI: 10.1097/meg.0000000000001100] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
303 Andrés-Otero MJ, De-Blas-Giral I, Puente-Lanzarote JJ, Serrano-Aulló T, Morandeira MJ, Lorente S, Lou-Bonafonte JM. Multiple approaches to assess fourteen non-invasive serum indexes for the diagnosis of liver fibrosis in chronic hepatitis C patients. Clin Biochem 2016;49:560-5. [PMID: 26968102 DOI: 10.1016/j.clinbiochem.2015.12.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
304 Ghany MG, Strader DB, Thomas DL, Seeff LB; American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009;49:1335-74. [PMID: 19330875 DOI: 10.1002/hep.22759] [Cited by in Crossref: 2134] [Cited by in F6Publishing: 1940] [Article Influence: 177.8] [Reference Citation Analysis]
305 Jiang C, Shen L, Xia L, Sun S, Fang W, Feng Q, Dong H, Ma Z. Mixed Imaging on Port-Venous Phase of Contrast-Enhanced Dual-Source Dual-Energy Computed Tomography: A Measurement Method Based on Couinaud Segments. J Comput Assist Tomogr 2018;42:944-53. [PMID: 30407245 DOI: 10.1097/RCT.0000000000000820] [Reference Citation Analysis]
306 Cengiz M, Ozenirler S. Comparative diagnostic accuracy of red cell distribution width-to-platelet ratio versus noninvasive fibrosis scores for the diagnosis of liver fibrosis in biopsy-proven nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2015;27:1293-1299. [PMID: 26302023 DOI: 10.1097/meg.0000000000000445] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
307 Varma P, Jayasekera C, Gibson RN, Stella DL, Nicoll AJ. The changing place of liver biopsy in clinical practice: an audit of an Australian tertiary hospital: Brief Communications. Intern Med J 2014;44:805-8. [DOI: 10.1111/imj.12503] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
308 Zhang D, Chen M, Wang R, Liu Y, Zhang D, Liu L, Zhou G. Comparison of acoustic radiation force impulse imaging and transient elastography for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B. Ultrasound Med Biol. 2015;41:7-14. [PMID: 25308941 DOI: 10.1016/j.ultrasmedbio.2014.07.018] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
309 Ahn J, Ahn JH, Yoon S, Son MY, Cho S, Oh JH. Quantification of non-alcoholic fatty liver disease progression in 3D liver microtissues using impedance spectroscopy. Biomaterials 2021;268:120599. [PMID: 33341736 DOI: 10.1016/j.biomaterials.2020.120599] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
310 Yu H, Touret A, Li B, O'brien M, Qureshi MM, Soto JA, Jara H, Anderson SW. Application of texture analysis on parametric T1 and T2 maps for detection of hepatic fibrosis: Texture Analysis on Parametric T1 and T2. J Magn Reson Imaging 2017;45:250-9. [DOI: 10.1002/jmri.25328] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
311 Shah AG, Smith PG, Sterling RK. Comparison of FIB-4 and APRI in HIV-HCV coinfected patients with normal and elevated ALT. Dig Dis Sci 2011;56:3038-44. [PMID: 21526398 DOI: 10.1007/s10620-011-1710-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
312 Robert M, Sofair AN, Thomas A, Bell B, Bialek S, Corless C, Van Ness G, Huie-White S, Stabach N, Zaman A. A comparison of hepatopathologists' and community pathologists' review of liver biopsy specimens from patients with hepatitis C. Clin Gastroenterol Hepatol. 2009;7:335-338. [PMID: 19138761 DOI: 10.1016/j.cgh.2008.11.029] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
313 Tsui PH, Zhou Z, Lin YH, Hung CM, Chung SJ, Wan YL. Effect of ultrasound frequency on the Nakagami statistics of human liver tissues. PLoS One 2017;12:e0181789. [PMID: 28763461 DOI: 10.1371/journal.pone.0181789] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
314 Park BJ, Kim YJ, Kim DH, Kim W, Jung YJ, Yoon JH, Kim CY, Cho YM, Kim SH, Lee KB, Jang JJ, Lee HS. Visceral adipose tissue area is an independent risk factor for hepatic steatosis. J Gastroenterol Hepatol. 2008;23:900-907. [PMID: 17995942 DOI: 10.1111/j.1440-1746.2007.05212.x] [Cited by in Crossref: 94] [Cited by in F6Publishing: 95] [Article Influence: 6.7] [Reference Citation Analysis]
315 Keller J, Kaltenbach TE, Haenle MM, Oeztuerk S, Graeter T, Mason RA, Seufferlein T, Kratzer W. Comparison of Acoustic Structure Quantification (ASQ), shearwave elastography and histology in patients with diffuse hepatopathies. BMC Med Imaging. 2015;15:58. [PMID: 26637242 DOI: 10.1186/s12880-015-0100-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
316 Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371:838-851. [PMID: 18328931 DOI: 10.1056/s0140-6736(08)60383-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
317 Gonzalez HC, Jafri SM, Gordon SC. Role of Liver Biopsy in the Era of Direct-Acting Antivirals. Curr Gastroenterol Rep 2013;15. [DOI: 10.1007/s11894-012-0307-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
318 Rutledge SM, Im GY. Current and Future Biomarkers in Alcoholic Hepatitis. Clin Liver Dis 2021;25:493-516. [PMID: 34229836 DOI: 10.1016/j.cld.2021.03.010] [Reference Citation Analysis]
319 Lee JG, Sohn JH, Jeong JY, Kim TY, Kim SM, Cho YS, Kim Y. Combined effect of hepatic venous pressure gradient and liver stiffness on long-term mortality in patients with cirrhosis. Korean J Intern Med 2020;35:88-98. [PMID: 30791681 DOI: 10.3904/kjim.2018.151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
320 Yen YH, Kuo FY, Kee KM, Chang KC, Tsai MC, Hu TH, Lu SN, Wang JH, Hung CH, Chen CH. APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level. PLoS One. 2018;13:e0199760. [PMID: 29953518 DOI: 10.1371/journal.pone.0199760] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
321 Zhang YN, Fowler KJ, Ozturk A, Potu CK, Louie AL, Montes V, Henderson WC, Wang K, Andre MP, Samir AE, Sirlin CB. Liver fibrosis imaging: A clinical review of ultrasound and magnetic resonance elastography. J Magn Reson Imaging 2020;51:25-42. [PMID: 30859677 DOI: 10.1002/jmri.26716] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
322 Chou CT, Chen RC, Wu WP, Lin PY, Chen YL. Prospective Comparison of the Diagnostic Performance of Magnetic Resonance Elastography with Acoustic Radiation Force Impulse Elastography for Pre-operative Staging of Hepatic Fibrosis in Patients with Hepatocellular Carcinoma. Ultrasound Med Biol. 2017;43:2783-2790. [PMID: 28965721 DOI: 10.1016/j.ultrasmedbio.2017.08.1879] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
323 Vidovic N, Lochowsky RS, Goldmann G, Rockstroh J, Wasmuth JC, Spengler U, Sauerbruch T, Lammert F, Oldenburg J, Grünhage F. Correlation of transient elastography with APRI and FIB-4 in a cohort of patients with congenital bleeding disorders and HCV or HIV/HCV coinfection: NON-INVASIVE MARKERS IN HCV-POSITIVE HAEMOPHILIC PATIENTS. Haemophilia 2010;16:778-85. [DOI: 10.1111/j.1365-2516.2010.02204.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
324 Zhou IY, Gao DS, Chow AM, Fan S, Cheung MM, Ling C, Liu X, Cao P, Guo H, Man K, Wu EX. Effect of diffusion time on liver DWI: An experimental study of normal and fibrotic livers: Effects of Diffusion Time on Liver DWI. Magn Reson Med 2014;72:1389-96. [DOI: 10.1002/mrm.25035] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
325 Liu J, Ren W, Ai H, Dun G, Ji Y, Zhang Y, Wan Q, Lin S. Acoustic Structure Quantification Versus Point Shear Wave Speed Measurement for the Assessment of Liver Fibrosis in Viral Hepatitis B. Ultrasound Med Biol 2018;44:1177-86. [PMID: 29609809 DOI: 10.1016/j.ultrasmedbio.2018.02.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
326 Motola DL, Caravan P, Chung RT, Fuchs BC. Noninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future Directions. Curr Pathobiol Rep 2014;2:245-56. [PMID: 25396099 DOI: 10.1007/s40139-014-0061-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
327 Koizumi Y, Hirooka M, Abe M, Tokumoto Y, Yoshida O, Watanabe T, Nakamura Y, Imai Y, Yukimoto A, Kumagi T, Takeshita E, Ikeda Y, Hiasa Y. Comparison between real-time tissue elastography and vibration-controlled transient elastography for the assessment of liver fibrosis and disease progression in patients with primary biliary cholangitis. Hepatol Res. 2017;47:1252-1259. [PMID: 28044427 DOI: 10.1111/hepr.12861] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
328 Wang J, Xia J, Zhang R, Yan X, Yang Y, Zhao X, Chang H, Wang G, Chen G, Liu Y, Chen Y, Jia B, Zhang Z, Ding W, Huang R, Wu C. A novel index using routine clinical parameters for predicting significant liver inflammation in chronic hepatitis B. J Viral Hepat 2018;25:1151-60. [PMID: 29741221 DOI: 10.1111/jvh.12925] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
329 Tsai E, Lee TP. Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography. Clin Liver Dis. 2018;22:73-92. [PMID: 29128062 DOI: 10.1016/j.cld.2017.08.004] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 11.3] [Reference Citation Analysis]
330 Myers RP, Crotty P, Pomier-layrargues G, Ma M, Urbanski SJ, Elkashab M. Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy: Discordances between biopsy and elastography. Liver International 2010;30:1471-80. [DOI: 10.1111/j.1478-3231.2010.02331.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 5.5] [Reference Citation Analysis]
331 Huang Y, Qi Y, Zhan C, Zeng F, Wu S. Diagnosing Drug-Induced Liver Injury by Multispectral Optoacoustic Tomography and Fluorescence Imaging Using a Leucine-Aminopeptidase-Activated Probe. Anal Chem 2019;91:8085-92. [DOI: 10.1021/acs.analchem.9b00107] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 14.0] [Reference Citation Analysis]
332 Forestier J, Dumortier J, Guillaud O, Ecochard M, Roman S, Boillot O, Lutringer D, Scoazec JY, Subtil F, Mion F. Noninvasive diagnosis and prognosis of liver cirrhosis: a comparison of biological scores, elastometry, and metabolic liver function tests. Eur J Gastroenterol Hepatol. 2010;22:532-540. [PMID: 20164779 DOI: 10.1097/meg.0b013e3283343f58] [Cited by in Crossref: 33] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
333 Cheung KJ, Libbrecht L, Tilleman K, Deforce D, Colle I, Van Vlierberghe H. Galectin-3-binding protein: a serological and histological assessment in accordance with hepatitis C-related liver fibrosis. Eur J Gastroenterol Hepatol. 2010;22:1066-1073. [PMID: 20186066 DOI: 10.1097/MEG.0b013e328337d602] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
334 D’Onofrio M, Crosara S, De Robertis R, Canestrini S, Demozzi E, Gallotti A, Mucelli RP. Acoustic radiation force impulse of the liver. World J Gastroenterol 2013; 19(30): 4841-4849 [PMID: 23946588 DOI: 10.3748/wjg.v19.i30.4841] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 36] [Article Influence: 5.4] [Reference Citation Analysis]
335 Qi X, An M, Wu T, Jiang D, Peng M, Wang W, Wang J, Zhang C, Chess Study Group OBOT. Transient Elastography for Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B: A Meta-Analysis. Can J Gastroenterol Hepatol 2018;2018:3406789. [PMID: 29977884 DOI: 10.1155/2018/3406789] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
336 Becker L, Salameh W, Sferruzza A, Zhang K, ng Chen R, Malik R, Reitz R, Nasser I, Afdhal NH. Validation of hepascore, compared with simple indices of fibrosis, in patients with chronic hepatitis C virus infection in United States. Clin Gastroenterol Hepatol. 2009;7:696-701. [PMID: 19514117 DOI: 10.1016/j.cgh.2009.01.010] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 3.9] [Reference Citation Analysis]
337 Mbaye PS, Sarr A, Sire JM, Evra ML, Ba A, Daveiga J, Diallo A, Fall F, Chartier L, Simon F, Vray M. Liver stiffness measurement and biochemical markers in Senegalese chronic hepatitis B patients with normal ALT and high viral load. PLoS One 2011;6:e22291. [PMID: 21799814 DOI: 10.1371/journal.pone.0022291] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
338 Chen Y, Luo Y, Huang W, Hu D, Zheng RQ, Cong SZ, Meng FK, Yang H, Lin HJ, Sun Y, Wang XY, Wu T, Ren J, Pei SF, Zheng Y, He Y, Hu Y, Yang N, Yan H. Machine-learning-based classification of real-time tissue elastography for hepatic fibrosis in patients with chronic hepatitis B. Comput Biol Med. 2017;89:18-23. [PMID: 28779596 DOI: 10.1016/j.compbiomed.2017.07.012] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 9.8] [Reference Citation Analysis]
339 Tom WW, Yeh BM, Cheng JC, Qayyum A, Joe B, Coakley FV. Hepatic Pseudotumor Due To Nodular Fatty Sparing: The Diagnostic Role of Opposed-Phase MRI. American Journal of Roentgenology 2004;183:721-4. [DOI: 10.2214/ajr.183.3.1830721] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
340 Shi Y, Guo Q, Xia F, Sun J, Gao Y. Short- and midterm repeatability of magnetic resonance elastography in healthy volunteers at 3.0 T. Magn Reson Imaging. 2014;32:665-670. [PMID: 24650683 DOI: 10.1016/j.mri.2014.02.018] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
341 Laursen TL, Sandahl TD, Kazankov K, George J, Grønbæk H. Liver-related effects of chronic hepatitis C antiviral treatment. World J Gastroenterol 2020; 26(22): 2931-2947 [PMID: 32587440 DOI: 10.3748/wjg.v26.i22.2931] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
342 Stine JG, Munaganuru N, Barnard A, Wang JL, Kaulback K, Argo CK, Singh S, Fowler KJ, Sirlin CB, Loomba R. Change in MRI-PDFF and Histologic Response in Patients With Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol 2020:S1542-3565(20)31220-9. [PMID: 32882428 DOI: 10.1016/j.cgh.2020.08.061] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
343 Chotiyaputta W, Degertekin B, McKenna BJ, Samala N, Fontana RJ, Lok AS. Characteristics of chronic hepatitis B patients who underwent liver biopsies. J Viral Hepat 2011;18:792-803. [PMID: 20726947 DOI: 10.1111/j.1365-2893.2010.01364.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
344 Ouyang GX, Zhang YM, Zhu SL, Wang P, Ren Y, Li JH, Liu YK, Chen J, Xiang BD, Li LQ, Liu JY, Zhang ZM. A novel, non-invasive model for diagnosing liver fibrosis stage in patients with hepatocellular carcinoma. Sci Rep 2018;8:13074. [PMID: 30166568 DOI: 10.1038/s41598-018-31351-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
345 Zhang L, Li QY, Duan YY, Yan GZ, Yang YL, Yang RJ. Artificial neural network aided non-invasive grading evaluation of hepatic fibrosis by duplex ultrasonography. BMC Med Inform Decis Mak 2012;12:55. [PMID: 22716936 DOI: 10.1186/1472-6947-12-55] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
346 Tonev D, Shumbayawonda E, Tetlow LA, Herdman L, French M, Rymell S, Thomaides-Brears H, Caseiro-Alves F, Castelo-Branco M, Ferreira C, Coenraad M, Lamb H, Beer M, Kelly M, Banerjee R, Dollinger M; RADIcAL1. The Effect of Multi-Parametric Magnetic Resonance Imaging in Standard of Care for Nonalcoholic Fatty Liver Disease: Protocol for a Randomized Control Trial. JMIR Res Protoc 2020;9:e19189. [PMID: 33104014 DOI: 10.2196/19189] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
347 Levine RA, Sanderson SO, Ploutz–snyder R, Murray F, Kay E, Hegarty J, Nolan N, Kelleher D, Mcdonald G, O’keane JC, Crowe J. Assessment of Fibrosis Progression in Untreated Irish Women With Chronic Hepatitis C Contracted From Immunoglobulin Anti-D. Clinical Gastroenterology and Hepatology 2006;4:1271-7. [DOI: 10.1016/j.cgh.2006.05.028] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
348 Leroy V, Hilleret MN, Sturm N, Trocme C, Renversez JC, Faure P, Morel F, Zarski JP. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C. J Hepatol. 2007;46:775-782. [PMID: 17321634 DOI: 10.1016/j.jhep.2006.12.013] [Cited by in Crossref: 164] [Cited by in F6Publishing: 148] [Article Influence: 11.7] [Reference Citation Analysis]
349 Zhang H, Chao WY, Cheng Q, Huang S, Wang X, Wu D, Xu G. Interstitial photoacoustic spectral analysis: instrumentation and validation. Biomed Opt Express 2017;8:1689-97. [PMID: 28663857 DOI: 10.1364/BOE.8.001689] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
350 Mushtaq S, Ghani E, Azam K, Hussain T. Comparison of chitinase-3-like protein 1, aspartate aminotransferase-to-platelet ratio index, and fibrosis-4 index with shear-wave elastography. Eur J Gastroenterol Hepatol 2019;31:357-62. [PMID: 30431458 DOI: 10.1097/MEG.0000000000001291] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
351 Tanwar S, Trembling PM, Hogan BJ, Parkes J, Harris S, Grant P, Nastouli E, Ocker M, Wehr K, Herold C, Neureiter D, Schuppan D, Rosenberg WM. Biomarkers of Hepatic Fibrosis in Chronic Hepatitis C: A Comparison of 10 Biomarkers Using 2 Different Assays for Hyaluronic Acid. J Clin Gastroenterol 2017;51:268-77. [PMID: 27380461 DOI: 10.1097/MCG.0000000000000581] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
352 Tatsumi C, Kudo M, Ueshima K, Kitai S, Takahashi S, Inoue T, Minami Y, Chung H, Maekawa K, Fujimoto K, Akiko T, Takeshi M. Noninvasive evaluation of hepatic fibrosis using serum fibrotic markers, transient elastography (FibroScan) and real-time tissue elastography. Intervirology. 2008;51 Suppl 1:27-33. [PMID: 18544945 DOI: 10.1159/000122602] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 5.3] [Reference Citation Analysis]
353 Sulkowski MS, Thomas DL. Epidemiology and natural history of hepatitis C virus infection in injection drug users: implications for treatment. Clin Infect Dis 2005;40 Suppl 5:S263-9. [PMID: 15768333 DOI: 10.1086/427440] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 2.0] [Reference Citation Analysis]
354 Ziol M, Handra-luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, de Lédinghen V, Marcellin P, Dhumeaux D, Trinchet J, Beaugrand M. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005;41:48-54. [DOI: 10.1002/hep.20506] [Cited by in Crossref: 1018] [Cited by in F6Publishing: 962] [Article Influence: 59.9] [Reference Citation Analysis]
355 Shiha G, Seif S, Eldesoky A, Elbasiony M, Soliman R, Metwally A, Zalata K, Mikhail N. A simple bedside blood test (Fibrofast; FIB-5) is superior to FIB-4 index for the differentiation between non-significant and significant fibrosis in patients with chronic hepatitis C. Hepatol Int 2017;11:286-91. [PMID: 28425016 DOI: 10.1007/s12072-017-9796-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
356 Lu M, Chacra W, Rabin D, Rupp LB, Trudeau S, Li J, Gordon SC. Validity of an automated algorithm using diagnosis and procedure codes to identify decompensated cirrhosis using electronic health records. Clin Epidemiol 2017;9:369-76. [PMID: 28744162 DOI: 10.2147/CLEP.S136134] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
357 Barr RG, Ferraioli G, Palmeri ML, Goodman ZD, Garcia-tsao G, Rubin J, Garra B, Myers RP, Wilson SR, Rubens D, Levine D. Elastography Assessment of Liver Fibrosis: Society of Radiologists in Ultrasound Consensus Conference Statement. Ultrasound Quarterly 2016;32:94-107. [DOI: 10.1097/ruq.0000000000000209] [Cited by in Crossref: 64] [Cited by in F6Publishing: 17] [Article Influence: 12.8] [Reference Citation Analysis]
358 Akima T, Tamano M, Hiraishi H. Liver stiffness measured by transient elastography is a predictor of hepatocellular carcinoma development in viral hepatitis. Hepatol Res. 2011;41:965-970. [PMID: 21883739 DOI: 10.1111/j.1872-034x.2011.00846.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
359 Wahl K, Rosenberg W, Vaske B, Manns MP, Schulze-Osthoff K, Bahr MJ, Bantel H. Biopsy-controlled liver fibrosis staging using the enhanced liver fibrosis (ELF) score compared to transient elastography. PLoS One 2012;7:e51906. [PMID: 23284811 DOI: 10.1371/journal.pone.0051906] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
360 Chen SH, Li YF, Lai HC, Kao JT, Peng CY, Chuang PH, Su WP, Chiang IP. Noninvasive assessment of liver fibrosis via spleen stiffness measurement using acoustic radiation force impulse sonoelastography in patients with chronic hepatitis B or C. J Viral Hepat. 2012;19:654-663. [PMID: 22863270 DOI: 10.1111/j.1365-2893.2012.01588.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
361 Huang R, Wang G, Tian C, Liu Y, Jia B, Wang J, Yang Y, Li Y, Sun Z, Yan X. Gamma-glutamyl-transpeptidase to platelet ratio is not superior to APRI,FIB-4 and RPR for diagnosing liver fibrosis in CHB patients in China. Sci Rep. 2017;7:8543. [PMID: 28819319 DOI: 10.1038/s41598-017-09234-w] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
362 Ura K, Furusyo N, Ogawa E, Hayashi T, Mukae H, Shimizu M, Toyoda K, Murata M, Hayashi J. Serum WFA(+) -M2BP is a non-invasive liver fibrosis marker that can predict the efficacy of direct-acting anti-viral-based triple therapy for chronic hepatitis C. Aliment Pharmacol Ther 2016;43:114-24. [PMID: 26503582 DOI: 10.1111/apt.13431] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
363 Chung S, Kim KE, Park MS, Bhagavatula S, Babb J, Axel L. Liver stiffness assessment with tagged MRI of cardiac-induced liver motion in cirrhosis patients. J Magn Reson Imaging 2014;39:1301-7. [PMID: 24719241 DOI: 10.1002/jmri.24260] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
364 Ando W, Yokomori H, Kaneko F, Kaneko M, Igarashi K, Suzuki H. Serum Autotaxin Concentrations Reflect Changes in Liver Stiffness and Fibrosis After Antiviral Therapy in Patients with Chronic Hepatitis C. Hepatol Commun. 2018;2:1111-1122. [PMID: 30202824 DOI: 10.1002/hep4.1230] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
365 Nam TH, Park BJ, Sung DJ, Kim MJ, Han NY, Sim KC, Lee JH, Cho SB. Non-invasive assessment of liver fibrosis using acoustic structure quantification: comparison with transient elastography in chronic viral hepatitis. Abdom Radiol (NY) 2016;41:239-47. [PMID: 26867905 DOI: 10.1007/s00261-015-0597-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
366 Tsui PH, Ho MC, Tai DI, Lin YH, Wang CY, Ma HY. Acoustic structure quantification by using ultrasound Nakagami imaging for assessing liver fibrosis. Sci Rep 2016;6:33075. [PMID: 27605260 DOI: 10.1038/srep33075] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
367 Ragazzo TG, Paranagua-Vezozzo D, Lima FR, de Campos Mazo DF, Pessoa MG, Oliveira CP, Alves VAF, Carrilho FJ. Accuracy of transient elastography-FibroScan®, acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C. Clinics (Sao Paulo) 2017;72:516-25. [PMID: 29069254 DOI: 10.6061/clinics/2017(09)01] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
368 Ma C, Liu A, Wang Y, Geng X, Hao L, Song Q, Sun B, Wang H, Zhao G. The hepatocyte phase of Gd-EOB-DTPA-enhanced MRI in the evaluation of hepatic fibrosis and early liver cirrhosis in a rat model: an experimental study. Life Sci. 2014;108:104-108. [PMID: 24881519 DOI: 10.1016/j.lfs.2014.05.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
369 Lambrecht J, Verhulst S, Mannaerts I, Sowa JP, Best J, Canbay A, Reynaert H, van Grunsven LA. A PDGFRβ-based score predicts significant liver fibrosis in patients with chronic alcohol abuse, NAFLD and viral liver disease. EBioMedicine 2019;43:501-12. [PMID: 31036530 DOI: 10.1016/j.ebiom.2019.04.036] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
370 Dioguardi Burgio M, Bruno O, Agnello F, Torrisi C, Vernuccio F, Cabibbo G, Soresi M, Petta S, Calamia M, Papia G, Gambino A, Ricceri V, Midiri M, Lagalla R, Brancatelli G. The cheating liver: imaging of focal steatosis and fatty sparing. Expert Rev Gastroenterol Hepatol. 2016;10:671-678. [PMID: 27027652 DOI: 10.1586/17474124.2016.1169919] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
371 Cequera A, García de León Méndez M. Biomarkers for liver fibrosis: Advances, advantages and disadvantages. Revista de Gastroenterología de México (English Edition) 2014;79:187-99. [DOI: 10.1016/j.rgmxen.2014.07.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
372 Albanis E, Friedman SL. Diagnosis of hepatic fibrosis in patients with chronic hepatitis C. Clin Liver Dis. 2006;10:821-833. [PMID: 17164119 DOI: 10.1016/j.cld.2006.08.027] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
373 Johnson KD, Laoveeravat P, Yee EU, Perisetti A, Thandassery RB, Tharian B. Endoscopic ultrasound guided liver biopsy: Recent evidence. World J Gastrointest Endosc 2020; 12(3): 83-97 [PMID: 32218888 DOI: 10.4253/wjge.v12.i3.83] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
374 Dinh MH, Stosor V, Rao SM, Miller FH, Green RM. Cryptogenic liver disease in HIV-seropositive men. HIV Med. 2009;10:447-453. [PMID: 19459992 DOI: 10.1111/j.1468-1293.2009.00712.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
375 Seo YS. [Transient elastography, true or false?]. Korean J Hepatol. 2009;15:431-437. [PMID: 20037261 DOI: 10.3350/kjhep.2009.15.4.431] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
376 Verloh N, Probst U, Utpatel K, Zeman F, Brennfleck F, Werner JM, Fellner C, Stroszczynski C, Evert M, Wiggermann P, Haimerl M. Influence of hepatic fibrosis and inflammation: Correlation between histopathological changes and Gd-EOB-DTPA-enhanced MR imaging. PLoS One 2019;14:e0215752. [PMID: 31083680 DOI: 10.1371/journal.pone.0215752] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
377 de Lédinghen V, Le Bail B, Rebouissoux L, Fournier C, Foucher J, Miette V, Castéra L, Sandrin L, Merrouche W, Lavrand F, Lamireau T. Liver Stiffness Measurement in Children Using FibroScan: Feasibility Study and Comparison With Fibrotest, Aspartate Transaminase to Platelets Ratio Index, and Liver Biopsy. Journal of Pediatric Gastroenterology & Nutrition 2007;45:443-50. [DOI: 10.1097/mpg.0b013e31812e56ff] [Cited by in Crossref: 167] [Cited by in F6Publishing: 66] [Article Influence: 11.9] [Reference Citation Analysis]
378 d'Assignies G, Fontés G, Kauffmann C, Latour M, Gaboury L, Boulanger Y, Van Beers BE, Soulez G, Poitout V, Tang A. Early detection of liver steatosis by magnetic resonance imaging in rats infused with glucose and intralipid solutions and correlation to insulin levels. Metabolism 2013;62:1850-7. [PMID: 24035445 DOI: 10.1016/j.metabol.2013.08.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
379 Argo CK, Northup PG, Al-Osaimi AM, Caldwell SH. Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J Hepatol 2009;51:371-9. [PMID: 19501928 DOI: 10.1016/j.jhep.2009.03.019] [Cited by in Crossref: 353] [Cited by in F6Publishing: 335] [Article Influence: 29.4] [Reference Citation Analysis]
380 Anderson SW, Barry B, Soto JA, Ozonoff A, O'Brien M, Jara H. Quantifying hepatic fibrosis using a biexponential model of diffusion weighted imaging in ex vivo liver specimens. Magn Reson Imaging. 2012;30:1475-1482. [PMID: 22921938 DOI: 10.1016/j.mri.2012.05.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
381 Gabr SA, Alghadir AH. Prediction of fibrosis in hepatitis C patients: assessment using hydroxyproline and oxidative stress biomarkers. Virusdisease 2014;25:91-100. [PMID: 24426315 DOI: 10.1007/s13337-013-0182-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
382 Hu Y, Gong HY, Lin HJ. Real-time Tissue Elastography for Assessment of Liver Stiffness in Adults Without Known Liver Disease. J Ultrasound Med 2015;34:1895-900. [PMID: 26384610 DOI: 10.7863/ultra.14.10001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
383 Zhang C, Liu H, Cui Y, Li X, Zhang Z, Zhang Y, Wang D. Molecular magnetic resonance imaging of activated hepatic stellate cells with ultrasmall superparamagnetic iron oxide targeting integrin αvβ₃ for staging liver fibrosis in rat model. Int J Nanomedicine 2016;11:1097-108. [PMID: 27051285 DOI: 10.2147/IJN.S101366] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
384 Sporea I, Şirli R, Bota S, Fierbinţeanu-Braticevici C, Petrişor A, Badea R, Lupşor M, Popescu A, Dănilă M. Is ARFI elastography reliable for predicting fibrosis severity in chronic HCV hepatitis? World J Radiol 2011; 3(7): 188-193 [PMID: 21860715 DOI: 10.4329/wjr.v3.i7.188] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
385 Valva P, Ríos DA, De Matteo E, Preciado MV. Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage. World J Gastroenterol 2016; 22(4): 1367-1381 [PMID: 26819506 DOI: 10.3748/wjg.v22.i4.1367] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
386 Hwang M, Piskunowicz M, Darge K. Advanced Ultrasound Techniques for Pediatric Imaging. Pediatrics 2019;143:e20182609. [PMID: 30808770 DOI: 10.1542/peds.2018-2609] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
387 Dzyubak B, Glaser K, Yin M, Talwalkar J, Chen J, Manduca A, Ehman RL. Automated liver stiffness measurements with magnetic resonance elastography. J Magn Reson Imaging. 2013;38:371-379. [PMID: 23281171 DOI: 10.1002/jmri.23980] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]
388 Gerstenmaier JF, Gibson RN. Ultrasound in chronic liver disease. Insights Imaging 2014;5:441-55. [PMID: 24859758 DOI: 10.1007/s13244-014-0336-2] [Cited by in Crossref: 48] [Cited by in F6Publishing: 33] [Article Influence: 6.9] [Reference Citation Analysis]
389 Suzuki A, Lymp J, St Sauver J, Angulo P, Lindor K. Values and limitations of serum aminotransferases in clinical trials of nonalcoholic steatohepatitis. Liver Int 2006;26:1209-16. [PMID: 17105586 DOI: 10.1111/j.1478-3231.2006.01362.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
390 Kolor B. Patient education and treatment strategies implemented at a pharmacist-managed hepatitis C virus clinic. Pharmacotherapy 2005;25:1230-41. [PMID: 16164396 DOI: 10.1592/phco.2005.25.9.1230] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
391 Feng Y, Feng M, Gao H, Zhang X, Xin X, Feng Q, Chen W, He T. A novel semiautomatic parenchyma extraction method for improved MRI R2* relaxometry of iron loaded liver. J Magn Reson Imaging 2014;40:67-78. [PMID: 24677406 DOI: 10.1002/jmri.24331] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
392 Kim AI, Saab S. Treatment of hepatitis C. Am J Med. 2005;118:808-815. [PMID: 16084169 DOI: 10.1016/j.amjmed.2005.01.073] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 3.7] [Reference Citation Analysis]
393 Surrey LF, Russo P, Rychik J, Goldberg DJ, Dodds K, O'Byrne ML, Glatz AC, Rand EB, Lin HC. Prevalence and characterization of fibrosis in surveillance liver biopsies of patients with Fontan circulation. Hum Pathol 2016;57:106-15. [PMID: 27476041 DOI: 10.1016/j.humpath.2016.07.006] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 9.6] [Reference Citation Analysis]
394 Wang H, Wang J, Xia J, Yan X, Feng Y, Li L, Chen J, Liu D, Ding W, Yang Y, Huang R, Wu C. Red cell distribution width to platelet ratio predicts liver fibrosis in patients with autoimmune hepatitis. Medicine (Baltimore) 2020;99:e21408. [PMID: 32846758 DOI: 10.1097/MD.0000000000021408] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
395 Mueller S, Millonig G, Sarovska L, Friedrich S, Reimann FM, Pritsch M, Eisele S, Stickel F, Longerich T, Schirmacher P. Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis. World J Gastroenterol. 2010;16:966-972. [PMID: 20180235 DOI: 10.3748/wjg.16.966] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
396 Poynard T, Yuen MF, Ratziu V, Lai CL. Viral hepatitis C. Lancet. 2003;362:2095-2100. [PMID: 14697814 DOI: 10.1016/s0140-6736(03)15109-4] [Cited by in Crossref: 604] [Cited by in F6Publishing: 199] [Article Influence: 35.5] [Reference Citation Analysis]
397 Moreno S, García-Samaniego J, Moreno A, Ortega E, Pineda JA, del Romero J, Tural C, von Wichmann MA, Berenguer J, Castro A. Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infection. J Viral Hepat. 2009;16:249-258. [PMID: 19215579 DOI: 10.1111/j.1365-2893.2009.01088.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
398 Molina-Molina E, Shanmugam H, Di Ciaula A, Grattagliano I, Di Palo DM, Palmieri VO, Portincasa P. (13C)-Methacetin breath test provides evidence of subclinical liver dysfunction linked to fat storage but not lifestyle. JHEP Rep 2021;3:100203. [PMID: 33490935 DOI: 10.1016/j.jhepr.2020.100203] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
399 Fang C, Konstantatou E, Romanos O, Yusuf GT, Quinlan DJ, Sidhu PS. Reproducibility of 2-Dimensional Shear Wave Elastography Assessment of the Liver: A Direct Comparison With Point Shear Wave Elastography in Healthy Volunteers. J Ultrasound Med. 2017;36:1563-1569. [PMID: 28370146 DOI: 10.7863/ultra.16.07018] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
400 Stift J, Semmler G, Wöran K, Simbrunner B, Scheiner B, Schwabl P, Paternostro R, Pinter M, Stättermayer AF, Meischl T, Beer A, Trauner M, Mandorfer M, Reiberger T. Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy. Dig Liver Dis 2020;52:1473-9. [PMID: 32928675 DOI: 10.1016/j.dld.2020.08.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
401 Helmke S, Colmenero J, Everson GT. Noninvasive assessment of liver function. Curr Opin Gastroenterol. 2015;31:199-208. [PMID: 25714706 DOI: 10.1097/mog.0000000000000167] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
402 Zhang Y, Zheng Y, Yang X, Liu X, Zhang H, Xu X, Meng F. Comparison of Acoustic Structure Quantification, Transient Elastography (FibroScan) and Histology in Patients with Chronic Hepatitis B and without Moderate to Severe Hepatic Steatosis. Ultrasound Med Biol 2019;45:684-92. [PMID: 30638967 DOI: 10.1016/j.ultrasmedbio.2018.10.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
403 Uto H, Mawatari S, Kumagai K, Ido A, Tsubouchi H. Clinical features of hepatitis C virus carriers with persistently normal alanine aminotransferase levels. Hepat Mon 2012;12:77-84. [PMID: 22509183 DOI: 10.5812/hepatmon.829] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
404 Sökücü S, Gökçe S, Güllüoğlu M, Aydoğan A, Celtik C, Durmaz O. The role of the non-invasive serum marker FibroTest-ActiTest in the prediction of histological stage of fibrosis and activity in children with naïve chronic hepatitis B infection. Scand J Infect Dis 2010;42:699-703. [PMID: 20429710 DOI: 10.3109/00365541003774616] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
405 Bottero J, Lacombe K, Guéchot J, Serfaty L, Miailhes P, Bonnard P, Wendum D, Molina JM, Lascoux-Combe C, Girard PM. Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patients. J Hepatol. 2009;50:1074-1083. [PMID: 19398234 DOI: 10.1016/j.jhep.2009.01.022] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 4.4] [Reference Citation Analysis]
406 Afdhal NH, Manning D. Diagnosis of liver fibrosis in 2008 and beyond. Gastroenterol Clin Biol. 2008;32:88-90. [PMID: 18973851 DOI: 10.1016/s0399-8320(08)73998-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
407 Kovač JD, Daković M, Stanisavljević D, Alempijević T, Ješić R, Seferović P, Maksimović R. Diffusion-weighted MRI versus transient elastography in quantification of liver fibrosis in patients with chronic cholestatic liver diseases. Eur J Radiol 2012;81:2500-6. [PMID: 22100369 DOI: 10.1016/j.ejrad.2011.10.024] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
408 Glaser KJ, Manduca A, Ehman RL. Review of MR elastography applications and recent developments. J Magn Reson Imaging 2012;36:757-74. [PMID: 22987755 DOI: 10.1002/jmri.23597] [Cited by in Crossref: 149] [Cited by in F6Publishing: 122] [Article Influence: 18.6] [Reference Citation Analysis]
409 Verloh N, Utpatel K, Haimerl M, Zeman F, Fellner C, Dahlke M, Renner P, Seyfried T, Müller M, Stroszczynski C, Evert M, Wiggermann P. DWI - histology: a possible means of determining degree of liver fibrosis? Oncotarget 2018;9:20112-8. [PMID: 29732007 DOI: 10.18632/oncotarget.24981] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
410 Obmann VC, Marx C, Hrycyk J, Berzigotti A, Ebner L, Mertineit N, Gräni C, Heverhagen JT, Christe A, Huber AT. Liver segmental volume and attenuation ratio (LSVAR) on portal venous CT scans improves the detection of clinically significant liver fibrosis compared to liver segmental volume ratio (LSVR). Abdom Radiol (NY) 2021;46:1912-21. [PMID: 33156949 DOI: 10.1007/s00261-020-02834-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
411 Shoji B, Ikeda F, Fujioka S, Kobashi H, Yasunaka T, Miyake Y, Shiraha H, Takaki A, Nouso K, Iwasaki Y, Yamamoto K. Laparoscopic findings of reddish markings predict hepatocellular carcinoma in patients with hepatitis B virus-related liver disease. J Gastroenterol 2010;45:1172-82. [DOI: 10.1007/s00535-010-0266-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
412 Connolly JC, Lim JK. Non-invasive Fibrosis Assessment of Patients with Hepatitis C: Application of Society Guidelines to Clinical Practice. Curr Hepatology Rep 2019;18:249-58. [DOI: 10.1007/s11901-019-00471-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
413 Kumada T, Toyoda H, Yasuda S, Sone Y, Ogawa S, Takeshima K, Tada T, Ito T, Sumida Y, Tanaka J. Prediction of Hepatocellular Carcinoma by Liver Stiffness Measurements Using Magnetic Resonance Elastography After Eradicating Hepatitis C Virus. Clin Transl Gastroenterol 2021;12:e00337. [PMID: 33888672 DOI: 10.14309/ctg.0000000000000337] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
414 Wang C, He T, Liu X, Zhong S, Chen W, Feng Y. Rapid look-up table method for noise-corrected curve fitting in the R2* mapping of iron loaded liver. Magn Reson Med 2015;73:865-71. [PMID: 24706563 DOI: 10.1002/mrm.25184] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
415 Xia WY, Gao L, Dai EH, Chen D, Xie EF, Yang L, Zhang SC, Zhang BF, Xu J, Pan SY. Liquid biopsy for non-invasive assessment of liver injury in hepatitis B patients. World J Gastroenterol 2019; 25(29): 3985-3995 [PMID: 31413532 DOI: 10.3748/wjg.v25.i29.3985] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
416 Vargas V. [Non-invasive methods for prediction of hepatic fibrosis in chronic hepatitis C]. Med Clin (Barc) 2005;124:775-7. [PMID: 15927104 DOI: 10.1157/13075850] [Reference Citation Analysis]
417 Grunwald D, Kothari D, Malik R. Noninvasive markers in the assessment and management of autoimmune liver diseases. European Journal of Gastroenterology & Hepatology 2014;26:1065-72. [DOI: 10.1097/meg.0000000000000176] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
418 Vince AR, Hayes MA, Jefferson BJ, Stalker MJ. Hepatic Injury Correlates With Apoptosis, Regeneration, and Nitric Oxide Synthase Expression in Canine Chronic Liver Disease. Vet Pathol 2014;51:932-45. [DOI: 10.1177/0300985813513041] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
419 Mendes LC, Stucchi RS, Vigani AG. Diagnosis and staging of fibrosis in patients with chronic hepatitis C: comparison and critical overview of current strategies. Hepat Med. 2018;10:13-22. [PMID: 29662329 DOI: 10.2147/hmer.s125234] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
420 Usluer G, Erben N, Aykin N, Dagli O, Aydogdu O, Barut S, Cevik F, Ormen B. Comparison of non-invasive fibrosis markers and classical liver biopsy in chronic hepatitis C. Eur J Clin Microbiol Infect Dis. 2012;31:1873-1878. [PMID: 22231498 DOI: 10.1007/s10096-011-1513-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
421 Sagir A, Erhardt A, Schmitt M, Häussinger D. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology. 2008;47:592-595. [PMID: 18098325 DOI: 10.1002/hep.22056] [Cited by in Crossref: 362] [Cited by in F6Publishing: 339] [Article Influence: 27.8] [Reference Citation Analysis]
422 van Werven JR, Hoogduin JM, Nederveen AJ, van Vliet AA, Wajs E, Vandenberk P, Stroes ES, Stoker J. Reproducibility of 3.0 Tesla magnetic resonance spectroscopy for measuring hepatic fat content. J Magn Reson Imaging. 2009;30:444-448. [PMID: 19629974 DOI: 10.1002/jmri.21837] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 4.7] [Reference Citation Analysis]
423 Taibbi A, Picone D, Midiri M, La Grutta L, Bartolotta TV. Diffuse Liver Diseases: Role of imaging.Semin Ultrasound CT MR. 2018;39:193-205. [PMID: 29571555 DOI: 10.1053/j.sult.2017.11.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
424 Seo YS, Lee KG, Jung ES, An H, Park S, Keum B, Yim HJ, Jeen YT, Chun HJ, Kim CD, Ryu HS, Um SH. Dynamic changes in liver stiffness during the course of acute hepatitis A. Scandinavian Journal of Gastroenterology 2010;45:449-56. [DOI: 10.3109/00365520903536515] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
425 Friedman SL. Hepatic Fibrosis. In: Schiff ER, Maddrey WC, Sorrell MF, editors. Schiff's Diseases of the Liver. Oxford: Wiley-Blackwell; 2011. pp. 295-315. [DOI: 10.1002/9781119950509.ch12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
426 Beckebaum S, Iacob S, Klein CG, Dechêne A, Varghese J, Baba HA, Sotiropoulos GC, Paul A, Gerken G, Cicinnati VR. Assessment of Allograft Fibrosis by Transient Elastography and Noninvasive Biomarker Scoring Systems in Liver Transplant Patients. Transplantation 2010;89:983-93. [DOI: 10.1097/tp.0b013e3181cc66ca] [Cited by in Crossref: 53] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
427 Yeung J, Ganeshan B, Endozo R, Hall A, Wan S, Groves A, Taylor SA, Bandula S. Equilibrium CT Texture Analysis for the Evaluation of Hepatic Fibrosis: Preliminary Evaluation against Histopathology and Extracellular Volume Fraction. J Pers Med 2020;10:E46. [PMID: 32485820 DOI: 10.3390/jpm10020046] [Reference Citation Analysis]
428 Cheung RC, Currie S, Shen H, Bini EJ, Ho SB, Anand BS, Hu KQ, Wright TL, Morgan TR;  VA HCV-001 Study Group. Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice? J Clin Gastroenterol. 2008;42:827-834. [PMID: 18285716 DOI: 10.1097/mcg.0b013e318046ea9a] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
429 Brady CW, Mchutchison JG, Patel K. Fibrosis markers in hepatitis C. Curr hepatitis rep 2006;5:86-93. [DOI: 10.1007/s11901-006-0010-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
430 Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy. J Magn Reson Imaging 2011;34:729-49. [PMID: 22025886 DOI: 10.1002/jmri.22775] [Cited by in Crossref: 434] [Cited by in F6Publishing: 199] [Article Influence: 43.4] [Reference Citation Analysis]
431 Poynard T, Munteanu M, Imbert-bismut F, Charlotte F, Thabut D, Le Calvez S, Messous D, Thibault V, Benhamou Y, Moussalli J, Ratziu V. Prospective Analysis of Discordant Results between Biochemical Markers and Biopsy in Patients with Chronic Hepatitis C. Clinical Chemistry 2004;50:1344-55. [DOI: 10.1373/clinchem.2004.032227] [Cited by in Crossref: 216] [Cited by in F6Publishing: 215] [Article Influence: 12.7] [Reference Citation Analysis]
432 van der Meer AJ, Maan R, Veldt BJ, Feld JJ, Wedemeyer H, Dufour J, Lammert F, Duarte-rojo A, Manns MP, Zeuzem S, Hofmann WP, de Knegt RJ, Hansen BE, Janssen HL. Improvement of platelets after SVR among patients with chronic HCV infection and advanced hepatic fibrosis: Platelets improve following HCV eradication. Journal of Gastroenterology and Hepatology 2016;31:1168-76. [DOI: 10.1111/jgh.13252] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
433 Yin M, Venkatesh SK. Ultrasound or MR elastography of liver: which one shall I use? Abdom Radiol (NY). 2018;43:1546-1551. [PMID: 28988274 DOI: 10.1007/s00261-017-1340-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 8.5] [Reference Citation Analysis]
434 Ozkurt H, Keskiner F, Karatag O, Alkim C, Erturk SM, Basak M. Diffusion Weighted MRI for Hepatic Fibrosis: Impact of b-Value. Iran J Radiol 2014;11:e3555. [PMID: 24693297 DOI: 10.5812/iranjradiol.3555] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
435 Rousselet M, Michalak S, Dupré F, Croué A, Bedossa P, Saint-andré J, Calès P. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 2005;41:257-64. [DOI: 10.1002/hep.20535] [Cited by in Crossref: 379] [Cited by in F6Publishing: 361] [Article Influence: 23.7] [Reference Citation Analysis]
436 Parkes J, Guha IN, Harris S, Rosenberg WM, Roderick PJ. Systematic review of the diagnostic performance of serum markers of liver fibrosis in alcoholic liver disease. Comp Hepatol. 2012;11:5. [PMID: 23273224 DOI: 10.1186/1476-5926-11-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
437 Ismail MH, Pinzani M. Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies. Hepat Med. 2011;3:69-80. [PMID: 24367223 DOI: 10.2147/hmer.s905] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
438 Poynard T, McHutchison J, Manns M, Myers RP, Albrecht J. Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin. Hepatology. 2003;38:481-492. [PMID: 12883493 DOI: 10.1053/jhep.2003.50319] [Cited by in Crossref: 181] [Cited by in F6Publishing: 168] [Article Influence: 10.1] [Reference Citation Analysis]
439 Oliver JB, Peters S, Bongu A, Beidas A, Dikdan G, Brown L, Koneru B. Prerecovery liver biopsy in the brain-dead donor: A case-control study of logistics, safety, precision, and utility: PRERECOVERY LIVER BIOPSY IN THE BRAIN-DEAD DONOR. Liver Transpl 2014;20:237-44. [DOI: 10.1002/lt.23786] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
440 Lee Y, Kim KJ, Yoo ME, Kim G, Yoon H, Jo K, Youn J, Yun M, Park JY, Shim CY, Lee B, Kang S, Ha J, Cha B, Kang ES. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients. Journal of Hepatology 2018;68:764-72. [DOI: 10.1016/j.jhep.2017.11.023] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 13.0] [Reference Citation Analysis]
441 Stift J, Semmler G, Walzel C, Mandorfer M, Schwarzer R, Schwabl P, Paternostro R, Scheiner B, Wöran K, Pinter M, Stättermayer AF, Trauner M, Peck-Radosavljevic M, Ferlitsch A, Reiberger T. Transjugular aspiration liver biopsy performed by hepatologists trained in HVPG measurements is safe and provides important diagnostic information. Dig Liver Dis 2019;51:1144-51. [PMID: 30862438 DOI: 10.1016/j.dld.2019.01.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
442 Barry B, Buch K, Soto JA, Jara H, Nakhmani A, Anderson SW. Quantifying liver fibrosis through the application of texture analysis to diffusion weighted imaging. Magnetic Resonance Imaging 2014;32:84-90. [DOI: 10.1016/j.mri.2013.04.006] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 6.3] [Reference Citation Analysis]
443 Huang ZP, Zhang XL, Zeng J, Zheng J, Wang P, Zheng RQ. Study of detection times for liver stiffness evaluation by shear wave elastography. World J Gastroenterol 2014; 20(28): 9578-9584 [PMID: 25071355 DOI: 10.3748/wjg.v20.i28.9578] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
444 Shackel NA, Seth D, Haber PS, Gorrell MD, McCaughan GW. The hepatic transcriptome in human liver disease. Comp Hepatol 2006;5:6. [PMID: 17090326 DOI: 10.1186/1476-5926-5-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
445 Jeong JY, Kim TY, Sohn JH, Kim Y, Jeong WK, Oh YH, Yoo KS. Real time shear wave elastography in chronic liver diseases: Accuracy for predicting liver fibrosis, in comparison with serum markers. World J Gastroenterol 2014; 20(38): 13920-13929 [PMID: 25320528 DOI: 10.3748/wjg.v20.i38.13920] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
446 Sebastiani G, Alberti A. How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C? J Viral Hepat. 2012;19 Suppl 1:18-32. [PMID: 22233410 DOI: 10.1111/j.1365-2893.2011.01518.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
447 Kazour I, Serai SD, Xanthakos SA, Fleck RJ. Using T1 mapping in cardiovascular magnetic resonance to assess congestive hepatopathy. Abdom Radiol (NY) 2018;43:2679-85. [PMID: 29500649 DOI: 10.1007/s00261-018-1528-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
448 Takeda T, Yasuda T, Nakayama Y, Nakaya M, Kimura M, Yamashita M, Sawada A, Abo K, Takeda S, Sakaguchi H, Shiomi S, Asai H, Seki S. Usefulness of noninvasive transient elastography for assessment of liver fibrosis stage in chronic hepatitis C. World J Gastroenterol 2006; 12(48): 7768-7773 [PMID: 17203518 DOI: 10.3748/wjg.v12.i48.7768] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
449 Taouli B, Ehman RL, Reeder SB. Advanced MRI methods for assessment of chronic liver disease. AJR Am J Roentgenol. 2009;193:14-27. [PMID: 19542391 DOI: 10.2214/ajr.09.2601] [Cited by in Crossref: 128] [Cited by in F6Publishing: 47] [Article Influence: 10.7] [Reference Citation Analysis]
450 Rus G, Faris IH, Torres J, Callejas A, Melchor J. Why Are Viscosity and Nonlinearity Bound to Make an Impact in Clinical Elastographic Diagnosis? Sensors (Basel) 2020;20:E2379. [PMID: 32331295 DOI: 10.3390/s20082379] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 12.0] [Reference Citation Analysis]
451 D'ambrosio R, Colombo M. Should surveillance for liver cancer be modified in hepatitis C patients after treatment-related cirrhosis regression? Liver Int 2016;36:783-90. [DOI: 10.1111/liv.13106] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
452 Haimerl M, Jung E, Beyer L, Pregler B, Dollinger M, Sieroń D, Niessen C, Stroszczynski C, Wiggermann P, Prantl L, Jung E, Jung F. Chronic liver disease: Correlation of CEUS-based microperfusion and indocyanine green clearance. CH 2015;61:195-204. [DOI: 10.3233/ch-151990] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
453 Calvaruso V, Cammà C, Di Marco V, Maimone S, Bronte F, Enea M, Dardanoni V, Manousou P, Pleguezuelo M, Xirouchakis E. Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy. J Viral Hepat. 2010;17:469-474. [PMID: 19780940 DOI: 10.1111/j.1365-2893.2009.01199.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 0.2] [Reference Citation Analysis]
454 Ekong UD, Melin-aldana H, Whitington PF. Regression of Severe Fibrotic Liver Disease in 2 Children With Neonatal Hemochromatosis. Journal of Pediatric Gastroenterology & Nutrition 2008;46:329-33. [DOI: 10.1097/mpg.0b013e318046772f] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
455 Schaible J, Utpatel K, Verloh N, Einspieler I, Pregler B, Zeman F, Wiggermann P, Schreyer AG, Stroszczynski C, Beyer LP. Full-Core Biopsy Systems Take Larger Liver Tissue Samples with Lower Fragmentation Rates Than Conventional Side-Notch Systems: A Randomized Trial. Cancer Manag Res 2020;12:1121-8. [PMID: 32104092 DOI: 10.2147/CMAR.S209824] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
456 Morisaka H, Motosugi U, Glaser KJ, Ichikawa S, Ehman RL, Sano K, Ichikawa T, Onishi H. Comparison of diagnostic accuracies of two- and three-dimensional MR elastography of the liver. J Magn Reson Imaging 2017;45:1163-70. [PMID: 27662640 DOI: 10.1002/jmri.25425] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
457 Bottari A, Silipigni S, Carerj ML, Cattafi A, Maimone S, Marino MA, Mazziotti S, Pitrone A, Squadrito G, Ascenti G. Dual-source dual-energy CT in the evaluation of hepatic fractional extracellular space in cirrhosis. Radiol Med 2020;125:7-14. [PMID: 31587181 DOI: 10.1007/s11547-019-01089-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
458 Ito K, Murotani K, Nakade Y, Inoue T, Nakao H, Sumida Y, Kamada Y, Yoneda M. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels and liver fibrosis: A meta-analysis: WFA+-M2BP and liver fibrosis. Journal of Gastroenterology and Hepatology 2017;32:1922-30. [DOI: 10.1111/jgh.13802] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
459 Serai SD, Yin M. MR Elastography of the Abdomen: Basic Concepts. In: Pohlmann A, Niendorf T, editors. Preclinical MRI of the Kidney. New York: Springer US; 2021. pp. 301-23. [DOI: 10.1007/978-1-0716-0978-1_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
460 van Katwyk S, Coyle D, Cooper C, Pussegoda K, Cameron C, Skidmore B, Brener S, Moher D, Thavorn K. Transient elastography for the diagnosis of liver fibrosis: a systematic review of economic evaluations. Liver Int. 2016;37:851-861. [PMID: 27699993 DOI: 10.1111/liv.13260] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
461 Mori M, Fujii H, Ogawa T, Kobayashi S, Iwai S, Morikawa H, Enomoto M, Tamori A, Sawada A, Takeda S. Close correlation of liver stiffness with collagen deposition and presence of myofibroblasts in non-alcoholic fatty liver disease. Hepatol Res. 2011;41:897-903. [PMID: 21682831 DOI: 10.1111/j.1872-034x.2011.00842.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
462 Onishi H, Theisen D, Zachoval R, Reiser MF, Zech CJ. Intrahepatic diffuse periportal enhancement patterns on hepatobiliary phase gadoxetate disodium-enhanced liver MR images: Do they correspond to periportal hyperintense patterns on T2-weighted images? Medicine (Baltimore) 2019;98:e14784. [PMID: 30882651 DOI: 10.1097/MD.0000000000014784] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
463 Hashem S, Esmat G, Elakel W, Habashy S, Abdel Raouf S, Darweesh S, Soliman M, Elhefnawi M, El-Adawy M, ElHefnawi M. Accurate Prediction of Advanced Liver Fibrosis Using the Decision Tree Learning Algorithm in Chronic Hepatitis C Egyptian Patients. Gastroenterol Res Pract 2016;2016:2636390. [PMID: 26880886 DOI: 10.1155/2016/2636390] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
464 Seeff LB, Everson GT, Morgan TR, Curto TM, Lee WM, Ghany MG, Shiffman ML, Fontana RJ, Di Bisceglie AM, Bonkovsky HL, Dienstag JL; HALT–C Trial Group. Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin Gastroenterol Hepatol 2010;8:877-83. [PMID: 20362695 DOI: 10.1016/j.cgh.2010.03.025] [Cited by in Crossref: 242] [Cited by in F6Publishing: 217] [Article Influence: 22.0] [Reference Citation Analysis]
465 Gu J, Zhang E, Liang B, Zhang Z, Chen X, Xiong M, Huang Z. Liver Collagen Contents Are Closely Associated with the Severity of Cirrhosis and Posthepatectomy Liver Failure in Patients with Hepatocellular Carcinoma and Child-Pugh Grade A Liver Function. Ann Surg Oncol 2021;28:4227-35. [PMID: 33452603 DOI: 10.1245/s10434-020-09557-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
466 Roth CG, Marzio DH, Guglielmo FF. Contributions of Magnetic Resonance Imaging to Gastroenterological Practice: MRIs for GIs. Dig Dis Sci 2018;63:1102-22. [PMID: 29549474 DOI: 10.1007/s10620-018-4991-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
467 Lim AKP, Patel N, Hamilton G, Mylvahan K, Kuo Y, Goldin RD, Taylor-robinson SD. 31P MR Spectroscopy in Assessment of Response to Antiviral Therapy for Hepatitis C Virus–Related Liver Disease. American Journal of Roentgenology 2007;189:819-23. [DOI: 10.2214/ajr.07.2418] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
468 Qiu T, Wang H, Song J, Ling W, Shi Y, Guo G, Luo Y. Assessment of liver fibrosis by ultrasound elastography and contrast-enhanced ultrasound: a randomized prospective animal study. Exp Anim 2018;67:117-26. [PMID: 29081454 DOI: 10.1538/expanim.17-0098] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
469 Li X, Xu H, Gao P. Red Blood Cell Distribution Width-to-Platelet Ratio and Other Laboratory Indices Associated with Severity of Histological Hepatic Fibrosis in Patients with Autoimmune Hepatitis: A Retrospective Study at a Single Center. Med Sci Monit 2020;26:e927946. [PMID: 33180750 DOI: 10.12659/MSM.927946] [Reference Citation Analysis]
470 Zhan C, Kannengiesser S, Chandarana H, Fenchel M, Ream J, Shanbhogue KP. MR elastography of liver at 3 Tesla: comparison of gradient-recalled echo (GRE) and spin-echo (SE) echo-planar imaging (EPI) sequences and agreement across stiffness measurements. Abdom Radiol (NY) 2019;44:1825-33. [PMID: 30796479 DOI: 10.1007/s00261-019-01932-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
471 Sulkowski MS, Mehta SH, Torbenson MS, Higgins Y, Brinkley SC, de Oca RM, Moore RD, Afdhal NH, Thomas DL. Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults. AIDS. 2007;21:2209-2216. [PMID: 18090048 DOI: 10.1097/qad.0b013e3282f10de9] [Cited by in Crossref: 131] [Cited by in F6Publishing: 64] [Article Influence: 10.1] [Reference Citation Analysis]
472 Ahmed Y, Hussein RS, Basha TA, Khalifa AM, Ibrahim AS, Abdelmoaty AS, Abdella HM, Fahmy AS. Detecting liver fibrosis using a machine learning-based approach to the quantification of the heart-induced deformation in tagged MR images. NMR Biomed. 2020;33:e4215. [PMID: 31730265 DOI: 10.1002/nbm.4215] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
473 . Guideline 4: Management of HCV-infected patients before and after kidney transplantation. Kidney International 2008;73:S53-68. [DOI: 10.1038/ki.2008.87] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
474 White IR, Patel K, Symonds WT, Dev A, Griffin P, Tsokanas N, Skehel M, Liu C, Zekry A, Cutler P. Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection. J Transl Med. 2007;5:33. [PMID: 17625010 DOI: 10.1186/1479-5876-5-33] [Cited by in Crossref: 31] [Cited by in F6Publishing: 37] [Article Influence: 2.2] [Reference Citation Analysis]
475 Lazzarini AL, Levine RA, Ploutz-Snyder RJ, Sanderson SO. Advances in digital quantification technique enhance discrimination between mild and advanced liver fibrosis in chronic hepatitis C. Liver Int. 2005;25:1142-1149. [PMID: 16343064 DOI: 10.1111/j.1478-3231.2005.01155.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 3.3] [Reference Citation Analysis]
476 Lebensztejn DM, Sobaniec-Lotowska ME, Kaczmarski M, Voelker M, Schuppan D. Matrix-derived serum markers in monitoring liver fibrosis in children with chronic hepatitis B treated with interferon alpha. World J Gastroenterol 2006; 12(21): 3338-3343 [PMID: 16733849 DOI: 10.3748/wjg.v12.i21.3338] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
477 Focà E, Fabbiani M, Prosperi M, Quiros Roldan E, Castelli F, Maggiolo F, Di Filippo E, Di Giambenedetto S, Gagliardini R, Saracino A, Di Pietro M, Gori A, Sighinolfi L, Pan A, Postorino MC, Torti C; Italian MASTER Cohort. Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study. Medicine (Baltimore) 2016;95:e4091. [PMID: 27442636 DOI: 10.1097/MD.0000000000004091] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 3.8] [Reference Citation Analysis]
478 de Souza DA, Parente DB, de Araújo AL, Mortelé KJ. Modern imaging evaluation of the liver: emerging MR imaging techniques and indications. Magn Reson Imaging Clin N Am 2013;21:337-63. [PMID: 23642557 DOI: 10.1016/j.mric.2013.01.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
479 Lee HW, Na K, Kim SU, Kim BK, Park JY, Nahm JH, Lee JI, Kim DY, Ahn SH, Han KH, Park YN. Predictive validation of qualitative fibrosis staging in patients with chronic hepatitis B on antiviral therapy. Sci Rep 2019;9:15628. [PMID: 31666552 DOI: 10.1038/s41598-019-51638-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
480 Hoodeshenas S, Yin M, Venkatesh SK. Magnetic Resonance Elastography of Liver: Current Update. Top Magn Reson Imaging. 2018;27:319-333. [PMID: 30289828 DOI: 10.1097/rmr.0000000000000177] [Cited by in Crossref: 39] [Cited by in F6Publishing: 12] [Article Influence: 19.5] [Reference Citation Analysis]
481 Wu R, Zhang Y, Xiang Y, Tang Y, Cui F, Cao J, Zhou L, You Y, Duan L. Association between serum S100A9 levels and liver necroinflammation in chronic hepatitis B. J Transl Med 2018;16:83. [PMID: 29615081 DOI: 10.1186/s12967-018-1462-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
482 Bhogal H, Sterling RK. Staging of liver disease: which option is right for my patient? Infect Dis Clin North Am. 2012;26:849-861. [PMID: 23083819 DOI: 10.1016/j.idc.2012.08.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
483 Wu S, Kong Y, Piao H, Jiang W, Xie W, Chen Y, Lu L, Ma A, Xie S, Ding H, Shang J, Zhang X, Feng B, Han T, Xu X, Huo L, Cheng J, Li H, Wu X, Zhou J, Sun Y, Ou X, Zhang H, You H, Jia J. On-treatment changes of liver stiffness at week 26 could predict 2-year clinical outcomes in HBV-related compensated cirrhosis. Liver Int 2018;38:1045-54. [DOI: 10.1111/liv.13623] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
484 Cobbold JFL, Crossey MME, Colman P, Goldin RD, Murphy PS, Patel N, Fitzpatrick J, Vennart W, Thomas HC, Cox IJ, Taylor-robinson SD. Optimal combinations of ultrasound-based and serum markers of disease severity in patients with chronic hepatitis C: Biomarker combinations in hepatitis C. Journal of Viral Hepatitis 2010;17:537-45. [DOI: 10.1111/j.1365-2893.2009.01209.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
485 Gara N, Zhao X, Kleiner DE, Liang TJ, Hoofnagle JH, Ghany MG. Discordance among transient elastography, aspartate aminotransferase to platelet ratio index, and histologic assessments of liver fibrosis in patients with chronic hepatitis C. Clin Gastroenterol Hepatol. 2013;11:303-8.e1. [PMID: 23142332 DOI: 10.1016/j.cgh.2012.10.044] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
486 Reiberger T, Rutter K, Ferlitsch A, Payer BA, Hofer H, Beinhardt S, Kundi M, Ferenci P, Gangl A, Trauner M. Portal pressure predicts outcome and safety of antiviral therapy in cirrhotic patients with hepatitis C virus infection. Clin Gastroenterol Hepatol. 2011;9:602-608.e1. [PMID: 21397726 DOI: 10.1016/j.cgh.2011.03.002] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 4.7] [Reference Citation Analysis]
487 Vince AR, Hayes MA, Jefferson BJ, Stalker MJ. Sinusoidal endothelial cell and hepatic stellate cell phenotype correlates with stage of fibrosis in chronic liver disease in dogs. J Vet Diagn Invest 2016;28:498-505. [PMID: 27423735 DOI: 10.1177/1040638716658499] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
488 Thorpe J, Saeed S, Moodie EE, Klein MB. Antiretroviral treatment interruption leads to progression of liver fibrosis in HIV-hepatitis C virus co-infection. AIDS. 2011;25:967-975. [PMID: 21330904 DOI: 10.1097/qad.0b013e3283455e4b] [Cited by in Crossref: 27] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
489 Nguyen AP, Pham YHT, Vu GH, Nguyen MH, Hoang TN, Holterman A. Biliary atresia liver histopathological determinants of early post-Kasai outcome. J Pediatr Surg 2021;56:1169-73. [PMID: 33838902 DOI: 10.1016/j.jpedsurg.2021.03.039] [Reference Citation Analysis]
490 Chen B, Ye B, Zhang J, Ying L, Chen Y. RDW to platelet ratio: a novel noninvasive index for predicting hepatic fibrosis and cirrhosis in chronic hepatitis B. PLoS One 2013;8:e68780. [PMID: 23874760 DOI: 10.1371/journal.pone.0068780] [Cited by in Crossref: 78] [Cited by in F6Publishing: 82] [Article Influence: 9.8] [Reference Citation Analysis]
491 Maor Y, Bashari D, Kenet G, Lubetsky A, Luboshitz J, Schapiro JM, Penaranda G, Bar-meir S, Martinowitz U, Halfon P. Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy? Haemophilia 2006;12:372-9. [DOI: 10.1111/j.1365-2516.2006.01290.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
492 Chindamo MC, Nunes-pannain VL, Araújo-neto JM, Moraes-coelho HS, Luiz RR, Villela-nogueira CA, Perez RM. Intermediate fibrosis staging in hepatitis C: a problem not overcome by optimal samples or pathologists’ expertise. Annals of Hepatology 2015;14:652-7. [DOI: 10.1016/s1665-2681(19)30759-8] [Cited by in Crossref: 5] [Article Influence: 0.8] [Reference Citation Analysis]
493 Calès P, Lainé F, Boursier J, Deugnier Y, Moal V, Oberti F, Hunault G, Rousselet MC, Hubert I, Laafi J. Comparison of blood tests for liver fibrosis specific or not to NAFLD. J Hepatol. 2009;50:165-173. [PMID: 18977552 DOI: 10.1016/j.jhep.2008.07.035] [Cited by in Crossref: 170] [Cited by in F6Publishing: 139] [Article Influence: 13.1] [Reference Citation Analysis]
494 Khalili H, Dayyeh BA, Friedman LS. Assessment of Liver Function in Clinical Practice. In: Ginès P, Kamath PS, Arroyo V, editors. Chronic Liver Failure. Totowa: Humana Press; 2011. pp. 47-76. [DOI: 10.1007/978-1-60761-866-9_3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
495 Millonig G, Reimann FM, Friedrich S, Fonouni H, Mehrabi A, Büchler MW, Seitz HK, Mueller S. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology 2008;48:1718-23. [DOI: 10.1002/hep.22577] [Reference Citation Analysis]
496 Mummadi RR, Petersen JR, Xiao SY, Snyder N. Role of simple biomarkers in predicting fibrosis progression in HCV infection. World J Gastroenterol 2010; 16(45): 5710-5715 [PMID: 21128320 DOI: 10.3748/wjg.v16.i45.5710] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
497 Pineda JA, González J, Ortega E, Tural C, Macías J, Griffa L, Burgos A. Prevalence and factors associated with significant liver fibrosis assessed by transient elastometry in HIV/hepatitis C virus-coinfected patients. J Viral Hepat. 2010;17:714-719. [PMID: 20002560 DOI: 10.1111/j.1365-2893.2009.01229.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
498 Larrey D, Meunier L, Ursic-Bedoya J. Liver Biopsy in Chronic Liver Diseases: Is There a Favorable Benefit: Risk Balance? Ann Hepatol. 2017;16:487-489. [PMID: 28612749 DOI: 10.5604/01.3001.0010.0272] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
499 Popov Y, Schuppan D. Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. Hepatology. 2009;50:1294-1306. [PMID: 19711424 DOI: 10.1002/hep.23123] [Cited by in Crossref: 214] [Cited by in F6Publishing: 222] [Article Influence: 17.8] [Reference Citation Analysis]
500 Macías J, Mira J, Gilabert I, Neukam K, Roldán C, Viloria M, Moro A, Pineda JA. Combined use of aspartate aminotransferase, platelet count and matrix metalloproteinase 2 measurements to predict liver fibrosis in HIV/hepatitis C virus-coinfected patients. HIV Med 2011;12:14-21. [PMID: 20497249 DOI: 10.1111/j.1468-1293.2010.00836.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
501 Arun J, Jhala N, Lazenby AJ, Clements R, Abrams GA. Influence of liver biopsy heterogeneity and diagnosis of nonalcoholic steatohepatitis in subjects undergoing gastric bypass. Obes Surg. 2007;17:155-161. [PMID: 17476865 DOI: 10.1007/s11695-007-9041-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
502 Shin WG, Park SH, Jun SY, Jung JO, Moon JH, Kim JP, Kim KO, Park CH, Hahn TH, Yoo KS, Kim JH, Park CK. Simple tests to predict hepatic fibrosis in nonalcoholic chronic liver diseases. Gut Liver 2007;1:145-50. [PMID: 20485631 DOI: 10.5009/gnl.2007.1.2.145] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
503 European Association for Study of Liver. Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63:237-264. [PMID: 25911335 DOI: 10.1016/j.jhep.2015.04.006] [Cited by in Crossref: 918] [Cited by in F6Publishing: 788] [Article Influence: 153.0] [Reference Citation Analysis]
504 . Guideline 3: Preventing HCV transmission in hemodialysis units. Kidney International 2008;73:S46-52. [DOI: 10.1038/ki.2008.86] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
505 Carvalho-Filho RJ, Schiavon LL, Narciso-Schiavon JL, Sampaio JP, Lanzoni VP, Ferraz ML, Silva AE. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection. Liver Int. 2008;28:486-493. [PMID: 18339075 DOI: 10.1111/j.1478-3231.2008.01675.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
506 Fouad R, Elbaz T, Abdel Alem S, Elsharkawy A, Negm M, Khairy M, Hassany M, Cordie A, El Akel W, Esmat G. Evaluation of accuracy of elastography point quantification versus other noninvasive modalities in staging of fibrosis in chronic hepatitis C virus patients. Eur J Gastroenterol Hepatol 2018;30:882-7. [PMID: 29727382 DOI: 10.1097/MEG.0000000000001151] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
507 Xia B, Wang F, Friedrich-Rust M, Zhou F, Zhu J, Yang H, Ruan W, Zeng Z. Feasibility and Efficacy of Transient Elastography using the XL probe to diagnose liver fibrosis and cirrhosis: A meta-analysis. Medicine (Baltimore) 2018;97:e11816. [PMID: 30278481 DOI: 10.1097/MD.0000000000011816] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
508 Crespo S, Bridges M, Nakhleh R, McPhail A, Pungpapong S, Keaveny AP. Non-invasive assessment of liver fibrosis using magnetic resonance elastography in liver transplant recipients with hepatitis C. Clin Transplant 2013;27:652-8. [PMID: 23837611 DOI: 10.1111/ctr.12180] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
509 Gou Y, Liu B, Jiang W, Yu H, Bai X. The Diagnostic Value of Ultrasound Elastography in Patients with Hepatitis B Virus Infection: A Prospective Study. J Int Med Res 2010;38:2117-25. [DOI: 10.1177/147323001003800627] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
510 Andersen ES, Rødgaard-Hansen S, Moessner B, Christensen PB, Møller HJ, Weis N. Macrophage-related serum biomarkers soluble CD163 (sCD163) and soluble mannose receptor (sMR) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis C: a pilot study. Eur J Clin Microbiol Infect Dis 2014;33:117-22. [PMID: 24424890 DOI: 10.1007/s10096-013-1936-3] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 4.9] [Reference Citation Analysis]
511 Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, S Sulkowski M, Torriani FJ, Dieterich DT, Thomas DL, Messinger D, Nelson M;  APRICOT Clinical Investigators. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43:1317-1325. [PMID: 16729309 DOI: 10.1002/hep.21178] [Cited by in Crossref: 1954] [Cited by in F6Publishing: 1867] [Article Influence: 130.3] [Reference Citation Analysis]
512 Zhao X, Wang B, Li X, Wang T. Newly proposed fibrosis staging criterion for assessing carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents. Pathology International 2008;58:580-8. [DOI: 10.1111/j.1440-1827.2008.02274.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
513 Jang SY, Tak WY, Park SY, Kweon YO, Lee YR, Kim G, Hur K, Han MH, Lee WK. Diagnostic Efficacy of Serum Mac-2 Binding Protein Glycosylation Isomer and Other Markers for Liver Fibrosis in Non-Alcoholic Fatty Liver Diseases. Ann Lab Med 2021;41:302-9. [PMID: 33303715 DOI: 10.3343/alm.2021.41.3.302] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
514 Xiao L, Xian J, Li Y, Geng A, Yang X, Han L, Xu H. Parameters associated with significant liver histological changes in patients with chronic hepatitis B. ISRN Gastroenterol 2014;2014:913890. [PMID: 24616815 DOI: 10.1155/2014/913890] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
515 Baur K, Mertens JC, Schmitt J, Iwata R, Stieger B, Eloranta JJ, Frei P, Stickel F, Dill MT, Seifert B, Ferrari HA, von Eckardstein A, Bochud PY, Müllhaupt B, Geier A; Swiss Hepatitis C Cohort Study Group. Combined effect of 25-OH vitamin D plasma levels and genetic vitamin D receptor (NR 1I1) variants on fibrosis progression rate in HCV patients. Liver Int 2012;32:635-43. [PMID: 22151003 DOI: 10.1111/j.1478-3231.2011.02674.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 6.9] [Reference Citation Analysis]
516 Huang H, Wang J, Li W, Chen R, Chen X, Zhang F, Xu D, Lu F. Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naïve HBV-infected individuals. J Clin Virol 2018;99-100:71-8. [PMID: 29353073 DOI: 10.1016/j.jcv.2017.12.016] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 10.3] [Reference Citation Analysis]
517 Serpaggi J, Carnot F, Nalpas B, Canioni D, Guéchot J, Lebray P, Vallet-Pichard A, Fontaine H, Bedossa P, Pol S. Direct and indirect evidence for the reversibility of cirrhosis. Hum Pathol 2006;37:1519-26. [PMID: 16997354 DOI: 10.1016/j.humpath.2006.07.007] [Cited by in Crossref: 68] [Cited by in F6Publishing: 51] [Article Influence: 4.5] [Reference Citation Analysis]
518 Sebhatu P, Martin MT. Genotype 1 hepatitis C virus and the pharmacist's role in treatment. Am J Health Syst Pharm 2016;73:764-74. [PMID: 27126832 DOI: 10.2146/ajhp150704] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
519 Laharie D, Seneschal J, Schaeverbeke T, Doutre M, Longy-boursier M, Pellegrin J, Chabrun E, Villars S, Zerbib F, de Lédinghen V. Assessment of liver fibrosis with transient elastography and FibroTest in patients treated with methotrexate for chronic inflammatory diseases: A case–control study. Journal of Hepatology 2010;53:1035-40. [DOI: 10.1016/j.jhep.2010.04.043] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 4.8] [Reference Citation Analysis]
520 Nakamura Y, Aikata H, Fukuhara T, Honda F, Morio K, Morio R, Hatooka M, Kobayashi T, Nagaoki Y, Kawaoka T, Tsuge M, Hiramatsu A, Imamura M, Kawakami Y, Ochi H, Kobayashi T, Ohdan H, Shiroma N, Arihiro K, Chayama K. Liver fibrosis assessment by FibroScan compared with pathological findings of liver resection specimen in hepatitis C infection: Assessing liver fibrosis by FibroScan. Hepatol Res 2017;47:767-72. [DOI: 10.1111/hepr.12815] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
521 Nandwana SB, Finazzo J, Alexander LF, Cox K. Using qualitative descriptors of chronic liver disease on MRI: A practice prone to error. Clin Imaging 2021;74:89-92. [PMID: 33461018 DOI: 10.1016/j.clinimag.2020.12.023] [Reference Citation Analysis]
522 Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115:209-218. [PMID: 15690074 DOI: 10.1172/JCI200524282.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
523 Fraquelli M, Branchi F. The role of transient elastography in patients with hepatitis B viral disease. Digestive and Liver Disease 2011;43:S25-31. [DOI: 10.1016/s1590-8658(10)60689-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
524 Petersen JR, Stevenson HL, Kasturi KS, Naniwadekar A, Parkes J, Cross R, Rosenberg WM, Xiao SY, Snyder N. Evaluation of the aspartate aminotransferase/platelet ratio index and enhanced liver fibrosis tests to detect significant fibrosis due to chronic hepatitis C. J Clin Gastroenterol. 2014;48:370-376. [PMID: 24045284 DOI: 10.1097/mcg.0b013e3182a87e78] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
525 J.s. Cross T, Jothimani D, Heneghan MA, Harrison PM. Non-invasive assessment of fibrosis in liver grafts due to hepatitis C virus recurrence: Non-invasive assessment of HCV post OLT. Clinical Transplantation 2011;25:345-51. [DOI: 10.1111/j.1399-0012.2011.01396.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
526 Holmberg SD, Lu M, Rupp LB, Lamerato LE, Moorman AC, Vijayadeva V, Boscarino JA, Henkle EM, Gordon SC. Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort. Clin Infect Dis. 2013;57:240-246. [PMID: 23592832 DOI: 10.1093/cid/cit245] [Cited by in Crossref: 89] [Cited by in F6Publishing: 93] [Article Influence: 11.1] [Reference Citation Analysis]
527 Huhdanpaa H, Douville C, Baum K, Krishnamurthy VN, Holcombe S, Enchakalody B, Wang L, Wang SC, Su GL. Development of a quantitative method for the diagnosis of cirrhosis. Scand J Gastroenterol 2011;46:1468-77. [PMID: 21992231 DOI: 10.3109/00365521.2011.613946] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
528 Xu XL, Jiang LS, Wu CS, Pan LY, Lou ZQ, Peng CT, Dong Y, Ruan B. The role of fibrosis index FIB-4 in predicting liver fibrosis stage and clinical prognosis: A diagnostic or screening tool? J Formos Med Assoc 2021:S0929-6646(21)00344-2. [PMID: 34325952 DOI: 10.1016/j.jfma.2021.07.013] [Reference Citation Analysis]
529 Kornek M, Lynch M, Mehta SH, Lai M, Exley M, Afdhal NH, Schuppan D. Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis. Gastroenterology 2012;143:448-58. [PMID: 22537612 DOI: 10.1053/j.gastro.2012.04.031] [Cited by in Crossref: 117] [Cited by in F6Publishing: 112] [Article Influence: 13.0] [Reference Citation Analysis]
530 Lambrecht J, Jan Poortmans P, Verhulst S, Reynaert H, Mannaerts I, van Grunsven LA. Circulating ECV-Associated MiRNA s as Potential Clinical Biomarkers in Early Stage HBV and HCV Induced Liver Fibrosis. Front Pharmacol. 2017;8:56. [PMID: 28232800 DOI: 10.3389/fphar.2017.00056] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
531 Parente DB, Oliveira Neto JA, Brasil PEAA, Paiva FF, Ravani JPR, Gomes MB, Lanzoni V, Campos CFF, Machado-silva L, Perez RM, Rodrigues RS. Preperitoneal fat as a non-invasive marker of increased risk of severe non-alcoholic fatty liver disease in patients with type 2 diabetes: Preperitoneal fat and severe fatty liver. Journal of Gastroenterology and Hepatology 2018;33:511-7. [DOI: 10.1111/jgh.13903] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
532 Huwart L, Salameh N, ter Beek L, Vicaut E, Peeters F, Sinkus R, Van Beers BE. MR elastography of liver fibrosis: preliminary results comparing spin-echo and echo-planar imaging. Eur Radiol. 2008;18:2535-2541. [PMID: 18504591 DOI: 10.1007/s00330-008-1051-5] [Cited by in Crossref: 63] [Cited by in F6Publishing: 55] [Article Influence: 4.8] [Reference Citation Analysis]
533 Horowitz JM, Kamel IR, Arif-tiwari H, Asrani SK, Hindman NM, Kaur H, Mcnamara MM, Noto RB, Qayyum A, Lalani T. ACR Appropriateness Criteria ® Chronic Liver Disease. Journal of the American College of Radiology 2017;14:S391-405. [DOI: 10.1016/j.jacr.2017.08.045] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
534 Conde I, Vinaixa C, Berenguer M. Hepatitis C-related cirrhosis. Current status. Med Clin (Barc) 2017;148:78-85. [PMID: 27855947 DOI: 10.1016/j.medcli.2016.09.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
535 Sumer S, Aktug Demir N, Kölgelier S, Cagkan Inkaya A, Arpaci A, Saltuk Demir L, Ural O. The Clinical Significance of Serum Apoptotic Cytokeratin 18 Neoepitope M30 (CK-18 M30) and Matrix Metalloproteinase 2 (MMP-2) Levels in Chronic Hepatitis B Patients with Cirrhosis. Hepat Mon. 2013;13:e10106. [PMID: 24032040 DOI: 10.5812/hepatmon.10106] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
536 Oellerich M, Beck J, Kanzow P, Schmitz J, Kollmar O, Walson PD, Schütz E. Graft-derived cell-free DNA as a marker of graft integrity after transplantation. Personalized Immunosuppression in Transplantation. Elsevier; 2016. pp. 153-76. [DOI: 10.1016/b978-0-12-800885-0.00007-2] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
537 Halfon P, Bourliere M, Deydier R, Botta-fridlund D, Renou C, Tran A, Portal I, Allemand I, Bertrand JJ, Rosenthal-allieri A, Rotily M, Sattonet C, Benderitter T, Paul MCS, Bonnot HP, Penaranda G, Degott C, Masseyeff MF, Ouzan D. Independent Prospective Multicenter Validation of Biochemical Markers (Fibrotest-Actitest) for the Prediction of Liver Fibrosis and Activity in Patients with Chronic Hepatitis C: The Fibropaca Study. Am J Gastroenterology 2006;101:547-55. [DOI: 10.1111/j.1572-0241.2006.00411.x] [Cited by in Crossref: 98] [Cited by in F6Publishing: 99] [Article Influence: 6.5] [Reference Citation Analysis]
538 Li J, Wang D, Chen TW, Xie F, Li R, Zhang XM, Jing ZL, Yang JQ, Ou J, Cao JM. Magnetic Resonance Diffusion Kurtosis Imaging for Evaluating Stage of Liver Fibrosis in a Rabbit Model. Acad Radiol 2019;26:e90-7. [PMID: 30072289 DOI: 10.1016/j.acra.2018.06.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
539 Rhodes FA, Trembling P, Panovska-Griffiths J, Tanwar S, Westbrook RH, Rodger A, Rosenberg WM. Systematic review: Investigating the prognostic performance of four non-invasive tests in alcohol-related liver disease. J Gastroenterol Hepatol 2021;36:1435-49. [PMID: 33171534 DOI: 10.1111/jgh.15335] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
540 Castéra L, Bernard PH, Le Bail B, Foucher J, Trimoulet P, Merrouche W, Couzigou P, de Lédinghen V. Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers. Aliment Pharmacol Ther. 2011;33:455-465. [PMID: 21235598 DOI: 10.1111/j.1365-2036.2010.04547.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 5.8] [Reference Citation Analysis]
541 Baba M, Furuya K, Bandou H, Kasai K, Sadaoka K. Discrimination of individuals in a general population at high-risk for alcoholic and non-alcoholic fatty liver disease based on liver stiffness: a cross section study. BMC Gastroenterol. 2011;11:70. [PMID: 21669003 DOI: 10.1186/1471-230x-11-70] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
542 Omran MM, Farid K, Emran TM, Attallah AA. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients. Arab J Gastroenterol. 2011;12:74-79. [PMID: 21684477 DOI: 10.1016/j.ajg.2011.04.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
543 Bortolotti F, Guido M. Reversal of liver cirrhosis: a desirable clinical outcome and its pathogenic background. J Pediatr Gastroenterol Nutr. 2007;44:401-406. [PMID: 17414134 DOI: 10.1097/mpg.0b013e318032069a] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
544 Hashem AM, Rasmy MEM, Wahba KM, Shaker OG. Single stage and multistage classification models for the prediction of liver fibrosis degree in patients with chronic hepatitis C infection. Computer Methods and Programs in Biomedicine 2012;105:194-209. [DOI: 10.1016/j.cmpb.2011.10.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
545 Ichikawa S, Motosugi U, Morisaka H, Sano K, Ichikawa T, Tatsumi A, Enomoto N, Matsuda M, Fujii H, Onishi H. Comparison of the diagnostic accuracies of magnetic resonance elastography and transient elastography for hepatic fibrosis. Magn Reson Imaging. 2015;33:26-30. [PMID: 25308096 DOI: 10.1016/j.mri.2014.10.003] [Cited by in Crossref: 68] [Cited by in F6Publishing: 51] [Article Influence: 9.7] [Reference Citation Analysis]
546 Menter A, Gelfand JM, Connor C, Armstrong AW, Cordoro KM, Davis DMR, Elewski BE, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kiselica M, Kivelevitch D, Korman NJ, Kroshinsky D, Lebwohl M, Leonardi CL, Lichten J, Lim HW, Mehta NN, Paller AS, Parra SL, Pathy AL, Prater EF, Rahimi RS, Rupani RN, Siegel M, Stoff B, Strober BE, Tapper EB, Wong EB, Wu JJ, Hariharan V, Elmets CA. Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies. J Am Acad Dermatol 2020;82:1445-86. [PMID: 32119894 DOI: 10.1016/j.jaad.2020.02.044] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 37.0] [Reference Citation Analysis]
547 Kelleher TB, Afdhal N. Assessment of liver fibrosis in co-infected patients. J Hepatol 2006;44:S126-31. [PMID: 16352364 DOI: 10.1016/j.jhep.2005.11.026] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
548 Nagamani SCS, Ali S, Izem R, Schady D, Masand P, Shneider BL, Leung DH, Burrage LC. Biomarkers for liver disease in urea cycle disorders. Mol Genet Metab 2021;133:148-56. [PMID: 33846069 DOI: 10.1016/j.ymgme.2021.04.001] [Reference Citation Analysis]
549 Poynard T, Imbert-bismut F, Munteanu M, Messous D, Thabut D, Ratziu V, Benhamou Y. Biomarkers as non-invasive assessment of hepatic fibrosis in chronic hepatitis C. J Gastroenterol Hepatol 2004;19:S236-45. [DOI: 10.1111/j.1440-1746.2004.03680.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
550 Ho MC, Lin JJ, Shu YC, Chen CN, Chang KJ, Chang CC, Tsui PH. Using ultrasound Nakagami imaging to assess liver fibrosis in rats. Ultrasonics 2012;52:215-22. [PMID: 21907377 DOI: 10.1016/j.ultras.2011.08.005] [Cited by in Crossref: 49] [Cited by in F6Publishing: 37] [Article Influence: 4.9] [Reference Citation Analysis]
551 Khan RS, Houlihan DD, Newsome PN. Investigation of jaundice. Medicine 2019;47:713-7. [DOI: 10.1016/j.mpmed.2019.08.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
552 He Y, Yan Y, Zhang S. Quantitative liver surface nodularity score based on imaging for assessment of early cirrhosis in patients with chronic liver disease: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e23636. [PMID: 33530167 DOI: 10.1097/MD.0000000000023636] [Reference Citation Analysis]
553 Parkes J, Guha IN, Roderick P, Harris S, Cross R, Manos MM, Irving W, Zaitoun A, Wheatley M, Ryder S. Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C. J Viral Hepat. 2011;18:23-31. [PMID: 20196799 DOI: 10.1111/j.1365-2893.2009.01263.x] [Cited by in Crossref: 108] [Cited by in F6Publishing: 109] [Article Influence: 10.8] [Reference Citation Analysis]
554 Kalantari H, Hoseini H, Babak A, Yaran M. Validation of hepascore as a predictor of liver fibrosis in patients with chronic hepatitis C infection. Hepat Res Treat. 2011;2011:972759. [PMID: 22254137 DOI: 10.1155/2011/972759] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
555 Jiang Z, Yamauchi K, Yoshioka K, Aoki K, Kuroyanagi S, Iwata A, Yang J, Wang K. Support Vector Machine-Based Feature Selection for Classification of Liver Fibrosis Grade in Chronic Hepatitis C. J Med Syst 2006;30:389-94. [DOI: 10.1007/s10916-006-9023-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
556 Kelleher TB, Mehta SH, Bhaskar R, Sulkowski M, Astemborski J, Thomas DL, Moore RE, Afdhal NH. Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index. J Hepatol. 2005;43:78-84. [PMID: 15894397 DOI: 10.1016/j.jhep.2005.02.025] [Cited by in Crossref: 153] [Cited by in F6Publishing: 133] [Article Influence: 9.6] [Reference Citation Analysis]
557 Singh S, Venkatesh SK, Wang Z, Miller FH, Motosugi U, Low RN, Hassanein T, Asbach P, Godfrey EM, Yin M, Chen J, Keaveny AP, Bridges M, Bohte A, Murad MH, Lomas DJ, Talwalkar JA, Ehman RL. Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. Clin Gastroenterol Hepatol 2015; 13: 440-451. e6. [PMID: 25305349 DOI: 10.1016/j.cgh.2014.09.046] [Cited by in Crossref: 288] [Cited by in F6Publishing: 255] [Article Influence: 41.1] [Reference Citation Analysis]
558 Castera L. Non-invasive assessment of liver fibrosis in chronic hepatitis C. Hepatol Int. 2011;5:625-634. [PMID: 21484142 DOI: 10.1007/s12072-010-9240-0] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 4.7] [Reference Citation Analysis]
559 Williams MJ, Lawson A, Neal KR, Ryder SD, Irving WL. Autoantibodies in chronic hepatitis C virus infection and their association with disease profile. J Viral Hepat. 2009;16:325-331. [PMID: 19302340 DOI: 10.1111/j.1365-2893.2008.01035.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
560 Sebastiani G, Alberti A. Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy. World J Gastroenterol 2006; 12(23): 3682-3694 [PMID: 16773685 DOI: 10.3748/wjg.v12.i23.3682] [Cited by in CrossRef: 174] [Cited by in F6Publishing: 165] [Article Influence: 11.6] [Reference Citation Analysis]
561 Friedrich-rust M, Hadji-hosseini H, Kriener S, Herrmann E, Sircar I, Kau A, Zeuzem S, Bojunga J. Transient elastography with a new probe for obese patients for non-invasive staging of non-alcoholic steatohepatitis. Eur Radiol 2010;20:2390-6. [DOI: 10.1007/s00330-010-1820-9] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 6.4] [Reference Citation Analysis]
562 Wang HM, Hung CH, Lu SN, Chen CH, Lee CM, Hu TH, Wang JH. Liver stiffness measurement as an alternative to fibrotic stage in risk assessment of hepatocellular carcinoma incidence for chronic hepatitis C patients. Liver Int. 2013;33:756-761. [PMID: 23405889 DOI: 10.1111/liv.12118] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 4.9] [Reference Citation Analysis]
563 Schütz E, Fischer A, Beck J, Harden M, Koch M, Wuensch T, Stockmann M, Nashan B, Kollmar O, Matthaei J, Kanzow P, Walson PD, Brockmöller J, Oellerich M. Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicenter cohort study. PLoS Med 2017;14:e1002286. [PMID: 28441386 DOI: 10.1371/journal.pmed.1002286] [Cited by in Crossref: 82] [Cited by in F6Publishing: 77] [Article Influence: 20.5] [Reference Citation Analysis]
564 Yu H, Buch K, Li B, O'brien M, Soto J, Jara H, Anderson SW. Utility of texture analysis for quantifying hepatic fibrosis on proton density MRI: Hepatic Fibrosis on Proton Density MRI. J Magn Reson Imaging 2015;42:1259-65. [DOI: 10.1002/jmri.24898] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
565 Li J, Zhang TY, Song LW, Qi X, Yu XP, Li FH, Zhou P, Qin YL, Yang L, Zhao JH, Mao RC, Zhang YM, Wang JY, Yang FF, Zhu HX, Yang SS, Huang YX, Yuan Q, Zhang J, Zhang JM, Xia NS. Role of quantitative hepatitis B core antibody levels in predicting significant liver inflammation in chronic hepatitis B patients with normal or near-normal alanine aminotransferase levels. Hepatol Res 2018;48:E133-45. [PMID: 28707778 DOI: 10.1111/hepr.12937] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
566 Kim JE, Lee JY, Kim YJ, Yoon JH, Kim SH, Lee JM, Han JK, Choi BI. Acoustic radiation force impulse elastography for chronic liver disease: comparison with ultrasound-based scores of experienced radiologists, Child-Pugh scores and liver function tests. Ultrasound Med Biol. 2010;36:1637-1643. [PMID: 20800940 DOI: 10.1016/j.ultrasmedbio.2010.07.016] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
567 Masuzaki R, Tateishi R, Yoshida H, Goto E, Sato T, Ohki T, Goto T, Yoshida H, Kanai F, Sugioka Y, Ikeda H, Shiina S, Kawabe T, Omata M. Comparison of liver biopsy and transient elastography based on clinical relevance. Can J Gastroenterol 2008;22:753-7. [PMID: 18818788 DOI: 10.1155/2008/306726] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
568 Bedossa P, Paradis V, Zucman-rossi J. Cellular and Molecular Techniques. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 88-110. [DOI: 10.1016/b978-0-7020-6697-9.00002-9] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
569 Searle J, Mendelson R, Zelesco M, Sanford J, Cheng W, McKinstry C, Ramsay D. Non-invasive prediction of the degree of liver fibrosis in patients with hepatitis C using an ultrasound contrast agent. A pilot study. J Med Imaging Radiat Oncol. 2008;52:130-133. [PMID: 18373803 DOI: 10.1111/j.1440-1673.2008.01930.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
570 Vanderschaeghe D, Laroy W, Sablon E, Halfon P, Van Hecke A, Delanghe J, Callewaert N. GlycoFibroTest is a highly performant liver fibrosis biomarker derived from DNA sequencer-based serum protein glycomics. Mol Cell Proteomics. 2009;8:986-994. [PMID: 19181623 DOI: 10.1074/mcp.m800470-mcp200] [Cited by in Crossref: 89] [Cited by in F6Publishing: 42] [Article Influence: 7.4] [Reference Citation Analysis]
571 Kim MS, Kim BI, Kwon H, Park HW, Park H, Bang KB, Hong HP, Rho MH. Discordance between conventional ultrasonography and ElastPQ for assessing hepatic fibrosis in chronic hepatitis B: frequency and independent factors. J Med Ultrasonics 2016;43:201-10. [DOI: 10.1007/s10396-015-0684-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
572 Cardoso AC, Carvalho-Filho RJ, Stern C, Dipumpo A, Giuily N, Ripault MP, Asselah T, Boyer N, Lada O, Castelnau C, Martinot-Peignoux M, Valla DC, Bedossa P, Marcellin P. Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C. Liver Int. 2012;32:612-621. [PMID: 22103765 DOI: 10.1111/j.1478-3231.2011.02660.x] [Cited by in Crossref: 97] [Cited by in F6Publishing: 95] [Article Influence: 9.7] [Reference Citation Analysis]
573 Sánchez-Conde M, Montes Ramírez ML, Bellón Cano JM, Caminoa A, Alvarez Rodríguez F, González Garcia J, Miralles Martín P, Bernardino de la Serna I, Bernardo de Quirós JC, Arribas López JR, Cosín Ochaíta J, Pascual Pareja JF, Alvarez E, Berenguer JB. Impact of liver steatosis on the correlation between liver stiffness and fibrosis measured by transient elastography in patients coinfected with human immunodeficiency virus and hepatitis C virus. J Viral Hepat 2011;18:e278-83. [PMID: 21129129 DOI: 10.1111/j.1365-2893.2010.01407.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
574 Adhoute X, Foucher J, Laharie D, Terrebonne E, Vergniol J, Castéra L, Lovato B, Chanteloup E, Merrouche W, Couzigou P. Diagnosis of liver fibrosis using FibroScan and other noninvasive methods in patients with hemochromatosis: a prospective study. Gastroenterol Clin Biol. 2008;32:180-187. [PMID: 18496894 DOI: 10.1016/j.gcb.2007.12.021] [Cited by in Crossref: 62] [Cited by in F6Publishing: 47] [Article Influence: 4.8] [Reference Citation Analysis]
575 Yoshioka K, Hashimoto S. Can non-invasive assessment of liver fibrosis replace liver biopsy? Hepatol Res 2012;42:233-40. [PMID: 22151829 DOI: 10.1111/j.1872-034X.2011.00928.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
576 Wang C, Zhang X, Liu X, He T, Chen W, Feng Q, Feng Y. Improved liver R2* mapping by pixel-wise curve fitting with adaptive neighborhood regularization: R * 2 Mapping With Adaptive Neighborhood Information. Magn Reson Med 2018;80:792-801. [DOI: 10.1002/mrm.27071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
577 Mangus RS, O'Connor MG, Tector AJ, Lim JD, Vianna RM. Use of the aspartate aminotransferase to platelet ratio index to follow liver fibrosis progression in infants with short gut. J Pediatr Surg 2010;45:1266-73. [PMID: 20620330 DOI: 10.1016/j.jpedsurg.2010.02.098] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
578 Zhang DK, Chen M, Liu Y, Wang RF, Liu LP, Li M. Acoustic radiation force impulse elastography for non-invasive assessment of disease stage in patients with primary biliary cirrhosis: A preliminary study. Clin Radiol. 2014;69:836-840. [PMID: 24837697 DOI: 10.1016/j.crad.2014.03.019] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
579 Jin N, Deng J, Chadashvili T, Zhang Y, Guo Y, Zhang Z, Yang GY, Omary RA, Larson AC. Carbogen gas-challenge BOLD MR imaging in a rat model of diethylnitrosamine-induced liver fibrosis. Radiology. 2010;254:129-137. [PMID: 20032147 DOI: 10.1148/radiol.09090410] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
580 Guo Y, Parthasarathy S, Goyal P, McCarthy RJ, Larson AC, Miller FH. Magnetic resonance elastography and acoustic radiation force impulse for staging hepatic fibrosis: a meta-analysis. Abdom Imaging. 2015;40:818-834. [PMID: 24711064 DOI: 10.1007/s00261-014-0137-6] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 8.3] [Reference Citation Analysis]
581 Fontana RJ, Everson GT, Tuteja S, Vargas HE, Shiffman ML. Controversies in the management of hepatitis C patients with advanced fibrosis and cirrhosis. Clinical Gastroenterology and Hepatology 2004;2:183-97. [DOI: 10.1016/s1542-3565(04)00002-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
582 Uto H, Mawatari S, Kumagai K, Ido A, Tsubouchi H. Clinical Features of Hepatitis C Virus Carriers With Persistently normal Alanine Aminotransferase Levels. Hepat Mon 2012;12:77-84. [DOI: 10.5812/hepatmon.4851] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
583 Karanjia RN, Crossey MME, Cox IJ, Fye HKS, Njie R, Goldin RD, Taylor-Robinson SD. Hepatic steatosis and fibrosis: Non-invasive assessment. World J Gastroenterol 2016; 22(45): 9880-9897 [PMID: 28018096 DOI: 10.3748/wjg.v22.i45.9880] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 25] [Article Influence: 5.4] [Reference Citation Analysis]
584 Peters MG, Bacchetti P, Boylan R, French AL, Tien PC, Plankey MW, Glesby MJ, Augenbraun M, Golub ET, Karim R, Parkes J, Rosenberg W. Enhanced liver fibrosis marker as a noninvasive predictor of mortality in HIV/hepatitis C virus-coinfected women from a multicenter study of women with or at risk for HIV. AIDS 2016;30:723-9. [PMID: 26595542 DOI: 10.1097/QAD.0000000000000975] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
585 Calle-toro JS, Barrera CA, Khrichenko D, Otero HJ, Serai SD. R2 relaxometry based MR imaging for estimation of liver iron content: A comparison between two methods. Abdom Radiol 2019;44:3058-68. [DOI: 10.1007/s00261-019-02074-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
586 Liao B, Wang Z, Lin S, Xu Y, Yi J, Xu M, Huang Z, Zhou Y, Zhang F, Hou J. Significant fibrosis is not rare in Chinese chronic hepatitis B patients with persistent normal ALT. PLoS One 2013;8:e78672. [PMID: 24205292 DOI: 10.1371/journal.pone.0078672] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
587 Hadefi A, Degré D, Trépo E, Moreno C. Noninvasive diagnosis in alcohol-related liver disease. Health Sci Rep 2020;3:e146. [PMID: 32166191 DOI: 10.1002/hsr2.146] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
588 Zhou J, Song L, Zhao H, Yan L, Ma A, Xie S, Zhang X, Zhang D, Xie Q, Zhang G, Shang J, Cheng J, Zhao W, Zou Z, Zhang M, Xia N, Wang G. Serum hepatitis B core antibody as a biomarker of hepatic inflammation in chronic hepatitis B patients with normal alanine aminotransferase. Sci Rep 2017;7:2747. [PMID: 28584279 DOI: 10.1038/s41598-017-03102-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
589 Goh SK, Muralidharan V, Christophi C, Do H, Dobrovic A. Probe-Free Digital PCR Quantitative Methodology to Measure Donor-Specific Cell-Free DNA after Solid-Organ Transplantation. Clin Chem. 2017;63:742-750. [PMID: 28100495 DOI: 10.1373/clinchem.2016.264838] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
590 Vallet-pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-venier V, Fontaine H, Pol S. FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology 2007;46:32-6. [DOI: 10.1002/hep.21669] [Cited by in Crossref: 1026] [Cited by in F6Publishing: 986] [Article Influence: 73.3] [Reference Citation Analysis]
591 Hannivoort RA, Hernandez-Gea V, Friedman SL. Genomics and proteomics in liver fibrosis and cirrhosis. Fibrogenesis Tissue Repair 2012;5:1. [PMID: 22214245 DOI: 10.1186/1755-1536-5-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
592 McIlroy D, Théodorou I, Ratziu V, Vidaud D, Pellet P, Debré P, Poynard T. FAS promoter polymorphisms correlate with activity grade in hepatitis C patients. Eur J Gastroenterol Hepatol 2005;17:1081-8. [PMID: 16148554 DOI: 10.1097/00042737-200510000-00012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
593 Henkel C, Schwamborn K, Zimmermann HW, Tacke F, Kühnen E, Odenthal M, Groseclose MR, Caprioli RM, Weiskirchen R. From proteomic multimarker profiling to interesting proteins: thymosin-β(4) and kininogen-1 as new potential biomarkers for inflammatory hepatic lesions. J Cell Mol Med 2011;15:2176-88. [PMID: 21496200 DOI: 10.1111/j.1582-4934.2010.01204.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
594 Miyoshi T, Hamaguchi M, Kitagawa N, Hashimoto Y, Fukui M. Correlation between Liver Stiffness by Two-Dimensional Shear Wave Elastography and Waist Circumference in Japanese Local Citizens with Abdominal Obesity. J Clin Med 2021;10:1971. [PMID: 34064337 DOI: 10.3390/jcm10091971] [Reference Citation Analysis]
595 Zarski J, Bedossa P, Bronowicki J, Doffoel M, Poynard T. Utilisation des marqueurs non invasifs de fibrose dans la prise en charge de l’hépatite C. Gastroentérologie Clinique et Biologique 2007;31:34-9. [DOI: 10.1016/s0399-8320(07)92561-0] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
596 Tural C, Tor J, Sanvisens A, Pérez-Alvarez N, Martínez E, Ojanguren I, García-Samaniego J, Rockstroh J, Barluenga E, Muga R, Planas R, Sirera G, Rey-Joly C, Clotet B. Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency virus and hepatitis C virus. Clin Gastroenterol Hepatol 2009;7:339-45. [PMID: 19171202 DOI: 10.1016/j.cgh.2008.11.019] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
597 Chow AM, Tan M, Gao DS, Fan SJ, Cheung JS, Man K, Lu ZR, Wu EX. Molecular MRI of liver fibrosis by a peptide-targeted contrast agent in an experimental mouse model. Invest Radiol 2013;48:46-54. [PMID: 23192162 DOI: 10.1097/RLI.0b013e3182749c0b] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
598 Denk H. What is expected from the pathologist in the diagnosis of viral hepatitis? Virchows Arch 2011;458:377-92. [PMID: 21359546 DOI: 10.1007/s00428-011-1057-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
599 Cross T, Antoniades C, Harrison P. Non-invasive markers for the prediction of fibrosis in chronic hepatitis C infection. Hepatol Res 2008;38:762-9. [PMID: 18462378 DOI: 10.1111/j.1872-034X.2008.00364.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
600 Yin M, Glaser KJ, Talwalkar JA, Chen J, Manduca A, Ehman RL. Hepatic MR Elastography: Clinical Performance in a Series of 1377 Consecutive Examinations. Radiology. 2016;278:114-124. [PMID: 26162026 DOI: 10.1148/radiol.2015142141] [Cited by in Crossref: 156] [Cited by in F6Publishing: 137] [Article Influence: 26.0] [Reference Citation Analysis]
601 Wang J, Xia J, Yan X, Yang Y, Wei J, Xiong Y, Wu W, Liu Y, Chen Y, Jia B, Chen Z, Zhang Z, Ding W, Huang R, Wu C. The gamma-glutamyl transpeptidase to platelet ratio predicts liver inflammation in chronic hepatitis B with normal or mildly elevated alanine transaminase. Clin Res Hepatol Gastroenterol 2020;44:913-22. [PMID: 32147439 DOI: 10.1016/j.clinre.2020.01.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
602 Wang C, Liu C, Lin C, Wang P, Tseng T, Lin HH, Kao J. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients. Journal of the Formosan Medical Association 2015;114:923-8. [DOI: 10.1016/j.jfma.2015.07.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
603 Vicas C, Lupsor M, Socaciu M, Nedevschi S, Badea R. Influence of expert-dependent variability over the performance of noninvasive fibrosis assessment in patients with chronic hepatitis C by means of texture analysis. Comput Math Methods Med. 2012;2012:346713. [PMID: 22229041 DOI: 10.1155/2012/346713] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
604 Kang B, Lee SS, Cheong H, Hong SM, Jang K, Lee M. Shear Wave Elastography for Assessment of Steatohepatitis and Hepatic Fibrosis in Rat Models of Non-Alcoholic Fatty Liver Disease. Ultrasound in Medicine & Biology 2015;41:3205-15. [DOI: 10.1016/j.ultrasmedbio.2015.07.025] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
605 Catanzaro R, Milazzo M, Arona S, Sapienza C, Vasta D, Arcoria D, Marotta F. Diagnostic accuracy of enhanced liver fibrosis test to assess liver fibrosis in patients with chronic hepatitis C. Hepatobiliary Pancreat Dis Int. 2013;12:500-507. [PMID: 24103280 DOI: 10.1016/s1499-3872(13)60079-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
606 Lee SM, Lee JM, Kang HJ, Yang HK, Yoon JH, Chang W, An SJ, Lee KB, Baek SY. Liver fibrosis staging with a new 2D-shear wave elastography using comb-push technique: Applicability, reproducibility, and diagnostic performance. PLoS One 2017;12:e0177264. [PMID: 28510583 DOI: 10.1371/journal.pone.0177264] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 4.8] [Reference Citation Analysis]
607 Catanzaro R, Sciuto M, Lanzafame C, Balakrishnan B, Marotta F. Platelet to lymphocyte ratio as a predictive biomarker of liver fibrosis (on elastography) in patients with hepatitis C virus (HCV)-related liver disease. Indian J Gastroenterol 2020;39:253-60. [PMID: 32833144 DOI: 10.1007/s12664-020-01038-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
608 Li Q, Lu C, Li W, Huang Y, Chen L. The gamma-glutamyl transpeptidase-to-albumin ratio predicts significant fibrosis and cirrhosis in chronic hepatitis B patients. J Viral Hepat 2017;24:1143-50. [PMID: 28685907 DOI: 10.1111/jvh.12751] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
609 Cobbold JF, Patel D, Fitzpatrick JA, Patel N, Crossey MM, Abdalla MS, Goldin RD, Vennart W, Thomas HC, Taylor-Robinson SD. Accuracy and reliability of microbubble ultrasound measurements for the non-invasive assessment of hepatic fibrosis in chronic hepatitis C. Hepatol Res. 2012;42:515-522. [PMID: 22502745 DOI: 10.1111/j.1872-034x.2011.00948.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
610 Tang A, Desai A, Hamilton G, Wolfson T, Gamst A, Lam J, Clark L, Hooker J, Chavez T, Ang BD, Middleton MS, Peterson M, Loomba R, Sirlin CB. Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology 2015;274:416-25. [PMID: 25247408 DOI: 10.1148/radiol.14140754] [Cited by in Crossref: 131] [Cited by in F6Publishing: 117] [Article Influence: 18.7] [Reference Citation Analysis]
611 Wang H, Wang J, Huang R, Xia J, Zuo L, Yan X, Yang Y, Wu C. Red blood cell distribution width for predicting significant liver inflammation in patients with autoimmune hepatitis. Eur J Gastroenterol Hepatol 2019;31:1527-32. [PMID: 31107736 DOI: 10.1097/MEG.0000000000001447] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
612 Anastasiou J, Alisa A, Virtue S, Portmann B, Murray-lyon I, Williams R. Noninvasive markers of fibrosis and inflammation in clinical practice: prospective comparison with liver biopsy. European Journal of Gastroenterology & Hepatology 2010;22:474-80. [DOI: 10.1097/meg.0b013e328332dd0a] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
613 Marasco G, Colecchia A, Silva G, Rossini B, Eusebi LH, Ravaioli F, Dajti E, Alemanni LV, Colecchia L, Renzulli M, Golfieri R, Festi D. Non-invasive tests for the prediction of primary hepatocellular carcinoma. World J Gastroenterol 2020; 26(24): 3326-3343 [PMID: 32655261 DOI: 10.3748/wjg.v26.i24.3326] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
614 Nakagomi R, Tateishi R, Masuzaki R, Soroida Y, Iwai T, Kondo M, Fujiwara N, Sato M, Minami T, Uchino K, Enooku K, Nakagawa H, Asaoka Y, Kondo Y, Tanaka Y, Otsuka M, Kato N, Moriya K, Ikeda H, Koike K. Liver stiffness measurements in chronic hepatitis C: Treatment evaluation and risk assessment. J Gastroenterol Hepatol. 2019;34:921-928. [PMID: 30393960 DOI: 10.1111/jgh.14530] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
615 Soto M, Sampietro-Colom L, Lasalvia L, Mira A, Jiménez W, Navasa M. Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients. World J Gastroenterol 2017; 23(17): 3163-3173 [PMID: 28533673 DOI: 10.3748/wjg.v23.i17.3163] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
616 Aubé C, Bazeries P, Lebigot J, Cartier V, Boursier J. Liver fibrosis, cirrhosis, and cirrhosis-related nodules: Imaging diagnosis and surveillance. Diagnostic and Interventional Imaging 2017;98:455-68. [DOI: 10.1016/j.diii.2017.03.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
617 Venkatesh SK, Wang G, Lim SG, Wee A. Magnetic resonance elastography for the detection and staging of liver fibrosis in chronic hepatitis B. Eur Radiol. 2014;24:70-78. [PMID: 23928932 DOI: 10.1007/s00330-013-2978-8] [Cited by in Crossref: 111] [Cited by in F6Publishing: 106] [Article Influence: 13.9] [Reference Citation Analysis]
618 Chan J, Gogela N, Zheng H, Lammert S, Ajayi T, Fricker Z, Kim AY, Robbins GK, Chung RT. Direct-Acting Antiviral Therapy for Chronic HCV Infection Results in Liver Stiffness Regression Over 12 Months Post-treatment. Dig Dis Sci 2018;63:486-92. [PMID: 28887750 DOI: 10.1007/s10620-017-4749-x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 9.5] [Reference Citation Analysis]
619 Omran D, Yosry A, Darweesh SK, Nabeel MM, El-Beshlawey M, Saif S, Fared A, Hassany M, Zayed RA. Enhanced liver fibrosis test using ELISA assay accurately discriminates advanced stage of liver fibrosis as determined by transient elastography fibroscan in treatment naïve chronic HCV patients. Clin Exp Med 2018;18:45-50. [PMID: 28567544 DOI: 10.1007/s10238-017-0463-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
620 Nunes D, Fleming C, Offner G, Craven D, Fix O, Heeren T, Koziel MJ, Graham C, Tumilty S, Skolnik P, Stuver S, Horsburgh RC, Cotton D. Noninvasive Markers of Liver Fibrosis Are Highly Predictive of Liver-Related Death in a Cohort of HCV-Infected Individuals With and Without HIV Infection. American Journal of Gastroenterology 2010;105:1346-53. [DOI: 10.1038/ajg.2009.746] [Cited by in Crossref: 111] [Cited by in F6Publishing: 100] [Article Influence: 10.1] [Reference Citation Analysis]
621 Neuman MG, Cohen LB, Nanau RM. Hyaluronic acid as a non-invasive biomarker of liver fibrosis. Clin Biochem. 2016;49:302-315. [PMID: 26188920 DOI: 10.1016/j.clinbiochem.2015.07.019] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 7.7] [Reference Citation Analysis]
622 Salameh N, Peeters F, Sinkus R, Abarca-quinones J, Annet L, ter Beek LC, Leclercq I, Van Beers BE. Hepatic viscoelastic parameters measured with MR elastography: Correlations with quantitative analysis of liver fibrosis in the rat. J Magn Reson Imaging 2007;26:956-62. [DOI: 10.1002/jmri.21099] [Cited by in Crossref: 68] [Cited by in F6Publishing: 52] [Article Influence: 4.9] [Reference Citation Analysis]
623 Wibmer A, Nolz R, Trauner M, Ba-Ssalamah A. [Functional MR imaging of the liver]. Radiologe. 2015;55:1057-1066. [PMID: 26610680 DOI: 10.1007/s00117-015-0032-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
624 Li Y, Chen Y, Zhao Y. The diagnostic value of the FIB-4 index for staging hepatitis B-related fibrosis: a meta-analysis. PLoS One. 2014;9:e105728. [PMID: 25165830 DOI: 10.1371/journal.pone.0105728] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 6.1] [Reference Citation Analysis]
625 Dhingra S, Ward SC, Thung SN. Liver pathology of hepatitis C, beyond grading and staging of the disease. World J Gastroenterol 2016; 22(4): 1357-1366 [PMID: 26819505 DOI: 10.3748/wjg.v22.i4.1357] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
626 Sánchez-Conde M, Montes-Ramírez ML, Miralles P, Alvarez JM, Bellón JM, Ramírez M, Arribas JR, Gutiérrez I, López JC, Cosín J. Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers. J Viral Hepat. 2010;17:280-286. [PMID: 19732322 DOI: 10.1111/j.1365-2893.2009.01180.x] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 6.4] [Reference Citation Analysis]
627 Fung SK, Lok AS. Viral hepatitis in 2003. Curr Opin Gastroenterol 2004;20:241-7. [PMID: 15703648 DOI: 10.1097/00001574-200405000-00008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
628 Tomeno W, Yoneda M, Imajo K, Suzuki K, Ogawa Y, Shinohara Y, Mawatari H, Fujita K, Shibata W, Kirikoshi H, Maeda S, Nakajima A, Saito S. Evaluation of the Liver Fibrosis Index calculated by using real-time tissue elastography for the non-invasive assessment of liver fibrosis in chronic liver diseases. Hepatol Res. 2013;43:735-742. [PMID: 23216963 DOI: 10.1111/hepr.12023] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
629 Shiha G, Seif S, Maher M, Etreby S, Samir W, Zalata K. Comparison between transient elastography (Fibroscan) and liver biopsy for the diagnosis of hepatic fibrosis in chronic hepatitis C genotype 4: . Egyptian Liver Journal 2014;4:106-11. [DOI: 10.1097/01.elx.0000454686.81811.1a] [Cited by in Crossref: 6] [Article Influence: 0.9] [Reference Citation Analysis]
630 Suk KT, Kim DJ, Kim CH, Park SH, Cheong JY, Cho SW, Choi JY, Han KH, Sung HT, Hong SH. Diagnostic accuracy of biomarkers measured in the hepatic vein and peripheral vein in the prediction of advanced fibrosis in patients with chronic viral hepatitis. Clin Biochem. 2012;45:1075-1080. [PMID: 22579966 DOI: 10.1016/j.clinbiochem.2012.04.031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
631 Tanwar S, Trembling PM, Hogan BJ, Srivastava A, Parkes J, Harris S, Grant P, Nastouli E, Ocker M, Wehr K, Herold C, Neureiter D, Schuppan D, Rosenberg WM. Noninvasive markers of liver fibrosis: on-treatment changes of serum markers predict the outcome of antifibrotic therapy. European Journal of Gastroenterology & Hepatology 2017;29:289-96. [DOI: 10.1097/meg.0000000000000789] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
632 Wu WP, Chou CT, Chen RC, Lee CW, Lee KW, Wu HK. Non-Invasive Evaluation of Hepatic Fibrosis: The Diagnostic Performance of Magnetic Resonance Elastography in Patients with Viral Hepatitis B or C. PLoS One. 2015;10:e0140068. [PMID: 26469342 DOI: 10.1371/journal.pone.0140068] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
633 Sogawa K, Noda K, Umemura H, Seimiya M, Kuga T, Tomonaga T, Nishimura M, Kanai F, Imazeki F, Takizawa H. Serum fibrinogen alpha C-chain 5.9 kDa fragment as a biomarker for early detection of hepatic fibrosis related to hepatitis C virus. Proteomics Clin Appl. 2013;7:424-431. [PMID: 23382097 DOI: 10.1002/prca.201200094] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
634 Huang Y, Wang Z, Liao B, Liang JY, Zhou LY, Wang F, Li W, Liu JY, Xie XY, Lu MD. Assessment of liver fibrosis in chronic hepatitis B using acoustic structure quantification: quantitative morphological ultrasound. Eur Radiol. 2016;26:2344-2351. [PMID: 26486937 DOI: 10.1007/s00330-015-4056-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
635 Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115:209-218. [PMID: 15690074 DOI: 10.1172/jci24282] [Cited by in Crossref: 3033] [Cited by in F6Publishing: 1557] [Article Influence: 189.6] [Reference Citation Analysis]
636 Nguyen D, Talwalkar JA. Noninvasive assessment of liver fibrosis. Hepatology 2011;53:2107-10. [DOI: 10.1002/hep.24401] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 4.7] [Reference Citation Analysis]
637 Treacher A, Beauchamp D, Quadri B, Fetzer D, Vij A, Yokoo T, Montillo A. Deep Learning Convolutional Neural Networks for the Estimation of Liver Fibrosis Severity from Ultrasound Texture. Proc SPIE Int Soc Opt Eng 2019;10950:109503E. [PMID: 31741550 DOI: 10.1117/12.2512592] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
638 Jang HJ, Min JH, Lee JE, Shin KS, Kim K, Choi S. Assessment of liver fibrosis with gadoxetic acid-enhanced MRI: comparisons with transient elastography, ElastPQ, and serologic fibrosis markers. Abdom Radiol 2019;44:2769-80. [DOI: 10.1007/s00261-019-02041-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
639 Choong CC, Venkatesh SK, Siew EP. Accuracy of routine clinical ultrasound for staging of liver fibrosis. J Clin Imaging Sci 2012;2:58. [PMID: 23230540 DOI: 10.4103/2156-7514.101000] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
640 Shaheen AAM, Wan AF, Myers RP. FibroTest and FibroScan for the Prediction of Hepatitis C-Related Fibrosis: A Systematic Review of Diagnostic Test Accuracy. Am J Gastroenterology 2007;102:2589-600. [DOI: 10.1111/j.1572-0241.2007.01466.x] [Cited by in Crossref: 233] [Cited by in F6Publishing: 220] [Article Influence: 16.6] [Reference Citation Analysis]
641 Cowan ML, Maxwell JD. Treatment of hepatitis C virus infection in intravenous drug users. Acta Neuropsychiatr 2006;18:183-92. [DOI: 10.1111/j.1601-5215.2006.00136.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
642 Schiavon LL, Carvalho-filho RJ, Narciso-schiavon JL, Pinheiro SR, Barbosa DV, Lanzoni VP, Ferraz MLG, Silva AEB. Prediction of significant liver fibrosis in kidney transplant patients with chronic hepatitis C virus infection: the TX-3 index: Prediction of liver fibrosis in HCV KT patients. Journal of Viral Hepatitis 2010;17:391-9. [DOI: 10.1111/j.1365-2893.2009.01190.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
643 Kang W, Kim SU, Ahn SH. Non-invasive prediction of forthcoming cirrhosis-related complications. World J Gastroenterol 2014; 20(10): 2613-2623 [PMID: 24627597 DOI: 10.3748/wjg.v20.i10.2613] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
644 Duan WJ, Wang XZ, Ma AL, Shang J, Nan YM, Gao ZL, Tang H, Fu QC, Xie Q, Mao Q, Niu JQ, Han T, Li J, Han Y, Cao JB, Kong YY, Shi XY, Lv FD, Wang TL, Ma H, You H, Ou XJ, Jia JD. Multicenter prospective study to validate a new transient elastography device for staging liver fibrosis in patients with chronic hepatitis B. J Dig Dis 2020;21:519-25. [PMID: 32700794 DOI: 10.1111/1751-2980.12924] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
645 Afdhal NH. Biopsy or biomarkers: is there a gold standard for diagnosis of liver fibrosis? Clin Chem. 2004;50:1299-1300. [PMID: 15277345 DOI: 10.1373/clinchem.2004.035899] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 2.4] [Reference Citation Analysis]
646 Peng SS, Jeng YM, Hsu WM, Yang JC, Ho MC. Hepatic ADC map as an adjunct to conventional abdominal MRI to evaluate hepatic fibrotic and clinical cirrhotic severity in biliary atresia patients. Eur Radiol 2015;25:2992-3002. [PMID: 25921590 DOI: 10.1007/s00330-015-3716-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
647 Jain A, Sharma R, Ryan C, Safadjou S, Kashyap R, Mantry P, Maliakkal B, Orloff M. Response to antiviral therapy in liver transplant recipients with recurrent hepatitis C viral infection: a single center experience. Clinical Transplantation 2010;24:104-11. [DOI: 10.1111/j.1399-0012.2009.00961.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
648 Guéchot J. [Noninvasive assessment of liver fibrosis in patients with chronic hepatitis virus C]. Presse Med. 2006;35:1317-1326. [PMID: 16969327 DOI: 10.1016/s0755-4982(06)74811-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
649 Kim KM, Choi WB, Park SH, Yu E, Lee SG, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ. Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy individuals: a prospective study of living related potential liver donors. J Gastroenterol. 2007;42:382-388. [PMID: 17530363 DOI: 10.1007/s00535-007-2016-1] [Cited by in Crossref: 75] [Cited by in F6Publishing: 74] [Article Influence: 5.4] [Reference Citation Analysis]
650 Huang H, Shiffman ML, Cheung RC, Layden TJ, Friedman S, Abar OT, Yee L, Chokkalingam AP, Schrodi SJ, Chan J. Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C. Gastroenterology. 2006;130:1679-1687. [PMID: 16697732 DOI: 10.1053/j.gastro.2006.02.032] [Cited by in Crossref: 91] [Cited by in F6Publishing: 85] [Article Influence: 6.1] [Reference Citation Analysis]
651 Ho SY, Liu PH, Hsu CY, Hsia CY, Lee YH, Lee RC, Huang YH, Lee FY, Hou MC, Tsai YJ, Huo TI. Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization. PLoS One. 2017;12:e0180408. [PMID: 28672011 DOI: 10.1371/journal.pone.0180408] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
652 Meng F, Zheng Y, Zhang Q, Mu X, Xu X, Zhang H, Ding L. Noninvasive evaluation of liver fibrosis using real-time tissue elastography and transient elastography (FibroScan). J Ultrasound Med. 2015;34:403-410. [PMID: 25715361 DOI: 10.7863/ultra.34.3.403] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
653 Bourliere M, Penaranda G, Renou C, Botta-Fridlund D, Tran A, Portal I, Lecomte L, Castellani P, Rosenthal-Allieri MA, Gerolami R, Ouzan D, Deydier R, Degott C, Halfon P. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies. J Viral Hepat. 2006;13:659-670. [PMID: 16970597 DOI: 10.1111/j.1365-2893.2006.00736.x] [Cited by in Crossref: 96] [Cited by in F6Publishing: 90] [Article Influence: 6.4] [Reference Citation Analysis]
654 Wells SA. Quantification of Hepatic Fat and Iron with Magnetic Resonance Imaging. Magnetic Resonance Imaging Clinics of North America 2014;22:397-416. [DOI: 10.1016/j.mric.2014.04.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
655 Zhang H, Yang H, Lai C, Xu X, Huang K, Fu J. Quantitative relationship between liver fat content and metabolic syndrome in obese children and adolescents. Clin Endocrinol (Oxf) 2015;83:43-9. [PMID: 25711346 DOI: 10.1111/cen.12758] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
656 Trang T, Petersen JR, Snyder N. Non-invasive markers of hepatic fibrosis in patients co-infected with HCV and HIV: comparison of the APRI and FIB-4 index. Clin Chim Acta. 2008;397:51-54. [PMID: 18692034 DOI: 10.1016/j.cca.2008.07.009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
657 de Lédinghen V, Vergniol J. Transient elastography for the diagnosis of liver fibrosis. Expert Rev Med Devices. 2010;7:811-823. [PMID: 21050091 DOI: 10.1586/erd.10.46] [Cited by in Crossref: 62] [Cited by in F6Publishing: 61] [Article Influence: 6.2] [Reference Citation Analysis]
658 Neuberger J, Cain O. The Need for Alternatives to Liver Biopsies: Non-Invasive Analytics and Diagnostics. Hepat Med 2021;13:59-69. [PMID: 34163263 DOI: 10.2147/HMER.S278076] [Reference Citation Analysis]
659 Iorio R, Verrico A, Giannattasio A. Is liver biopsy mandatory in children with chronic hepatitis C? World J Gastroenterol 2007; 13(29): 4025-4026 [PMID: 17663524 DOI: 10.3748/wjg.v13.i29.4025] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
660 Valva P, Casciato P, Lezama C, Galoppo M, Gadano A, Galdame O, Galoppo MC, Mullen E, De Matteo E, Preciado MV. Serum apoptosis markers related to liver damage in chronic hepatitis C: sFas as a marker of advanced fibrosis in children and adults while M30 of severe steatosis only in children. PLoS One. 2013;8:e53519. [PMID: 23326448 DOI: 10.1371/journal.pone.0053519] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
661 Adolf S, Millonig G, Seitz HK, Reiter A, Schirmacher P, Longerich T, Mueller S. Systemic mastocytosis: a rare case of increased liver stiffness. Case Reports Hepatol 2012;2012:728172. [PMID: 25374708 DOI: 10.1155/2012/728172] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
662 Denzer U, Arnoldy A, Kanzler S, Galle PR, Dienes HP, Lohse AW. Prospective randomized comparison of minilaparoscopy and percutaneous liver biopsy: diagnosis of cirrhosis and complications. J Clin Gastroenterol. 2007;41:103-110. [PMID: 17198072 DOI: 10.1097/01.mcg.0000225612.86846.82] [Cited by in Crossref: 56] [Cited by in F6Publishing: 43] [Article Influence: 4.0] [Reference Citation Analysis]
663 Millonig G, Reimann FM, Friedrich S, Fonouni H, Mehrabi A, Büchler MW, Seitz HK, Mueller S. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology 2008;48:1718-23. [DOI: 10.1002/hep.22577] [Reference Citation Analysis]
664 Rath T, Roderfeld M, Güler C, Wenzel C, Graf J, Beitinger F, Roeb E, Zachoval R. YKL-40 and transient elastography, a powerful team to assess hepatic fibrosis. Scandinavian Journal of Gastroenterology 2011;46:1369-80. [DOI: 10.3109/00365521.2011.613949] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
665 Jaffer OS, Lung PF, Bosanac D, Patel VM, Ryan SM, Heneghan MA, Quaglia A, Sidhu PS. Acoustic radiation force impulse quantification: repeatability of measurements in selected liver segments and influence of age, body mass index and liver capsule-to-box distance. Br J Radiol. 2012;85:e858-e863. [PMID: 22763032 DOI: 10.1259/bjr/74797353] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 4.8] [Reference Citation Analysis]
666 Elesawy BH, Abd El Hafez A, Dorgham LS, El-Askary A. Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoring. Pathol Res Pract. 2014;210:922-928. [PMID: 25123964 DOI: 10.1016/j.prp.2014.07.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
667 Jafari R, Hectors SJ, Koehne de González AK, Spincemaille P, Prince MR, Brittenham GM, Wang Y. Integrated quantitative susceptibility and R2 * mapping for evaluation of liver fibrosis: An ex vivo feasibility study.